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The introduction into clinical medicine and the 
subsequent wide therapeutic use of various extracts and 
alkaloids of Bauwolfia serpentina P-enth in the treatment 
of high blood pressure and certain types of mental 
disorders9 has recently aroused much interest among pharma** 
colonists, clinicians and organic chemists# The root of 
R# serpentina has been used for centuries in Indian folk 
medicine for the treatment of a wide variety of 
conditions ranging from snake bite and dysentery to 
various types of mental disorder including excitement, 
maniacal behaviour associated with psychoses, epilepsy 
and anxiety#
The us© of this drug in human hypertension has been 
a recent development# Its beneficial effects in this 
condition were first reported by Ch&kr&varty and his 
colleagues^ in 1951#
jfiauwoli'ia. is a paratropicel genus of about 130 
species2*^  consisting of shrubs and small trees#
Eauwolfia serpentina Beath (family Apoeynaceat) is a 
small erect shrub about three feet high which is indigenous 
to India, Burma, Malaya, Siam and Java#
Of /
2Of the twenty or more alkaloids which have now 
been isolated from E* serpentina, reserpine has been the 
most extensively studied from both the pharmacological 
and clinical aspects# Two recent articles2*^  review the 
available literature#
Rescinnaanine, another clinically Important alkaloid
Bauwolfia serpentina ;was isolated in 1954 by Klohe
a *5
and his colleagues^* , This compound has been 
characterised as the 3 * 4 t 5 - trimethoxycinnamic acid 
ester of methyl reserpate, and like reserpine it is 
a tertiary indolie base related to yohimbine (Pig# 1, p.5).
Clinical trials of reseinnamine by Smirk and McQueen^
7and Hershberger jet alia have indicated that there is 
apparently no important difference between the 
hypotensive effects of reseinnamine and those of reserpine• 
They also observed that mental symptoms occurring in 
patients treated with reserpine such as depression, 
diurnal somnolence, lassitude, nocturnal dreaming and 
nightmares may often be relieved by changing the patients 
to reseinnamine, although the change to reseinnamine does 
not influence the control of blood pressure# Its 
administration was observed to be accompanied by much the 
same /
31'S
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figure 1» The structural formula of reseinnamine •
4.
same qualitative side effects as noted after reserpine, 
but the severity of the side effects was less?*8*
Lemieux and his colleagueshowever, observed that orally 
administered reseinnamine was clinically less potent 
than reserpine in the treatment of hypertension*
In lower animals reseinnamine has been reported to
have hypotensive properties similar to, 01 even greater
10than those of reserpine and also to have certain 
quantitatively different but otherwise similar effects 
on the central nervous system*
In the perfused, innervated but otherwise isolated
hindquarters of the rat, in which the vasomotor tone had
been increased by infusion of noradrenaline» pitressin
or barium chloride, icQueen and Blackman^ have shown
that both reserpine and reseinnamine exert a direct
vasodilator effect* Ilescinimmine has also been described
i j?by Cronheim £t alia as having all of the typical 
pharmacological properties of reserpine and Alaeroxylon 
(Kauwiloid - Uiker) - a concentrate of the pharmacologically 
active and clinically useful alkaloids of the root of 
Bauwolfia serpentina* When given orally or by 
intravenous injection to normotensive dogs, it was shown
to /
5.
to Cause bradycardia* hypotension and, at higher dose 
levels, sedation* The prolongation of pentobarbitone*
induced sleep in mice, vixich has been suggested as an 
index of the sedative activity of Alseroxylon^* 
is also observed with reseinnamine • tfescinnamin© has 
been reported to cause an increase in the pressor
response to adrenaline * and reversal of the pressor
response to hypoxia in dogsi2* The pressor responses 
due to bilateral occlusion of the carotid arteries and
electrical stimulation of the central end of the cut
vagus in dogs have also been reported to be significantly 
diminished by reseinnamine^ *
While reaeinnaniin© has been reported to possess 
similar therapeutic properties to reserpine in the 
treatment of hypertension in man, this drug has not so 
far been thoroughly investigated either in man or in 
laboratory animals* It was therefore felt that a more 
thorough evaluation of this drag was necessary in order 
to confirm and extend previous work* Very little 
information is available about the effects of reseinnamine 
on the cat* or on isolated tissues and organs* It was 
therefore decided to study the properties of reseinnamine 
on /
6.
on Isolated tissues as well as ©n the blood pressure 
Of the anaesthetised eat ete*
7.
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Throughout this part of th© thesis, the names of 
certain drugs have been abbreviated# The list of drugs 
used in this part, together with their shortened names, 
is as follows I**
1) Acetylcholine chloride is described as acetylcholine
2) Atropine sulphate it « » atropine
5) (+)W?ubocurarine
chloride » tt tubocurarin®
4.) {«»)«*Adrenalin© 
hydrochloride «» n » adrenalins
,5) (~)wHoradrenaline 
bitaHrate » i* «» noradrenaline
6) Histamine acid 
phosphate tt 91 n histamine
7) S^ydroxytxyptamine 
creatinine sulphate II ** tt SHnyaroxy-
tryptamine
8) Sodium pentobarbitone » « pentobarbitone
(9) Chloralose W w it chloralose •
The composition and riethods of preparation of all 
physiological saline solutions used in this investigation 
are to be found in Appendix I (pages 334 and 336).
In Appendix I are detailed also the methods nee;" in 
preparing /
10*
preparing solutions of reseinnamine*
The conventional abbreviations for volumes and weights 
of the metric system are used throughout this thesis*
11.
Q H A P f jsl E II
B* JBLFERraSKTAL
1. j&cperl*aent8 on the Blood Pressure of the Anaesthetised
Cat.   ~r - >-i..--
METHOD.
Oatg of either sex* weighing between 2.0 and 4*0 kg. 
were used. Anaesthesia was induced by means of an 
intrape rit one a 1 injection of chloralos®. A one per cent 
solution of chloralose in distilled water was made* When 
this solution was used* a dose of 8 ml. per kg. (80 mg. 
per kg.) was usually sufficient to produce surgical 
anaesthesia in about 3 minutes.
In some cats sodium pentobarbitone was used as the 
anaesthetic. 60 mg* per kg. injected intraoeritoneally 
was found to be an adequate anaesthetic dose.
The anaesthetised cat was laid on its back upon sn 
operating table; the legs were secured to the table and 
the head extended by passing a string through the skin at 
the apex of the lower jaw. The skin cowering the neck was 
cut away from the sternum up to the apex of the mandible.
The fascia covering the trachea was divided at the midline 
and the blunt point of an aneurysm needle was passed between 
the muscles of the neck and thence around the trachea. A 
strong /
12.
strong linen thread was passed around the trachea and a 
transverse incision mad© in it by mean© of a scalpel«
The out edge of the partly severed trachea was held in a 
pair of blunt forceps and a tracheal cannula inserted end 
tied into place* This was done as a precautionary 
measure in case it became necessary (due to drug-induced 
respiratory depression or failure) to keep the oat alive 
under artificial respiration* The amount of air entering 
and leaving the cannula could be controlled by means of 
an adjustable sleeve or side tube*
The external jugular vein, usually of the left ©ide, 
waa then c nnulated* To do this the skin of the left 
anterolateral part of the neck was removed and the left 
external jugular vein exposed* The fascia oovering the 
vein was carefully removed, a thread was tied around the 
cephalad end and a bulldog clip was put on the vein on the 
cardiac aspect* A small transverse cut was made in the 
dilated vein by means of a pair of sharp pointed iris 
scissors* A vein cannula, filled with a solution of 
heparin, w:s then inserted through the incision with the 
pointed end tc?ward the heart* The cannula was connected 
by means of rubber tubing to a 50 ml* burette containing 
normal /
normal saline* All the air bubbles had been previously 
removed from the system. The observation that the saline 
in the burette ran freely into the vein indicated that the 
cannula had been correctly inserted* Having completed 
the cannulation of the trachea and of the external jugular 
vein, an artery cannula was inserted into one of the 
carotid arteries* The artery was first tied off as near 
to the head as possible * a bulldog clip was then placed 
on the artery about three cm. below the ligature and a 
thread was passed under the vessel midway between the 
ligature and the bulldog clip* A small transverse out 
was made in the artery by means of a pair of sharp pointed 
iris scissors* An artery cannula, filled with a solution 
of heparin, was then inserted through the incision with the 
pointed end towards the heart* The cannula was connected 
to a mercury manometer, and the space between the mercury 
and the artery filled with a twenty-five per cent solution 
of sodium thiosulphet© as an anticoagulant* Air having 
been displaced from the cannula and the pressure in the 
manometer set at about 120 mm* of mercury, the artery clip 
was removed* A writing flag on one arm of the mercury 
manometer recorded the blood pressure on a smoked surface.
Drug /
Drug solutions were injected into the rubber 
connection between the vein cannula and the burette* Each 
injection waa followed by the infusion of 4 ml* of saline 
from the burette* The blood pressure was usually 
recorded from the eannulated common carotid artery, but 
when a reflex pressor response was elicited by means of 
bilateral occlusion of the common carotid arteries, the 
blood pressure level was recorded from one of the eannulated 
femoral arteries.
The effects of rescinnarrdne on various pressor 
reflexes were studied by comparing the nature and magnitude 
of the reflex responses observed before and after the 
injection of reacimiamlne• At least three uniform reflex 
responses were obtained before injection of rescinnamine* 
Pressor responses were obtained, following the elicitation 
of the following reflexes*-
(1) ^he Carotid Sinus Pressor Reflex* Bilateral 
occlusion of the common carotid arteries for a period of 
twenty to thirty secondsi this reflex was elicited either 
by the placing of bulldog clips on to the arteries or by 
pulling upon threads looped loosely around them*
(2) Occlusion of the Abdominal Aorta* The abdominal
cavity was opened by a midline incision* The rectue
muscles /
muscles and the fasciae were retracted, the viscera 
pushed to the right and the abdominal aorta carefully 
dissected free from the fascia at a point a little below 
the diaphragm* A thread w&a then passed loosely around 
the aorta by means of an aneurysm needle at a point just 
above the origin of the coelisc artery* The abdominal
aorta was occluded for ten seconds by pulling upon the
thread*
(3) Stimulation of the Out Central End of the Cervical 
X«aa» The right vago-*sympathetic trunk was carefully 
dissected free from its fascia and separated from adjacent 
structures* The vagus waa then freed from the cervical 
sympathetic trunk with which it runs. The vagus was 
divided by means of scissors at as low a point in the neck 
as possible* The central end of the cut vagus was placed 
upon a pair of platinum electrodes which were connected
to the output of a stimulator* The nerve was stimulated 
by means of square wav© impulses at a frequency of 800 to 
1,000 per minute, at 8 to 12 volts and with a pulse width
of 0*5 to 1*0 msec* stimulation was continued for
periods of fifteen to twenty seconds*
(4) Stimulation of the greater Splanchnic Nerve* This 
nerve joins the ooeliac ganglion which is situated a little 
below /
below the coeliac artery near to its origin from the aorta, 
and distributes fibres to the renal and suprarenal 
plexuses and to the other abdominal nerve plexuses* The
coeliac ganglion was carefully dissected free and the 
greater splanchnic nerve traced upward© and cleared from 
fascia* The nerve was divided close to the ganglion and 
the cut central end was placed upon a pair of platinum 
electrodes which were held in position by mean® of a clamp, 
and the abdomen closed* The nerve was stimulated with 
fifteen seconds bursts of impulse© by means of a Bobbie 
Melnnes square wave stimulator, at a frequency of 800 to 
1200 per minute, at 10 volts and with a pulse width of 
1*0 to 1*5 msec*
(5) Hypoxia* The cat was allowed to inhale a mixture 
of 95 per cent nitrogen and 5 per cent carbon dioxide from 
a Douglas bag for one and half minute periods*
In a number of anaesthetised cats (pentobarbitone or 
chloralose), the blood pressure level was raised by the 
continuous infusion of solutions of adrenaline or nor- 
adrenaline, and rescinnamlne was injected when the elevated 
blood pressure level had become steady* The concentration 
of the adrenaline or noradrenaline solutions which were 
infused /
infused waa 0*10 mg# per ml# and the rate of infusion was 
1*0 sal# per1 minute from a Palmerfa ©low infusion apparatus#
2* Experiments on the Blood Pressure of Spinal Cats# . 
METHOD#
Cats within the weight range of 2*0 to 3*0 kg# were 
given atropine (1*0 mg. per kg#) by intraperitoneal 
injection, about 15 minutes before induction of anaesthesia 
by ether# The common carotid arteries were dissected 
free from the accompanying vagosympathetic trunks and tied# 
The trachea was next freed from adjoining tissues and 
cannulated# The tracheal crnnula was connected by means
of rubber tubing to a bottle containing ether# The 
ether bottle could be joined rapidly and easily by means of 
rubber tubing to an artificial respiration pump# The cat 
was then turned over, and the spinal cord exposed in the 
vicinity of the long spine of the second cervical vertebra# 
The bony covering of the spinal cord and finally the cord 
itself were cut by me anas of bone forceps* As soon as the 
cord was transected, artificial respiration was commenced# 
Bleeding was arrested by means of cotton wool swabs soaked 
in hot normal saline# A probe was inserted through the 
foramen magnum, pushed up into the brain and the brain 
destroyed# -The cut end of the spinal canal was plugged 
with /
with plasticine and the ares, swabbed clear# The skin 
over the back of the neck was closed with the aid of 
surgical clips* and the animal again turned on to ite 
back# One of the carotid arteries waa cannulated and 
connected to a convention©! pressure recording system 
filled with a 25 per cent sodium thioeulphete solution#
A mercury manometer carrying a writing flag on one arm was 
incorporated into this eyetern and arranged so as to record 
the blood pressure on a smoked surface# The external 
jugular vein wee cannulated and connected by rubber tubing 
to a burette filled with normal saline# Drug solutions 
were injected into the rubber connection between the vein 
cannula and the burette# Facte injection waa followed by 
the infusion of 4 ml# of saline from the burette#
In all experiments* the preparation was left to 
settle for at lrast one hour before any experiment was 
carried out# Ko drug waa given unless the blood pressure 
level had remained constant for from 15 to 30 minute®#
3# gacperlawwt® on Isolated# Perfused llbblt and Kitten
^  "r n ’  ' "n” ....
The isolated hearts of both rabbits and kittens were
i
perfused according to the method of Lange ml orff # This 
involves perfusion of the coronary vessels through the 
aorta# /
aorta# Wegria^* in his review on the pharmacology of 
the coronary circulation# quotes several published 
criticisms of thi® method# It is pointed out that the 
recorded outflow will give a true picture of the state of 
tonus of the coronary vessels only if the aortic valves 
are competent* This is not always so# In the event of 
aortic incompetence# some perfusion fluid will leak past 
the valves into the left ventricle and so into the left 
atrium# end thence to the exterior# The increased 
outflow may therefore exceed the true coronary outflow by 
the amount of fluid which has phased into the left ventricle# 
The volume of fluid draining into the right atrium via 
the ventricle is not constant and# in addition, cannot be 
measured satisfactorily# It is also pointed out that the 
volume of coronary perfusate nay be increased by a purely 
mechanical massaging effect which cardiac muscle «* 
stimulated by a cardiotonic drug - has upon Hie coronary 
vessels# Under these circumstances# an increase in 
outflow might be taken to indicot© a coronary dilatation 
which in fact was not present# for these reasons it was 
decided that the fluid draining from the heart should be 
described simply bb the ,fcardiac outflow” • In spite of 
the objections raised to the us© of this method# it waa 
felt /
felt that the Lengendorff preparation would still give 
some useful inforraatlon about the effects of drugs on 
cardiac function in vitro# By carefully observing the 
heart rate# the amplitude of the contractions# and at the 
sam  time measuring the outflow* an estimate of alterations 
of cardiac function es well as of the tonus of the coronary 
vessels can be obtained#
MTHODm
Robb its and kittens used were within the weight
ranges of 1*0 to 2*0 kg# end 0*6 to 1*0 kg# respectively#
The animal was killed by a blow on the hesd# The throat
was cut and the blood allowed to drain out* The animal
was then placed upon its back on a dissecting board and the
thoracic cavity exposed# care being taken not to damage
the heart with scissors or other instruments# The lungs
were removed and a thread was tied loosely around the
aortic arch proximal to the origin of the innominate artery#
The venae cava© and aorta were then severed and after
removing the pericardium# the heart was lifted out of the
thorax and placed in s dish of warm Lockets solution
(Appendix I p#336) at a temperature of about 37°C# and
containing a little heparin to prevent the blood inside the
heart from clotting# A stream of Lockefs solution was 
allowed /
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allowed to run through the superior vena cava from-a 
pipette, and the heart was squeezed gently# After washing, 
a cannula was tied into the aorta taking cere that its tip 
was distal to the coronary ostia# The preparation was 
then set up by connecting the cannula to the perfusion 
apparatus# Perfusion of oxygenated Locke’s solution, 
containing double the normal concentration of glucose, was 
started at a constant rate of flow and at a pressure of 
35 mm# of mercury, care being taken that no air bubbles 
entered the aorta# Any blood remaining in the preparation 
was rapidly washed away, and as a rule the heart started to 
beat immediately# After about thirty minutes, v&ien the 
beat had become regular, a supporting thread was tied by 
means of a fine needle through the tip of the left 
ventricle# A bent entomological pin was inserted into 
the wall of the right ventricle and connected to a Starling’s 
heart lever which recorded the contractions of the heart on 
the surface of a smoked drum# Doubling the normal 
concentration of glucose in the perfusion fluid gave a more 
active preparation, and one which was fatigued less easily, 
fhe Locke’s solution from the two reservoirs used flowed 
through heating ooils in a water bath maintained 
thermostatically at 37°C# 3?he two coils were connected
fey /
by a glass Y~piece which was joined to the aortic cannula 
by a short length of rubber tubing* She tampersture 
drop between the thermostatically controlled water bath and 
the cannula was never more than G*2°G*
Reseinnamine was dissolved in Locke’s solution in 
one of the reservoirs to give the concentration of 1*0 jig* 
per ml* Alternatively a measured volume of the control 
solution was mixed with Locke’s solution in the bottle*
The other bottle contained Locke’s solution* Solutions 
of other drugs in Locke’s solution were Injected by means 
of a one ml* tuberculin syringe into the rubber tubing 
attached to the aortic cannula* In some experiments, a 
solution of reseinnamine waa also injected in this way*
The heart rate was counted by inspection of the tracing or 
by direct observation, and the outflow measured at five 
minute intervals by collecting the perfusate for e period 
Of one minute* In some experiments the outflow was 
measured by means of a Gaddura outflow recorder*
4* Experiments on the Isolated Auricles of the Guinea
P iff*
These experiments were carried out in order to study 
the action of reseinnamine on isolated cardiac muscle*
Adult guinea pigs of either sex were killed by a blew
on the head* The throat® were cut and the blood allowed
t© drain out# The hearts were removed ae rapidly as
possible and Immersed in well-*oxygenated Locke’s solution* 
Using a pair of fine scissors, the ventricles were carefully 
removed and the auricles placed upon a cork mat and 
moistened frequently with Locke’s solution* All extraneous 
tissue was dissected away until the horseshoe shaped 
auricles alone remained* These were then suspended in 
a 50 ml* organ bath by s»eans of two bent entomological 
pins to which fine cotton threads were tied* One thread 
was connected to the oxygen delivery tube at the base of 
the bath, the other to a Starling’s heart lever set up so 
as to record the contractions of the auricles upon a smoked 
surface* After about twenty to thirty minutes, the beat 
of the auricles had usually become regular and the 
experiment was com enced • All drugs were added to the 
bath m  solutions in Locke’s solution, and by means of a 
one ml* tuberculin syringe. Rescinnamin© was added in the 
form of a solution as described in Appendix I, page 334*
The effect of each drug was observed for a period of sixty 
seconds, after which the fluid in the bath was replaced* 
Sufficient /
Sufficient time was allowed for the auricles to regain a 
normal regular rhythm and amplitude of beat before the next 
addition of drug*
5* Experiments uaiag Striae of Horae Artery*
METHOD*
Lengths of carotid artery were removed at the 
slaughter house from freshly killed horses* A portion of 
the artery was freed from fascia and a strip about four 
cm* in length and two mm* wide was made by cutting the 
artery into a spiral by means of a pair of iris scissors* 
Threads were tied to both ends of the segment and the strip 
of artery set up in a forty ml* organ bath containing 
oxygenated Tyrode’s solution (Appendix I, page 356) 
at 37i Q*5°C. The thread at one end of the artery strip 
was fixed to the lower end of a glass tube supplying 
oxygen to the bath; the thread at the other end was attach­
ed to a modified frontal point writing lever giving a 
magnification of about 1 in 10. The strip was stretched 
for about fifteen minutes by means of a ten gramme weight* 
Before the experiment was started the additional weight was 
removed and the lever readjusted* Contractions of the 
strips of artery were induced by addition to the bath of 
adrenaline, /
adrenaline (1*0 to 2*0 |ig« per ml*), noradrenaline (1*0 to 
2*0 p,g* per ml #), 5 ~ hydroxytrypt&min© (0*10 t© 0*50 pg* per 
ml*), acetylcholine (0*02 to 0*1 pg* per -ml*) or histamine
(1*0 to 2*0 p,g* per ml*)* These were added to the bath as 
solutions in Tyrode's solution by means of a tuberculin 
syringe* Two types of experiments were performed*
(1) Contractions of the artery strip were elicited by 
the addition to the bath of the stimulant drug* While 
the artery strip was still in a stage of contraction, 
rescinnamine (2*0 to 40.0 pg* per ml*) was added to the 
bath* In moet cases the artezy strip relaxed following 
addition of rescinnamine to the bath* Comparisons were 
made by repeating the experiment using a control solution*
(2) Stimulant drugs (in the dose range mentioned above) 
were added to the bath and the effects observed for eight 
minutes* Before adding reecirmamine, at least two uniform 
submaximsl contractions were obtained to the same dose of 
the stimulant drugs added to th© bath at fifteen to twenty 
minute intervals* Kesciimamine (1*0 to 10*0 p.g*,per ml#) 
waa added to the bath ten minutes before th© next addition 
of th® stimulant drug and allowed to remain in contact 
with the tissue for eighteen minutes* The experiments 
were repeated using the control solution*
6. /
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6* Experiments on the Isolated Perfumed Rat Hindquarters* 
METHOD.
In these experiments the pressure at which the 
physiological fluid pasaed through th© blood vessels was 
kepi constant, and the alteration© in the rate of outflow 
of the perfusion fluid which were produced by the drug 
were recorded by means cf daddun’s drop recorder* The 
vessels were perfused with oxygenated Locke’s solution at 
room texp e re. ture *
Hats of either o©x# weighing between 200 end 300 g*, 
were killed by a blow on the heed# The throats were cut 
and the blood allowed to drain out* The abdominal cavity 
was opened by means of a. longitudinal incision extending 
from the sternum to the anus* The rectum, the 
oesophagus and the inferior and superior mesenteric 
arteries were divided between ligatures* The abdominal 
viscera were then removed* This brought into view th© 
abdominal aorta which was c^nnaleted* Th© body wall and 
vertebral column were transected above the point of 
Cannul&iion and the cannula- attached to the perfusion 
system by mean® of fine rubber tubing* The perfused hind­
quarters were set up in the apparatus shown, in Fig. 2, p. 27.
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Two reservoirs are included in this apparatus*
These are Joined by means of a glass three-way stopcock*
The rate of flow of fluid from the bubble trap to the 
injection cannula is controlled by the tap A in Fig* 2, 
p*27, and can be adjusted to a suitable rate value at the 
beginning of each experiment* The injection cannula,
(the design of which was based upon that suggested by 
Ga&dum and ICwiatkowskl^) (fig* 2,B), allowed the drug 
solution© to be injected at a constant rate. This was 
achieved by injecting the solution with a tuberculin 
syringe, fitted with a fine needle, through th© rubber cap 
at a rat© such that the level of fluid in the cannula 
(Fig* 2,C) was unaltered during the process* The 
hindquarters preparation was placed on a muslin rest lying 
in a filter funnel* The outflow was led via the filter 
funnel to the contacts of a Gaddum drop recording assembly***.
After setting up the preparation, a uniform outflow 
record was obtained for at least 15 minutes before drugs 
were injected* Heseinnamine was dissolved in the Bocke *s 
solution in one of the reservoirs to give the desired 
concentration (0.10 to 10 p,g* per ml*)* Alternatively, 
a measured volume of the control solution was mixed with 
the Locke's solution* In a few experiments, the solution
of /
of rescinnamine was injected into the cannula by means of 
a tuberculin syringe*
7* Experiments carried out Using the Isolated Guinea 
Pi^ s 1X€?U£3»
mmxs>»
Uuinea pigs of either sex, weighing between 0*3 and 
0*3 kg*,were killed by a blow on the head and the throats 
cut in order to drain out the blood* The abdominal 
cavity was opened and a piece of ileum about 3 cm* long 
was removed from the region about 3 cia* proximal to th© 
ileocaecal junction# It was then freed from extraneous 
tissue and th© contents washed out by means of a stream 
of Tyrodefs solution (AppendixI , p*336). Threads were 
tied to both ends of the segment which was then set up in 
a 2 ml* organ bath (tig* 3, p«30) containing oxygenated 
Tyrode’s solution* One thread was attached to a modified’' 
frontal point writing lever, and th© other to a hook fixed 
into the base of the bath* The fluid in the bath was 
oxygenated by passing oxygen through a hypodermic needle 
fixed into th© base of th© bath* The temperature was 
maintained thermostatically at 30- G*5°C* Solutions 
containing the stimulant drugs were added and washed out 
automatically using the overflow principle* Th© inlet 
tub© /
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tube at the lower end of the bath was connected via 
heating coils to two reservoirs* one of which contained 
the Tyrodefs solution* the other a solution of the 
stimulant drug in the same fluid* The dose of the 
stimulant drug to be used was determined at the start of 
each experiment by adding it to the bath by hand* The 
stimulant drug was then dissolved in Tyrode *s solution 
to give the dilution required* and the automatic 
* apparatus switched on* The electrical controlling equip­
ment (Appendix II* p*337) replaced the saline colution in 
th© bath by a solution containing the stimulant drug* a4 
three minute intervals* Since th* solution containing the 
stimulant drug flowed into the bath for five seconds* 
there was complete replacement of the solution in the bath* 
Reproducible submaximal contractions were obtained to 
acetylcholine or histamine added at three minute intervals 
and left in contact with the tissue for thirty seconds*
At th© end of this period the acetylcholine or histamine 
solution was washed out by the automatic inflow for a 
period of five seconds of pure Tyrode’s solution* The 
rescinnatsine solution was added to the bath by hand on© 
minute before the next inflow of acetylcholine or 
histamine* This point in the cycle was indie:ted by a 
signal /
signal light placed in the circuit (Appendix II, p*337)«
The contractions were allowed to return to a constant level 
before the next addition of rescinnamine.
8. Experiments Carried Out 'Jain# the Isolated
K a b b i ¥ ' ' ^ ....." ' *' 1 .
Rabbit© of either sex, weighing between 1.5 and 
2.5 kg. were killed by a. blow on the head. The throat was 
cut and the blood allowed to drain out. The abdominal 
cavity was opened and a piece of duodenum about 4 cm. long 
removed. This was freed from fatty and other tissues. 
Threads were tied to both ends of the segment, and the 
piece of duodenum was set up in o 40 ml. organ bath 
containing oxygenated Locke's solution at 3?i 0.5°C. The 
thread at one end of the duodenum was fixed to the lower 
end of a glass tube sup; lying oxygen to the bath, and the 
thread ©t the other end was attached to a modified 
frontal point writing lever giving o magnification of 1 in 
8* Adrenaline (0.05 to 0*10 pg. per ml.) and acetyl­
choline (0.004 to 0.04 per ml*) in solution in Locke’s 
solution were added to the bath by means of a one ml. 
tuberculin syringe, end the effect wee observed for two 
minutes. At the end of this period the fluid in the bath 
was replaced several times by running in fresh Locke *s 
solution /
solution* The next addition of adrenaline or acetyl­
choline was not .made until Hie tissue regained its 
original length* The solution of rescinnamine 
(1*0 to 4*0 jig. per ml*) and the same volume of Hie 
control eolation were added to the hath two minutes before 
the addition of adrenaline or acetylcholine, and the 
effects observed*
9* Experiments !Tgjng the Isolated Frog Rectua 
Abdominis Ouscle *
METHOD*
The procedure used for preparing the muscle to 
record the effects of drugs was essentially similar to 
that described by Buro^ An adult frog was stunned, by 
means of a blow on the head* decapitated and pithed* The 
frog waa laid on its back upon a cork covered dissecting 
board to which it was pinned# The rectus muscle was 
exposed by cutting away the akin of the abdomen* and then 
it was dissected from its insertion into the pelvic girdle 
to its insertion into the cartilage of the pectoral girdle# 
The rectus usole was .freed from the underlying connective 
tissues* removed from the frog and then suspended in an 
organ bath of 20 ml# capacity by means of two threads tied 
to either end oi the muscle• A loop m w  made in the 
thread /
thread at one end in order to fix the muscle to the bent 
wire in the base of Hie bath* and a long thread left 
at the other end* The long thread was tied to a 
modified frontal point writing lever which gave a magnific­
ation of 8 to 10 time©* The bath (Fig#4, p* 35) 
contained 20 ml# of o^rgenated frog lingerfn solution 
(Appendix I * p* 336) at room temperature# Acetylcholine 
was dissolved in frog Binge r*s solution to give the 
concentration required and added to th© bath by mean® of 
a one ml* graduated tuberculin syringe* The concentration 
of acetylcholine used to produce contraction© of th© muscle 
was from 0*10 to 0*20 jig* per ml#
Solutions of re^cinnamin© {5*0 to 50 jig* per ml#)* 
or th© control solution (Appendix I *p.334),were added to 
th© bath in the similar way* Uniform submximal 
contraction© to the same dose of acetylcholine were obtained 
before Hi© effect© of renclnnamlne were studied* The time 
Interval between each dose of acetylcholine was six minutes 5 
the resulting contractions were recorded for ninety 
seconds * The bath was washed out with fresh frog Binge r1® 
solution between each dose of acetylcholine * Beseitmair&ne 
in the dose range of from 5 to 50 jig. per ml• 9 or the 
control /
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control solution, were added one minute before the next 
addition of acetylcholine • Before the next addition of
reacimiamine # sufficient time was allowed for the muscle 
to regain its original length#
In so ie experiments the effects of tubocurarin® and 
atropine upon rescinnamine-induced contractions of the 
rectus muscle were studied* Tubocurnrine (5*0 to 10 jig* 
per ml*) and atropine (1*0 to 10 p,g* per ml*) were added 
to the bath either one minute before the addition of 
rescinnmaine or during the actual rwscinnaralns contraction* 
Bie apparatus used for these experiments is shown in 
Fig*4, p*35.
10* Experiments on the nictitating Membrane of the
Anaesthetised Oat*
METHOD*
In these experiments cats of either sex, weighing 
between 2*0 and 3*0 hg*, were used* The cat was 
anaesthetised by means of an intraperitoneal injection of 
sodium pentobarbitone (see p* 11), and tracheal and rein 
cannulae inserted as described on pages 11 and 12.
The head m n  rigidly fixed by passing a brass rod between 
the jaws and then tying the jaws firmly together with 
string /
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string. The ends of the rod were then gripped firmly 
in clamps, and these were * supported on uprights fixed to 
the side of the operating table. By means of a fine 
needle* a ©ilk thread was passed through the mid-point of 
the margin of the nictitating membrane of the right ©yw, 
and was tied firmly into place. The thread was then 
pulled forward end to one side, thus making an angle of 
about 30° to the long axis of the cat. It was then led 
around pulleys and attached to a frontal point writing 
lever. The contractions of the nictitating membrane 
were recorded on a smoked surface.
The right cervical sympathetic chain was now
dissected out and a fine cotton thread tied tightly around
it at as low a point as possible in the neck. The chain
was severed above the ligature and low in the neck. The
cut preganglionic cervical sympathetic chain was then
placed upon a pair of platinum electrodes and kept moist
with normal ©aline. Contractions of the nictitating
membrane were elicited by stimulation of the cervical
sympathetic by means of square impulses at a frequency of
800 to 1,200 per minute, 8 to 13 volts, the pulse width
being 0.5 to 1*0 msec* In any one experiment frequency
of stimulation, voltage and pulse width were constant.
The /
fhe nerve was stimulated*at 3 minute intervale *f or 15 
seconds• Having obtained standard reproducible
responses of the nictitating membrane by stimulating the 
nerve trunk* a solution of rescimmmine (0*50 t© 2*0 mg* 
per kg*) was indebted into the external jugular vein one 
minute before the next period of stimulation#
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1# Blood Pressure of the Anaesthetised Cat,
Keso inns mine in doses of 0,5 > to 2*0 mg# per kg# 
produced a sherp fall in blood pressure, the level of 
whibh usually returned to its original value (in some 
oases reaching a higher level) within five to ten 
minutes (Fig# 5, p#41 )• After the initial fall no 
significant change In the blood pressure level was 
observed for from one to two hours# Three to four hours 
after the intravenous injection of resclimamine* a 
significant drop in the blood pressure level (50 to 80 
mm# Hg#) was observed# This latency of action on the 
blood pressure is similar to that observed by Crohhel® 
et alia^ in urethane-anaesthetised dogs following the 
administration of rescinnamlne# The control solution had 
no observable action on the blood pressure level# In 
anaesthetised cats which had to start with a low blood 
pressure level (100 mm# Hg# or less), there was no 
significant fall in blood pressure even after four or five 
hours# Along with the lowering of blood pressure, a 
significant reduction in the heart rate was also noticed# 
Some of the control cat®, however, showed hypotension and 
bradycardia /
41.
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Figure 5. Cat. Pentobarbitone anaesthesia. 
Blood pressure record from the common carotid 
artery. Drugs administered intravenously.
At Ri rescinnamine 0.50 mg. per kg
At E2 « 0.10 mg. per kg
At
®3
i» 0.10 mg. per kg
bradycardia but to a lesser extent*
Beseinnamine in the dose range of 0*5 to 1*0 mg. 
per kg# caused either no reduction or a slight reduction 
in the response to both adrenaline, 0*5 to 2 ^g* per kg#, 
and noradrenaline. 0#5 to 2 t*g# per kg* (Fig* 6, p# 43 
and also Fig* 10, p* 48 )♦ Beseinnamin© did not modify
the characteristic depressor effect® of acetylcholine 
(0*50 to 1*0 tig* per kg#) or histamine (0*50 to 1#0 pg# 
per kg*) on % e  blood pressure of the anaesthetised cat# 
(Fig. 6, p.43 ).
The pressor response to bilateral occlusion of the 
carotid arteries was significantly reduced following 
0*50 to 1.0 mg* per kg* of rescimmmine but was not 
abolished (Fig*7* p# 44 )* Dhe maximum reduction was
observed about thirty ainutes after the injection of 
reseinnamin© «
Following the injection of 0*50 mg# per kg# 
resoinnamine, pressor responses due to occlusion of the 
abdominal aorta or stimulation of the central end of the 
greater splanchnic nerve were reduced by about sixty per 
cent at the end of about one hour (Fig* 8, p*45 )•
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Figure 6. Cat, chloralose anaesthesia. Blood 
pressure record from the common carotid artery* 
Drugs administered int rave nously *
At Ad, adrenaline 1.0 p,g. per leg.
At i\e, noradrenaline 1.0 pg* per kg.
At Ac, acetylcholine 1.0 \xgm per kg.
At Hm, histamine 1.0 pg. per kg*
At Res, reocinnamine 1.0 mg. per kg.
/
Figure 7. Cat, chloralose anaesthesia. Blood 
pressure record taken from the femoral artery. 
Drugs administered intravenously•
At Co, bilateral carotid occlusion for 30 seconds. 
At K, rcscinnamine 0.75 mg. per kg.
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Figure 8» Get* Pentobarbitone anaesthesia. Blood
pressure record taken from the common carotid artery.
JDrugs administered intravenously.
At Sp, stimulation of the cub central end of the 
greater splanchnic nerve at 10 volts, 1,000 
impulses per minute, pulse width 1.0 msec, for 
15 seconds.
At Ab, compression of abdominal aorta for 10 seconds.
At R, rescinnaain© 1.0 mg. per kg.
Part b is in continuation of a, and part c is in 
continuation of b.
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So.m reduction la the magnitude of these two reflex 
responses was observed within ten minutes after reseinmmine 
administration.
following 0*75 to 1.0 mg* per kg* of reecinnamine, 
the magnitude of the pressor response caused by electrical 
stimulation of the central end of the ri#t vague was 
reduced within ten minutes, and abolished at the end of 
about thirty minutes. In some cats there was an actual 
reversal of this reflex response following reseinnamine 
(Fig* 9, p* 47)•
following 0*50 mg. per kg* reeeixmamine, the pressor 
response elicited in the cat by hypoxia was found to be 
completely blocked within about fifteen minute®. Frier to 
the administration, of rescinnamine, hypoxia caused only a 
pressor response but after reseirtnomihe had been given the 
pressor response was- changed Into a complex depressor** 
pressor -depressor response (Fig* 10, p. 48). fhe control 
solution had no observable effects upon any of these 
reflexes.
One mg. per kg. of rescinnamine caused a slight 
reduction in the level of the blood pressure which had been 
artificially raised by continuous infusion of adrenaline 
dr /
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Figure 10# Cat* Chloralose anaesthesia* lood 
pressure record from the common carotid artery*
Dru, -,s administ©red intravenously *
At Ia# noradrenaline 2*0 |i.g# per kg# + 4 ml. saline
At Attf adrenaline 2*0 p,g* per kg* + 4 ml* saline
At H# i nit a la t ion of mixtures of 95$ nitrogen and
3$ CQg for 1-J minutes*
At E Eescinnaraine 0*50 mg# per kg* + 4 ml* saline
At Eg# Eeocinnamin© 1*0 mg* per kg* + 4 ml* saline
Part b is coatinuation of part a#
or noradrenaline * In bigger doses (2*0 to 4*0 mg* per 
kg*), rescinnamine lowered both adrenaline and no£~ 
adrenalins hypertension to normal levels within a few 
minutes (Figs *11 and 12, pages 50 and 51 )• $he blood 
pressure usually remained nt the normotensive level 
although th© infusion of adrenaline or noradrenaline was 
continued* Anaesthetised (pentobarbitone or chloraloee) 
and spinal cats behaved in the same way* The control
solution caused no significant effect*
2* Blood Pressure of the Spinal Cat*
In spinal cats, Vie blood' pressure of which was 
usually about 100 mau Hg*, resclmmmlne' caused no fall in 
the blood pressure level even after several hours* fhe 
characteristic effects of acetylcholine, histamine, 
adrenaline and noradrenaline on the blood pressure were 
not modified by resclnnamine * '
5* Isolated Perfused Babbit and Kitten Hearts*
Ho differences were noted in the results obtained 
when the experiments were carried out with either rabbit or 
kitten heart©* Perfusion of 1*0 j*g* per ml* of 
rescinnamine decreased the rate and amplitude of the 
controotions /
Figure 11* Cat* (a) Pentobarbitone and (b)
chlopalose anaesthesia* Blood pressure record 
from the common carotid artexy* Drugs 
administered intravenously*
At Ad, infusion of adrenaline 0*10 mg# per ml* at 
the rate of 1*0 ml* per minute*
(a) At C, Control solution*
At By0 Heacinnarain© 1*0 mg* per kg*
At Eg# " 4*0 mg* per kg.
At Sal,Saline 4 ml*
(b) At R# Reacinnamine 2.0 mg. per kg*
?igure 12* Gat* (a) Ghloralose anaesthesia, <b)
m i'—*- ■ -]-------
pentobai'bitone anaesthesia and (c) spinal animal 
Blood pressure record from the eoiiuton carotid 
artery* Drugs administered intravenously*
At Ha, infusion of noradrenaline 0*10 mg* per ml 
at the rate of 1 *: ml* per ujinute*
(a) At R, itescinnamine 2*0 mg* per kg*
At S, infusion of noradrenaline stopped*
(b) At E, Kescinnaiidne 2*0 mg* per kg*
At S, infusion of noradrenaline stopped*
(c) At R, Kescinnamine 2*0 mg* per kg*
contractions of the heart (Fig* 13, p* 53 )* The decrease 
In the rat© end amplitude was gradual end became evident 
within a few minutes after the start of the perfusion of 
the reeeinnamine solution* The heart outflow was also 
decreased* The rescinns mine effect was not reversible, 
and the decreased rate and amplitude did not increase after 
withdrawal of the drug (Fig* 15b, p* 53 )• The control 
solution equivalent to 1*0 per ml* of rescinnamine had 
qualitatively similar, but quantitatively much weaker 
effects upon the heart*
The increased rate and amplitude of contraction 
produced by adrenaline, 0*50 i*g*, or noradrenaline* 0*50 pg*, 
were not altered by resclnn&?&in©, 25 to *30 fig* (Fig*14a,p* 54). 
The effect of acetylcholine (0*05 ;ig*) was also unaffected 
by prior injection of 25 to 50 p.g* reeoinnamine (Fig*14b,p* 54). 
When reeclnnamine was injected at this dose level through 
the perfusion cannula, there was an immediate decrease in
the amplitude vhich recovered within a few minutes but did
not return to the original level* The heart rate and
heart outflow were not significantly altered*
4* Isolated Guinea Pig Auricles♦ ■
flhen reeeinnamine in concentrations 2*0, 4*0 or 8*0
|ig* per ml* was added to the bath, there was an immediate 
reduction /
53.
a
Figure 13* Isolated. rabbit heart. lumbers above 
the recording - upper row heart rote in beats per 
minute, lower row cardiac outflow in ml* per minute*
(a) At K, perfusion with reecinnamln® 1*0 pg* per ml*
(b) At E# perfusion with rescinnamine 1*0 pg* per ml*
At L, reacinnomine replaced by Locke’s solution.
ab
gi. -iro 14* Isolated kitten heart*
(a) Humbere above the recording refer to the number of 
beats per minute? upper row nor ml beat, saddle
row after administ rat ion of adrenaline end 
noradrenaline and lower row after s?d nin:t at rat ion 
of re e c i »xm mine ♦
At Ad, adrenaline 0*3 ug*
At Ha, noradrenaline OS 
At lip reaoinnamine 2$ £g*
At E„, rescinnamine 50 ng»
S'
(b) Htebere above the recording refer to the number of 
beats per minute*
At A, acetylcholine 0*05 p
At K, rescinna iine 30 i^ g*
reduction of the rat® and amplitude of the contractions. 
After washing,the rat© and amplitude returned to their 
original levels (fig. 15a,p* 56).
itescinnamine (2*0 to 8*0 jig* per ml.) did not show 
antagonism or potentiation to the inereased rate and 
amplitude produced by noradrenaline (0*02 $ig. ml.) ©r 
adrenaline (0*02 ng. per ml.) (Pig*15b and e, p. 56)®
The control solution had no significant effect*
5. Strips of Horse Carotid Arteries.• I 1.. ............
Hesoinnemine in the dose rang© of 2.0 to 40*0 pg. per 
ml. relaxed sustained contractions of artery strip© induced . 
by adrenalin© (1.0 to 2*0 p,g. per ml.), noradrenaline 
(1*0 to 2*0 jig. per ml.). 5 - hydroxytryptamine (0.10 to 
0*50 pg* per ml.), acetylcholine (0*02 to 0*1 p.g* per ml.) 
or histamine (1*0 to 2*0 p,g# per ml*}* 2he degree of 
relaxation depended upon the magnitude of the dose of 
resoinnamlne used. fh@ results of some of these 
experiments are shorn in Fig*16, p. 57. fhe control 
solution produced no observable effects. Rescinnaraine 
in doses of from 2*0 to 40*0 p,g. per ml. had little or no 
direct effect upon the artery strip.
Prior /
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190 192 188
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Figure 15» Isolated guinea pig auricles. Nuribore 
above the recordinga refer to the nunber of beats
>r fdnute •
(a) At B^# reeoiniiS/aine ?*0 [i * per • I,
At iig£ « 4,0 » « «
At W# wash out.
(b) At Ba# noradrenaline 0,04 fig* per ml*
At li, reacinnanine 2.0 " " *
(c) At A, edremline 0,04 V* U per 1*
At reeclnnamin© P,0 « ** «
At E2, « 8,0 " * •
At W, waofo out.
57.
2mm
Figure IS. Isolated strips of horse carotid artery*
(a) At Aeh, acetylcholine 0.02 H&. per ml.
At C. control solution
(b) At A oh. acetylcholine
o*o ug. per ml.
At E# reacimmmine 40.0 it » H
(c) At HT# 5-hydroxy-
tryptamine 0 . 1 0 US. per ml.
At t* rescinnamlne 5.0 II ii »
(a) At d. adrenaline 2.0 per ml.
At r* scinnamine 40.0 W N »
(•) At Ha, ' norad re na line 2.0 **>g* per ml.
At K# rescinnr dne 20.0
n ti
Prior addition of rescinnamina in doses of from 
1*0 to 10*0 iig* per ml* reduced the magnitude of the 
contraction induced by adrenalin* (1*0 to 2*0 p,g* per ml*)# 
noradrenaline (1*0 to 2*0 ug* per r£L*)# 5 - hydroaytryptaa* 
ine (0.005 to 0*05 ug* per ml*), acetylcholine (0*02 to 
0*10 ug* ^1*) ^2* hiatr.raine (0*10 to 0.50 ug* per ml.) 
(Ilg.17, p* 59). The control solution did not show 
any significant effect upon the contractions Induced by 
these drugs*
6. Isolated Perfused Hat Hindquarters*
In the perfused hindquarters of the rat# rescinn&mine 
has been shown by McQueen and Blackman^ to hare a direct 
peripheral vasodilator effect similar t© that caused by 
resorpine•
When perfused in concentrations of 9*10 to 1*0 fig* 
per ml*#solutions of reseinru&mine caused no change in the 
rate of outflow* When the concentration was increased to 
10*0 pg# per ml* there was a gradual decrease in the 
outflow apparently due to constriction of the blood vessels* 
A marked constrictor effect m m  also observed when 
resolimamine in the dose range of 0*05 to 0*10 mg* was 
injected through the injection cannula* Ho antagonism 
vfes /
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Figure 17* Isolated strips of horse carotid artery*
(a) All contractions produced by acetylcholine 
0*05 jig* per ml* Addition of acetyl­
choline to the bath was preceded 10 minutes 
earlier by
at C, control solution, and 
at K, reeciimamine 10 jig* per ml*
(b) All contractions produced by 5-hydroxytryotamine 
0*30 |tg* per tiiI# Addition of 5-hydroxytrypt- 
amine was preceded 10 minutes earlier by
at E, rescinnaiaine 10 jig, per ml*
60.
was shown to the vasoconstriction caused by 0.10 to 0.40 
jig. adrenaline following injection (0.10 ^g.) or 
perfusion (1.0 jig. per ml.) of resciiinamine• r£he control 
solution produced almost the same constrictor effect as 
the solution of rescinnaraine • In this investigation* 
it has not therefore been possible to demonstrate that in 
the Isolated perfused rat hindquarters rescinnamine has 
a direct peripheral vasodilator effect*
7. Isolated Guinea Pi ft Ileum.
In some preparations v®sciimamine* in doses of from 
.1*5 to 3*0 jig. per ml.* showed a direct stimulant effect 
whereas in others no direct action* even in doses of up to 
20 jig. ml.*- was seen. The stimulant effect was 
completely inhibited by 0.1 jig. atropine (Fig.18* p.61). 
The control solution showed no direct action.
Contractions of the guinea pig ileum following the 
addition to the bath of acetylcholine (0.04 to 0.08 pg. 
per ml.) or histamine (O.04 to 0.10 jig* per ml.) were 
reduced by 2.0 to 20.0 pg. per ml. of rescinnamine 
(Fig.19, p*62). The extent of the reduction in the 
amplitude of the contraction appeared to be related to the 
dose of rescinnamine in the cose of acetylcholine* but not 
in /
61.
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! l:;ure 19* Isolated guinea, pig ileum.
(a) Ail con[tractions produced by acetylcholine
0.08 jAg. per ml* Addition of acetylcholine 
to the bath was preceded one minute earlier 
toy
at A, rescinnandne 5 per ml. 
at B, w 10 pg, per ml#
at C, n 20 pg* per ml*
(h) All contractions produced by histamine 0.10 
p,g* per ml* Addition of histamine to the
bath was preceded one minute earlier by
at A# resoinnamine 8 |Ag. per ml*
at B$ '* 4 p.g* per ml*
in the ease of histamine* Recovery of the contract lone 
to the control height was usually complete# although the 
time required for the histam±nft«»induced contraction to 
recover was the more prolonged (Fig. 19b, p*62).
In the case of histamine the maximum inhibition was always 
produced some time after the addition of resoinnamine * 
generally after two to four additions of histamine 
In the case of acetylcholine, the 
contraction induced immediately after addition of 
resoinnamine showed the maximum inhibition (Fig*19*# p*62) • 
fhe control solution had no Inhibitory effect*
8* Isolated Rabbit Duodenum*
fiwo to four pg* per ml. of reoeinnamine had no
effect upon the spontaneous activity of the rabbit 
duodenum, but there w&& usually a reduction in the normal 
tone as recorded by a fall in the level of the recording 
lever (Pig*20b, p* 64 )• fhe control solution had no 
effect*
Contractions of the duodenum following addition to 
the bath of acetylcholine (0*004 to 0*04 g* per ml*) and 
the reduction in tone produced by 0.05 to 1*0 jig* per ml* 
of /
¥lmre 20* Isolated rabbit duodenum*
(a) At A, acetylcholine 0*004 pg* per al»
At K, rescirmamine 1*0 ^g* per ml*
(b) At A# adrenaline 0*)5 M>£* per ml*
At B, reecinnamine 2*0 j.tg* per ml*
of adrenaline were unaffected by doses of reeeinnaraine 
within the range of 1*0 to 4*0 *ig* per ml* (Fig*20, p*64).
9* Isolated Frog iiectue Abdominis Muscle*
In soil® experiments rescinnamine in doses of from 
5*0 to 50 tig* per ml* had a direct stimulant effect upon
the rectus muscle (Fig*21, p*66 )• Immediately after the 
addition of reocinnaoiine to the hath there was a slow 
contrsotural response* fhe magnitude of the contracture 
varied from test to test, even s&ten the same dose was used* 
(iig*21)*
Ihe contracture was not reduced by prior addition to 
the bath of atropine (1*0 to 10*0 jig* per ml*) or 
tubocurarin© (5*0 to 10*0 |*g* per ml*)* The control
solution had no direct stimulant effect*
When reeeinnaraine did not cause a contracture, it 
showed antagonism to acetylcholine-induced contractions of 
the rectus* Following 50 ytg* per ml* of re sc innamine, 
the magnitude of the acetylcholine-induced contractions was 
reduced by about 30 per cent, but doses of less than 30 
pg* per ml* had no significant effect (Fig*22b, p*67).
When reseirmamine (10 to 20 ^g* per ml*) wan allowed to 
x’emain /
ffigure 21* Isolated frog rectus abdominis nuocle*
(a) At R, reBcinnaTfdne 50 |ig« per Hi*
At c, control solution
At w, wash out,
(b) At R, re-oinna nine 15 \%g„ per ml*
At c, control solution
At w sh out*
ffi&ure 22. Isolated frog rectus abdominis muscle*
(a) bnlabelled contractions produced by acetyl­
choline .15 m> • per ml*
At C, control solution
At W, wash out
At K, reseinnamine 20 p.g. per ml.
(b) All contractions produced by acefcylcholine 
0.10 VL&p per ml.
At ares c inn am in® 10 prg. per ml#
At Eg, " 20 ng* per ml.
At n 50 (ig. per ml.
remain in contact with the rectus for longer periods# a 
marked inhibition of the acetylcholine-induced contraction 
was observed (P±g#22a# p. 67).
10# nictitating Membrane of the Anaesthetised Oat#
Kesciimamine in doses of from 1*0 to 2#0 mg# per kg# 
showed no direct effects upon the nictitating membrane of 
the anaesthetised cat* There was n© immediate effect 
upon the magnitude of contractions due to indirect 
tetanieatlon of the cervical sympathetic* but about thirty 
minutes after an injection of 2*0 mg* per kg* a 
significant reduction of the amplitude was observed# After 
about three hours had elapsed# the magnitude of the 
contraction was reduced to about 30 per cent of the original 
(»i6.23* *.69).
•ure 23* Cat. Pentobarbitone anaesthesia.
C ontraetio 3 of nictitating mtbrane elicited nt 
intervals of three linutes by preganglionic 
stimulation at a frequency of 1,000 i. ipulses per 
minute, 10 volts, raise width 1 msec* for 10 
seconds*
At A, rescinmnine 0*5 mg* per kg* intravenously* 
At B, rescinna mine 2.0 mg. per kg. intravenously.
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Discussion
Eesciimamine causes arx im&ediate but short~lived, 
sharp fall in the blood pressure I©/el of the anaesthetised 
cat (fig#5 ,p#4-l. )• There is also some. reduction in .
the level of the blood pressure at the end of three or four 
hours and this sight be considered to indicate a 
hypotensive action* On the other hand, there is almost
always a reduction in the blood pressure level of the
anaesthetised oat alter three or four hours on the 
operating table, end control experiment® Indicate that 
reseinaamine has apparently very little hypotensive effect 
upon the normotensive cat* Cronheim ei alia^ have,
however, claimed that rescinnamine has a definite hypo«*
teneive action on normotensive doge*
Ecscinnamine abolishes or reduces hypertension due to 
adrenaline or noradrenaline in anaesthetised and spinal 
Oats, but ganglion blocking agents and reserpine increase 
the hypertension caused by injected adrenaline or
p
noradrenaline * Eemelnn&rnine does not alter or may 
slightly inhibit the pressor responses due to adrenalins 
or noradrenaline in the cat, but in the clog it has been 
reported to potentiate the pressor response to adrenaline'*'*
The /
The magnitude of the prensor response tfbStsh is due 
to stimulation of the pressoreceptors, and which fellows 
bilateral ©©elusion of the carotid arteries, ia reduced
significantly following rescinnamine# It has been 
concluded by Eeymans^ that drugs which cause the 
muscular walls of the carotid sinus to contract inorease 
their intrinsic tension and decrease their disteneibility, 
thus causing stimulation of the receptors at the endings 
of the carotid sinus nerves# This stimulation reflexly 
Induces a fall in the systemic arterial blood pressure 
end decreases the hypertension normally produced by a 
decrease of the blood pressure in the carotid sinus*
Drugs udiich relax tiie arterial walla of the carotid sinus 
and increase their distensibility induce a reflex rise 
of systemic arterial blood pressure# Stimulation of 
ehemoreeeptor® by inhalation of a low-oxygen mixture also 
produces a reflex rise of blood pressure in oats# These 
reflex pressor responses, as well as those produced by 
faradisation of the central end of the cut vagus and the 
splanchnic nerves and by occlusion of the abdominal aorta, 
may have the sasw  mechanism of action, i*e* liberation 
of adrenaline and noradrenaline from the nerve endings 
of the adrenergic nerves^, the reflex being mediated 
through /
through higher centre© in the brain* The fact that 
adrenergic blocking agents and ganglion blocking agents 
depress these reflex pressor responses supports this 
view* Although, the peripheral sympathetic nervous 
system is considered to represent the final atop 
responsible for the rise of blood pressure which is 
brought about by these reflexes2 and noradrenaline is the 
transmitter set free from the adrenergic nerve endings4* 
the differences in the composition of the adrenal 
medullary secretion after stimulation of different 
afferent nerves and of press©** and ohemcre ceptore* are 
also of importance in causing the blood pressure to rise * .
Xn oats it has been shorn that when those pressor reflexes 
ax© brought into play* about two-thirds of the medullary 
secretion is normally noradrenaline * As ha© already 
been indicated* rescimmmino antagonises the pressor 
responses elicited by faradisation of the splanchnic 
adrves and by bilateral occlusion ©f the carotid, arteries 
and abdominal aorta* and it abolishes the pressor 
responses due t© faradisation of the cut end of the afferent 
vagus and hypoxia# Antagonism to these pressor reflexes 
indicates that rescinaaaine may act by interfering with 
sympathetic activity in the central nervous system* because 
it /
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it show® no antagonism to the peripheral effects of circulating 
adrenaline or noradrenaline • Kescixmamine may also exert
its hypotensive effect by a specific depressant action 
upon the sympathetic ganglia, and the observation that It 
markedly reduces the response© of the nictitating membrane 
to stimulation of the preganglionic sympathetic fibres 
lends support to this view# In the dog, rescinnanlne 
has been reported to cause reversal of the pressor 
response to hypoxia, diminution of the pressor response 
to bilateral carotid occlusion and blockade or reversal 
of the blood pressure rise elicited by faradisation of the 
afferent vagu®^# Bein^ , using ressrpine, has observed 
similar effects in cat® anaesthetised with dialurethane| 
but in contrast to rescixmamine, reserpine does not cause 
inhibition of the pressor response caused by stimulation 
of the afferent splanchnic nerves# Be in considered that 
reserpine acted upon the central nervous system and had 
a direct effect upon the sympathetic autonomic centres in 
the brain which were responsible for the regulation of 
the blood pressure#
Depression of the rhythmic activity of preparations 
of isolated cardiac muscle was observed following the use 
of /
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of roocinn&aine. The rate end n.plitu&e of the 
contractions of the Isolated kitten and rabbit heart were 
decreased and the cardiac outflow was reduced. In these 
preparations# the sit® of action of rescirrrinmine appears 
to be directly upon the cardiac muscle. On the other 
hand,| reseinn&mlne does not seen to alter the character-, 
istie actions of cardiotonic drugs such as adrenalins* 
noradrenaline etc. on the isolated heart. Beseinnomine 
caused depression of the spontaneous activity of the 
isolated auricles but did not alter the stimulant effects 
Of adrenaline or noradrenaline.
Ho vasodilator effect was observed in the isolated 
ret hindquarters preparation following perfusion of 
rescinnamine# ■ cQuecm and Tlaekrnan 8# however# observed 
vasodilatation in the perfused rat hindquarters in which 
vasomotor tone had been increased by the infusion of 
noradrenaline« In the isolated rat hindquarters 
preparation# it is perhaps to be expected that little# if 
aay#neurogenic vascular tone should remain and that# in 
these circumstances# little or no vasodilator effect would 
be expected.
In experiments performed using isolated strips of 
horse /
hors© carotid artery* reseinn&mine showed little direot 
relaxant effect hut caused relaxation of contractures of 
artery strips elicited by adrenaline* noradrenaline* 
5-hydroxytryptamine * histamine or acetylcholine • Prior 
addition of rescimiamine to the bath also antagonised the 
effects of these stimulant drugs•
In the isolated guinea pig ileum* reseinnamin© 
depressed the stimulant actions of acetylcholine and 
histamine* It also caused a slow contraction of the frog 
rectus abdominis muscle* This effect was followed by a 
reduction in the magnitude of aestylcholine-indueed 
contraction ox the rectus muscle* i*e« not only had 
resoimiamine a direot stimulant action on the Muscle but 
it antagonised the stimulant action of acetylcholine*
She isolated tissue preparations used in this 
investigation differ widely in their sources* structure 
tod properties* Certain eharacterietie feature© of the 
action of reseirmasine on isolated muscle preparations 
can however be demonstrated* These are* its general 
depressant effects on the muscular activity produced by 
other stimulant drugs and the non-specific nature of 
these depressant effects*
It /
It is not possible to suggest one single 
mechanism of action which can account for all of the 
effects of reseinnamine observed in the intact animal 
and in isolated tissue preparations* laile rescinnaro- 
ine undoubtedly h e  mom effects upon the central 
nervous system* it appears from the study of its effects 
upon isolated tissue preparations that it may also 
have definite peripheral sites of action* Many of the 
peripheral effects of reacIrmamine -my* however* be 
explained if it is assumed that reacinna.aine acts by 
depressing the ability of smooth cardiac and skeletal 
muscle to contract* The site or sites of this action 
within the colls cannot as yet be defined.
From experiments on intact animals and on isolated 
tissues* it is difficult to assess the clinical value 
of a drug* In the anaesthetised normotensiv©
oat resciimamine causes little or no fall in the blood 
pressure level except for a short-lived* sharp initial fall.
JPhanaacologicnl studies with this alkaloid were made by
\
Crohheim ejt alia who* however, found it to nos aces '11 of 
the typical properties /
properties of reserpin© and of the alseroxylon fraction 
fcouwolfie serpentina as measured on the normotensive 
anaesthetised dog. This is in agreement with the 
clinical findings obtained by Hershberger and his co- 
workers^ and by Smirk and McOueen^ who reported rescinnam- 
ine to have similar hypotensive effects to reserpin© in 
man* That rescinnamine markedly reduces adrenaline and 
noradrenaline hypertension in anaesthetised cate may have 
some significance in its use as a hypotensive drug in 
man. Lemieux and his colleagues^* on the other hand* did
not agree with the clinical results obtained by the previous
q 1 0
investigatorsfollowing oral administration of 
rescinnamine* although they observed a significant lowering 
of blood pressure in man following its intramuscular 
administration*
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C K A P T E B  Y
S U M M A R T*
Esselnnsmins has been used in the treatment of 
hypertension and is classed t© be an effective 
hypotensive agent in man*
fhe pharmacological properties of resciimasiine have 
been studied in experimental animals and there appears to 
he little or no difference between the properties of 
reecinnamine and reserpin©*
In Chapter II of this section, various experimental 
procedures using intact animals and isolated tissue 
preparations in the study of the pharmacological properties 
of reocinnamine are described*
In Chapter III, the results of these studies are 
described* In the normotensive anaesthetised cat,
caused little or no fall in the level of the 
blood pressure* It depressed or abolished the pressor 
responses elicited by (a) faradisation of the central end 
of the cut vagus, (b) faradisation of the splanchnic 
nerves, {©) bilateral occlusion of the carotid arteries,
(d) compression of the abdominal aorta and by (e) hypoxia* 
Hypertension in anaesthetised or spinal oats due to the 
infusion /
82.
infusion of adrenaline or norad re naline was reduced by an 
injection of resoixinamine, but the pressor effect® of 
single injections of adrenaline or noradrenaline were 
either unaltered or slightly depressed*
Although its action is delayed, reeeinnamine has been 
shown to possess some ganglion blocking activity.
Eeseinnamine depressed the activity of preparations 
of isolated cardiac muscle. In isolated vascular (horse 
carotid artery) and intestinal (guinea pig ileum) smooth 
muscle, resoiimamine reduced the magnitude of drug* 
induced contractions.
In preparations of the isolated frog rectus abdominis, 
muscle, although rasolnnamin© had some direct stimulant 
effect, acety lcholine-induced contractions were inhibited.
In Chapter IV, the results obtained in the present 
study as well as those of other workers are discussed.
She possibility of a significant peripheral component in 
the effect© of resoimiamne in human hypertension is also 
discussed. It is concluded that while the drug has a 
definite action upon the central nervous system * which 
probably contributes largely to its antihypertensive 
effwat /
effect la man - peripherally induced relaxation of th* 
vascular smooth muscle may also play a part.
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The oldest known neuromusoular blocking agents are 
those grouped together as the curare alkaloids. The 
term "Curare** ie a wide one and includes many types of 
South American arrow poison. Curare has a long and 
romantic history which has been well described in a 
comprehensive review by HcXntyre* who has discussed the 
botanical sources, nomenclature and chemical 
identification etc. sir falter Baleigh^ in his 
"Discovery of Guiana", published in 1595, mentions the
v
arrow poisons of the South American Indians, and the 
first eye witness account of the preparation of curare 
was given by Humboldt^ who believed that curare Wae 
prepared by the natives of British Guiana from various 
species of Strychnos♦
Prior to the important contribution of Gill* in 
supplying a sufficient amount of the authentic drug 
which had been prepared from Chondrodendron tomentoeum. 
different specimens of curare were not of uniform 
chemical constitution or pharmacological activity. The 
side effects which were produced by any given sample of 
curare were also very variable* The only consistent 
observation v.as that the drug produced a naralysi© of
skeletal /
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skeletal muscle. Yet another major obstacle was the 
fact that the sources of the different curares had not 
been satisfactorily identified. Some semblance of 
order was created by Boehm^ who showed that there were 
three kinds of curare which were commonly available.
These could be classified upon the basis of the 
containers in which they were stored, transported end 
appeared on the market. These were* tube curare, 
contained and marketed in bamboo tubes, pot curare, 
found in earthenware jars and calabash curare, found in 
gourds. This system of classification has many obvious 
limitations and is no longer commonly used since 
purified preparations of constant composition and poteney 
are now available for experimental investigation and 
clinical use. Alkaloidal extracts are indeed seldom now
employed, having been replaced by tubocurarin# * a pure 
crystalline alkaloid.
The main raw material for the preparation of the 
various curares which were used by the South American 
Indians was either the bark of one of the many species 
of the genua Strychnos (most frequently, Btrychnos toxi- 
fera), or of Chondrodendron toraentosum. but many other plants 
appear /
8 6 .
appear to have been used*
6Although Bousslngault and Roulin prepared an 
extract from curare in 1827, the first systematic 
approach to the problem of the isolation of the alkaloids 
of curare was made by Boehm**. Boehm isolated certain 
quaternary bases called curarlnes from the varieties 
of curare which were then available* Boehm named the 
products obtained from calabash curare, the curarin©a, 
those extracted from pot curare9 the protocurarines, and 
the extracts of tube curare* the tubocurarines. He also 
isolated from pot and tube curare tertiary bases with 
we k neuromuscular blocking activity which he called 
curines• The chemistry of tube and pot curare was later 
investigated by r.ing^ * In 1958 .'.vieIntyre obtained the 
first clinically useful, standardised curare preparation 
from Oh and rod e net r on tomentosum* Subsequently 
crystalline tuboeurarine (Fig. 24 * p.87) (previously
isolated from tube eurore by King? in 1955) was prepared
8from the same plant by Wintersteiner and 'Butcher • 
Bimethyltubocurarine (Fig* 24 ,p*87)# a clinically useful 
derivative of tubocurarin©* was also prepared, by King? 
and by bintersteiner and Butcher0.
Calabash /
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Calabash curare was studied by Meland and his
9 to 1? i*associates , by Karrer and SchmidJ*;J# by Schmid and
iarrer^ by v*aser^*^ an<^  by Marsh*0 Of the
numerous alkaloids isolated from calabash curare, one 
of the most interesting is C-toxiferine-I (Fig* 24 *p* 87). 
It is thought to be the most potent of all the neuro­
muscular blocking agents, yet it contains only one 
quaternary nitrogen atom* C-toxiferine-I was also 
isolated from the bark of Strychnos toxifera by King^ and
Pi
studied by pat on and Perry vdio found that this compound 
showed less variation of activity from species to species 
than any of the neuromuscular blocking agents which had 
been investigated up to this time.
Another type of neuromuscular blocking agent which
occurs naturally is p-erythroidine, an alkaloid which was
r>oisolated by Polkers and ajor* c from the seeds of 
hrythrina amerioana* l)ihydro~{3~e ry thro idine which was
prepared from p-erythroidine by Policers and Major^ also 
possesses neuromuscular blocking activity and i© about 
six times as potent as p-erythroidine• In contrast to 
tuboeurarine end the other alkaloids of curare, both of 
these compounds ere tertiary amines and contain no 
quaternary /
quaternary nitrogen atoms*
Although Humboldt and Bonpland^ as long ago as 
18?1 had carried out on the frog nerve-muscle 
preparation what were probably the first experiments 
with curare, the earliest scientifically designed 
experiment to demonstrate the neuromuscular blocking 
activity of cursre was that described and carried out by 
Claude Bernard*^,26 X850* In his classic experiment,
Bernard showed that curare paralysed its victims by 
blocking the transmission of the impulse from nerve to 
muscle* One leg of a decapitated frog was tightly 
ligatured and an extract of curare injected intra- 
peritoneally* This technique ensured that the injected 
drug did not enter the circulation of the ligatured limb, 
although the rest of the animal wag affected* tifaen the 
nerve was stimulated above the ligature, the ligatured 
limb contracted and it was concluded that the drug did 
not affect the nerve itself* v/hen the opposite limb was 
stimulated in a similar way it did not contract, but if 
an electric ©hock or a small quantity of acid was applied 
directly to the muscle, then this contracted in a normal 
fashion* Bernard concluded that the drug had no 
direct /
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direct action on the nerve or muscle and met therefore 
act upon the neuromuscular junction*
The history of the modern clinical usage of curare 
may be said to date from the e tudies of west^ who, in 
193?, employed in the treatment of patients with tetanus 
and certain spastic disorders a highly purified fraction
no
prepared from crude curare* In 1940, Bennett 
introduced the drug as an adjuvant to the leptezol shock 
treatment of psychiatric disorders, and in 1948 Griffith 
and Johnson^ reported the results of the first clinical 
trial of curare as a muscular relaxant in general 
anaesthesia* In their pioneer studies, Griffith and 
Johnson^ administered curare in the form of Intocostrin, 
a purified standardized fluid extract obtained from 
Chondrodendron tomentosua*
In addition to the purified natural form of curare, 
tuboeurarine, we possess to-day a large number of 
synthetic muscle relaxants some of which are used in 
clinical medicine. These are pure chemicals of known 
composition and their pharmacological effects can be 
measured with a high degree of precision, ' ince their 
effects are readily predictable, they are widely used in 
surgery /
surgery to cause muscular relaxation by blocking the 
transmission of impulses from the motor nerve to the 
muscle and thereby permitting the use of smaller doses 
of volatile and other anaesthetics with a very desirable 
reduction in the associated undesirable toxic aide 
effects and in post-operative morbidity and mortality#
The muscle relsxants are especially valuable in 
abdominal pelvic and thoracic surgery, and in various 
orthopoedie procedures# They have been used to 
facilitate laryngoscopy, bronchoscopy and oesophagoacopy* 
They are also useful in some nervous disorders which 
cause spastic paralysis,and in controlling various 
convulsive states including those induced by electro 
shock therapy#
The isolation and characterisation of tuboeurarine
7
from tube curare by King' in 1935 gave a renewed impetus
to the investigation of the mode of action of neuro-
30muscular blocking agents# hale and his co-workers'
showed that when a motor nerve was stimulated, a nerve
impulse was initiated and that when this reached the
nerve endings it brought about the release of acetyl-
31choline at the neuromuscular junction# Cowan' 
demonstrated /
demonstrated that the acetylcholine liberated by the
motor nerve impulse in response to nerve stimulation
depolarised the end-plate and the potential difference
produced by this depolarisation (called the end-plate
potential by Eccles and his co-workers-^) was responsible
for the initiation of the propagated muscle action
potential which produced the muscular contraction#
Although certain aspects of the mechanism of neuromuscular
transmission are still controversial, it is now generally
accepted that both electrical phenomena and the acetyl**
choline-acetylcholine esterase system play important
33 34.roles in neuromuscular transmission"*' # According to
the "ohemico-electrical" theory of Eeldberg^, the
depolarization of the end-plate is e used by the
acetylcholine secreted at the terminal membrane which
diffuse© through the sub-neural space to reach the post-
35junctional membrane* In contrast to this, Naohmansohn 
in his "eleotro-cheraical theory” claims that the current 
generated at the terminal membrane reaches the post­
junctional membrane by jumping the "few microne-wide* 
sub-neural space end then liberates acetylcholine which 
is responsible for the depolarization of the end-plate# 
for convenience, the sequence of events in neuromuscular 
transmission /
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transmission may be summarised as followsi (1) the 
propagated nerve impulse causes the liberation of 
acetylcholine at the region of the end-plate, (2) acetyl­
choline is adsorbed on to cholinergic receptors on the 
post-junctional membrane, (3) the end-plate is partly or 
completely depolarized with consequent generation of the 
end-plate potential, (4) the end-plate potential reaches 
a critical level and the muscle action potential is 
initiated, (5) acetylcholine is hydrolysed by acetyl­
cholinesterase to acetic acid and choline (it is possible 
that end-plate depolarization and enzyme hydrolysis 
occurs simultaneously), (6) the end-plate becomes 
repolarized, (7) muscular contraction occurs towards the 
end of the phase of repolarization, (8) the choline 
acetylase system forms acetylcholine by a synthetic 
process from choline and soetate ions* (This is a 
simplification of what is certainly a complex biochemical 
process^.)
Much of the work on the physiology of neuromuscular 
transmission was done with the help of muscle relaxante* 
The work of Bums and his co-workers^, Burns and Paton^8, 
Paton and Zainis^ end others gave a considerable amount 
of /
information on the mechanism of action of the neuro­
muscular blocking agents* A neuromuscular blocking 
agent may be defined as a drug ahioh interferes with the 
transmission of the nerve impulse through the 
neuromuscular junction to the muscle fibres without 
modifying conduction in the nerve, and without affecting 
twitch tension in response to direct stimulation*
Although compounds other than quaternary ammonium
O O Oderivatives, _e_*g* tertiary a m i n e s * a r e  also capable 
of blocking neuromuscular transmission, the clinically 
useful neuromuscular blocking agents are all quaternary 
bases which produce neuromuscular block by inhibiting 
either the depolarization or the repolarization phases 
of neuromuscular transmission* Attempts have been made 
by a number of investigators to classify the quaternary 
neuromuscular blocking agents* The method of
"Z fl
classification proposed by Pat on and 2'aiaie*'^  distinguishes 
three types of neuromuscular blocks (1) competitive 
block, (2) depolarization block and (3) mixed or inter­
mediate block* Competitive block is caused by drugs 
which produce their effects by competing with acetyl­
choline at the end-plate region* The end-plate 
potential is progressively reduced to e level below that 
of /
of the normal threshold value until impulse propagation 
ceases and muscle contraction is abolished* A large 
number of synthetic or naturally occurring substances 
of this type ere known* Tuboeurarine is generally 
considered to be the typical representative of this 
group since it is by far the most thoroughly studied*
Depolarization block may be contrasted with that 
caused by competition by virtue of the fact that 
depolarizing drugs produce a persistent depolarisation 
of the end-plate* This causes an electrical 
Inexcitability at the end-plate region which is suffic­
ient to prevent the generation of end-plate potentials 
which are of a magnitude adequate to cause excitation 
of the adjacent muscle membrane* On the basis of its 
actions on mammalian (cat), avion (chick) and amphibian 
(frog) muscle, decamethonlum may be taken m  being the 
most typical representative of the group of drugs which 
produce block by depolarization* End-plate depolariz­
ation caused by deeamethonium end other depolarising 
drugs is associated with an initial phase of excitation 
or increased excitability* It is during this phase 
that spontaneous fasciculation of the muscle and 
potentiation /
potentiation of twitch height with repetitive firing 
to single nerve impulses are seen* As depolarisation 
persists# the phase of increased excitability soon 
passes over into one of inexcitability*
The properties of drugs producing mixed or inter* 
mediate types of neuromuscular block are different from 
the two types described* When t r i d ccamethonium which 
is a higher member of the methonium series is injected 
into chickst a contractural response is seen but there 
elowly ensues a mixed type ox paralysis in which the 
legs are contracted and the head and neck are flaccid* 
Finally there appears a typical generalised flaccid 
paralysis* In the cat successive injections of 
tzideoamethonium lead to an increasing retractoriness* 
to paralysis of the tibialis muscle and to an increasing 
sensitivity of the soleus muscle to neuromuscular block* 
Thus decamethonium-like activity is replaced by a 
tuboeurarine-like effect# In the alkyl trimethyl ammonium
series studied by Dallemagne and Philippot40#41# iower 
members have predominantly decamethonium-like properties 
and cause depolarization of the end-platef whereas the 
higher member© have a mixed competitive-depolarising 
type /
type of effect* Similar results have been obtained
42 43with a series of choline esters of adipic acid * 
in which the methyl groups cn the choline nitrogen 
atoms were successively replaced by ethyl groups*
AdipyIcholine itself is a depolarising agent and this 
is still time when one methyl group is replaced by an 
ethyl group* Mth three ethyl substituents on each 
nitrogen atom it becomes tubocurnrine-like in its 
properties and antagonises the neuromuscular blocking 
activities of the parent compound* The diethyl methyl 
derivative is intermediate in its properties, ©o that 
it ean# for instance, produce a contracture of avian 
muscle and also terminate a similar contracture which 
has been elicited by administration of the parent 
substance* The block produced by this type of drug 
is not typical of either competitive block or of the 
depolarising block, and is described as a mixed or 
intermediate block*
fhe classification suggested by Bovet et alia^
grouped decamethonium, suxamethonium and related
substances under the heading "leptocurares11 ? compounds
related to tuboeurarine and gsllamine were described as
"pachycurares"* In proposing the use of this system
of /
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of classification, Bovet and his colleaguss suggested 
that those neuromuscular blocking ©gents with long, 
thin molecules should be called lent©curares. fhe 
leptocurares ©11 possessed deeamethonium-like 
properties, whereas those drugs with fat or thick 
molecules (termed p&chyeurares) resembled tuboeurarine#
This is not always true. Nicotine which has a thick 
molecule, and might be described as a pachyeurare, 
causes neuromuscular block in the cat by depolarization 
of the muscle. Tridec© methonium which has a structure 
which would lead to it© being classified as a lepto- 
curare behaves pharmacologically, in some respects, like 
tuboeurarine - a pachyeurare - in that when injected 
into chicks it does not cause th© typical spastic 
paralysis obtained with decamethonium, but produces ah 
effect resembling that caused by tuboeurarine. Another 
objection to Bovet*a system of classification is that 
it is a rather exclusive one, and implies that there are two 
discrete types of compound with two quite different modes 
of action. As has been shown this is certainly not the 
ease. More recently, Boldest divided the neuro- 
muscular blocking agents into (1) non-depolarizing 
and /
and (2) depolarizing agents. This system of 
classification possesses some advantages, and it offers 
a system into which most of the available experimental 
findings can be fitted, but it is difficult to allot 
to either group certain substances which have been 
shown to have some properties in common with deoamethon- 
ium, others in common with tuboeurarine and still others 
not shared by either tuboeurarine or decaraethonium.
3, 6 - bis {2~diethyl-aiiinopropoxy) pyridasin© bis - 
methiodide studied by Gesler and Hoppe^ possesses these 
anomalous properties and more closely resembles the
Aftcompound diprop amine investigated by Vi? inter and Lehman. 
These two compounds are shown in figure 25, page 100,
3aeh classification may possess certain merits of 
its own but the classification suggested by Paton and 
Zaimis appears to be more suitable for the purpose of 
discussing the various types of neuromuscular blocking 
agents which are quaternary ammonium derivatives. When 
tuboeurarine and other substances having a similar 
mechanism of action are classed as competitive, and 
deoamethonium and other substances with a similar type 
of action are described as depolarizing neuromuscular 
blocking /
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blocking agents, a number of substances which cause 
neuromuseulcr block, but in ? manner different from that 
caused by either tuboeurarine or deeamoth onium yet 
sharing certain properties in common with these 
compounds, may be conveniently classed as drugs with an 
intermediate type of action* The competitive and 
depolarizing types of neuromuscular blocking agent have 
properties which appear to be characteristic of the 
members of each group; but the compounds which belong 
to the intermediate class cannot be rigidly 
differentiated from the members of either of these two 
former groups* Compounds which are described as 
being intermediate in type may have certain properties 
in common with tuboeurarine, others in common with 
decamethonium: some properties may be unique and
have nothing in common with either of these compounds*
In the case of both the competitive and the depolariz­
ing type of neuromuscular blocking activity, it may be 
assumed that the members of both classes compete with 
acetylcholine for cholinergic receptors at the end~pl*te 
and are capable of preventing the access of acetyl­
choline to these receptors, partly because of their 
greater stability and partly because of their greater 
affinity for these receptors. After being
adsorbed /
adsorbed on to the cholinergic receptors the members of 
th© two groups behave in a different manner* fhie 
behaviour may be described as follows; After 
adsorption on to the cholinergic receptors, the activity 
of the eompetitivi® type of neuromuscular blocking agent 
is limited to the prevention of the access of acetyl­
choline to these receptors* The configuration of the 
receptor remains unchanged; there is no depolarisation, 
nor is there any change in the resting potential of the 
end-plate and consequently no muscular contraction can 
be initiated* This type of neuromuscular blocking 
agent exhibits a uniform behaviour and causes flaccid 
muscular paralysis in all of the mammalian, avian and 
amphibian species investigated*
Neuromuscular blocking agent© which act by depolar­
ization cause a typical depolarization block in birds, 
amphibians and in certain mammals (cats and 
These agents cause depolarization of the end-plate in 
a similar manner to acetylcholine but,in contrast to 
acetylcholine, the depolarization persists, spreads to 
the parts of the muscle fibre adjacent to the end-plate 
and makes the muscle fibre insensitive to subsequent 
stimulation* /
stimulation* In certain other species of mammals 
however, except perhaps for a brief period of depolar­
ization, the block produced by these ©gents shows the 
typical characteristics of competitive block.
The difference in the activity of the two groups 
of neuromuscular blocking agents can be explained by 
the hypothesis^0 that the type of block produced by 
these compounds depends primarily upon the chemical 
structure of the agent, and secondarily upon the 
properties of the cholinergic receptors. The chemical 
structure of the competitive type of neuromuscular 
blocking agent is such that, under physiological 
circumstances, they will not change the configuration 
of the receptors and will produce a competitive block 
in all species. The block produced by the depolariz­
ing blocking agents depends on the properties of the 
receptors in the post junctional membrane of the species 
involved. In some species where the configuration of 
the receptors can be changed easily, relatively small 
doses produce a depolarization block. In other species 
where the receptors are more resistant to changes of 
configuration, small doses of depolarizing drug 
produce /
produce no neuromuscular block at all and largo doses 
cause a-'competitive type of neuromuscular block*
The major differences in the two types of neuro­
muscular blocking agents are described in Table 1,
page 105•
Comparison of Competitive and Depolarizing 
Muscle Relaxants
Competitive 
type of 
muscle 
relaxant
Depolarizing 
type of muscle 
relaxant
1* Initial excitatory effect 
on striated muscle
Hone Transient 
faseieulation 
i,e* excitation
2* Effects of administering 
different competitive 
muscle relaxants
Additive Antagonistic
% Effects of administering 
different depolarizing 
muscle relaxants
Antagonistic Additive
4. Indirect tetanizstion of Poorly sus­ Well sustained
the partially blocked 
muscle
tained
contraction
contraction
5* Effect of ether Increased Ho effect or
6#
anaesthesia 
Effect of
effect antagonism
(a) Previous tetanizstion 
of the motor nerve
Antagonism Ho effect
(b) Potassium Antagonism Ho effect
(c) Anticholinesterases Antagonism Little effeotf 
occasionally 
feeble potentiat­
ion or antagonism
T.
(d) Edrophonium
Effect of current applied 
to the end-plate region.
Antagonism Ho effect or 
potentiation
(a) Anodal Current Intensifies
paralysis
Lessens paralysis
(b) Cathodal Current lessens
paralysis
Intensifies
paralysis.
The first attempts at the production of synthetic
muscle relaxants were the syntheses by Crum-Brown and
Eraser^ in 1369 of the quaternary derivatives of strychnine
and brucine, raethylstrychnine and raethylbruoine# Crum-Brown
and Prezer repeated Bernard’s experiments and showed that
these quaternary derivatives of strychnine and brucine had
certain properties analagous to those of natural curare*
It was recognised later that this type of action was a
characteristic of many quaternary amines”*®, and that some
*51tertiary ammonium compounds such as atilbamidine^', quinine, 
nicotine and p-erythroidine had similar properties# Many 
well known drugs including atropine, quinine, strychnine etc# 
show a marked increase in neuromuscular blocking potency when 
their nitrogen atoms are quaternized, while the neuromuscular 
blocking activity of p-erythroidine and dihydro-p-erythroidine 
is actually abolished by quatemization of the nitrogen atora^. 
Other atoms may be substituted for nitrogen* thus neuro­
muscular blocking activity has been reported among sulphonium, 
phosphonium, arsonium, stibonium end iodinium compounds •
Partly because of the relative difficulty in getting 
supplies of Chondrodeadron foment osuia and partly bo cause of 
the incidence of untoward side effects^ #54 occasionally
accompanied /
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accompanied the use of tuboeurarine, a systematic search for 
synthetic neuromuscular blocking agents was started by 
several independent groups of investigators* The main 
object of this was to obtain synthetic compounds with a more 
selective action on the neuromuscular junction* The early 
attempts by Yvest^ to utilize in man the eurerizing action 
of trimethyl hexyl ammonium iodide, and that of trimethyl- 
oetylammonium iodide by Burnian^, were not successful because 
the actions of these compounds were not. sufficiently 
selective•
Many of the recent advances in the history of synthetic
neuromuscular blocking agents are due largely to the work
of Bovet and his co-workers who, after a consideration of
the chemical structure of tuboeurarine, attempted the 
%
synthesis of quinoline and isoquinoline derivatives with 
curarlzing action*
In 1946 Bovet and his colleagues**^ ***8 described the 
preparation and neuromuscular blocking activity of 
8^ - - diquinolyloxy - 1,5 - pentane, di-iodoethylate
(3381 H*P* )(Pig*26, p*!D8)« This compound was the first 
synthetic compound which had significant curarizing activity 
in mammals and which had a potency and selectivity co?3parable 
with /
108
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with that of the naturally occurring alkaloid* That 
even simpler compounds which lacked the quinoline or iso­
quinoline nucleus could exhibit eurarizing activity was 
shown in 1947 by Bovet and his co-workers*^ when they 
synthesised and tested a series of bis quaternary 
derivatives in the aromatic amine series) the most 
interesting member of this series was the bis-(dimethyl 
amino 2t ? - phenoxy) - 1, 5 pentane diiodoinethylate 
(3565 R•£*) (Fig*26, p*108)* In certain species and in 
certain preparations, this compound was equal to or even 
greater in neuromuscular blocking activity than tubocurar­
in© • In the seme year, a series of ethers of 
p-hydroxyethyltriethylrrinioiiium were prepared and examined
Kfl £Q
by Bovet e£ alia 9 • Tri-( (3-trie thyla nmoniumethoxy) -
1,2,3-benzene triiodide (Gallamine) (Fig*26, p.108), the 
most potent member of this scries, showed both in 
experimental animals and in clinical trials certain 
promising features* The undesirable side effects which 
occasionally follow the use of tuboeurarine were absent* 
When the potency of this compound was estime.ted by the 
rabbit head drop test*^, it was shown to have an activity 
of about one fourth of that of tuboeurarine* Its use in 
anaesthesiology /
anaesthesiology was first reported by Huguenard^ 
and later by Mush in and his associates^. Gallamine 
appears to act in the same way as tubocurarine in that 
the neuromuscular block is antagonised by neostigmine^ 
and edrophonium^*^, and the neuromuscular blocking effect 
is potentiated by ether anaesthesia^, The duration of 
action of gallamine is signifleantly shorter than that of 
equipotent doses of tubocurarine, and cumulative effects 
result from the repeated administration of this drug. 
Shortly after the publication by Bovet and his co-workers 
of the results of these studies on the pharmacology of 
gallaraine, Barlow and Ing6^*69 and Baton and 7pimis^,^ ’^#^ ^ 
simultaneously but independently reported on the 
neuromuscular blocking activity of d e c a me th onium, the most 
active member of the polymethylene bis trimethyiammonium 
series (Eig.27# p.lll)* It was from the members of this 
series of compounds that drugs which were appreciably more 
potent than tubocurarine were obtained^ 72.
Becamethonium was found to be ©bout ten times as potent as 
tubocurarine in causing neuromuscular block in the tibialis 
muscle-sciatic nerve preparation of th© oat. Eserine and 
neostigmine had no effect on decame thonium block but 
tubocurarine /
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27* The structural formulae of decamethonium
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7 ?tubocurarine had an antagonistic effect • Deoernetbonium
73was fir?3t used in clinical anaesthesia by Organ® et alia 
in 1949* It is a satisfactory agent for the production
of muscular relaxation for moderately short surgical 
Operations but has latterly been used very little*
The dimethyl ether of tubocurarine was prepared by King^
in 1935 and the pharmacological properties of this compound
were described by Collier and his co-workers*^* in 1948*
In this compound the two hydroxy-groups in the tubocurarine
molecule were replaced by roethoxy-groups (Fig*24, p#87 )•
Biaethyltubocurarine was found to be about three times as
7*5potent as tubocurarine in manf^  and to possess pharmacolog­
ical properties similar to those of tubocurarine, except 
that the histamine liberating and ganglion blocking action 
of this compound were less marked^,77* Dimethyl- 
tuboeurerine was evaluated clinically by Stoe1ting and 
his co-workers^®*^ in 1948*
The neuromuscular blocking activity of suxamethonium, 
which may be looked upon as bis acetylcholine (Fig*27,p*111),
OQ
was discovered independently in 1949 by Bovet erfc alia" and 
by Phillips • Its neuromuscular blocking activity was 
overlooked /
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overlooked by Hunt and Taveau8  ^(who Investigated this 
compound in 1906), because their experimental technique 
involved the use of curare to immobilise the
experimental animals* Although suxamethonium is a 
potent neuromuscular blocking agent it hr® a short duration 
of action. This was believed to be because the molecule 
of suxamethonium was almost completely hydrolyzed in the 
organism by plasma cholinesteraee• Hydrolysis first
took place in two stages: first, fairly rapidly, to form
succinylmonoch oline and choline8  ^ and secondly,
much more slowly, to form succinic acid and choline*
The paralysing effect of suxamethonium was found not to be 
antagonised by neostigmine or edrophonium and was actually 
intensified and prolonged by these two anticurare agents*
The pharmacological properties of suxamethonium were also 
studied by Castillo and de eer8  ^and by de Beer and his 
colleague®8?, and the first clinical trial® were reported 
by Brucke ejb alia88, fhesleff88 and Mayrhofer ©nd Has ©further* 
In relaxant doses, (provided that adequate carbon dioxide 
removal is ensured) suxamethonium only affects neuromuscular 
transmission8^•
Another interesting compound, benzoquinonium (Fig.28, 
p.114), /
A. B en z o q u in o m u m  C h lorid e
O - C H
CH
B. L -a a d e x ia m  Io d id e
figure 28* The structural formulae of ben*©-
quinonium and laudexlua*
2*114), which had a hi$i degree of neuroiausculer blocking
op
activity was synthesised by Oavallito eifc alia but 
prituarily as part of a program© of study of agents with 
antibacterial activity* It was investigated 
pharmacologically by Hoppe93*94 in 1950* This compound 
was found to be five times more potent than tubocurarine 
when tested by means of the rabbit head drop method, but 
in man it was only slightly more potent, while its 
duration of action was intermediate between that of 
tubocurarine and deearaethonium* Benzoquinonium reduced 
the effectiveness of a subsequent injection of 
decamethonium-7 , and the muscular relaxation caused by 
this drug was potentiated by ether anaesthesia^ ®nd was 
not preceded by initial stimulation* In these respects > 
it resembled tubocurarine but on the other hand its 
neuromuscular blocking activity was only partially and 
Irregularly antagonised by neostigmine*^ and was actually 
intensified by edrophonium* The first clinical trial of 
this drug as a muscle relaxant in anaesthetised patients 
was reported by Arrowood^* Besides its neuromuscular 
blocking action, benzoquinoniua stimulated th© vagus 
causing a marked increase in salivary and bronchial 
secretion, and a tendency to bradycardia^*^•
Laudexium /
Laudexium (Fig.28,p*114), another clinically useful 
neuromuscular blocking agent, was synthesised by Taylor 
and Collier^®*99 during an investigation of a series of 
decamethylene bis - ls2*3*4 - tetrahydro-?~methyl 
isoquinoliniura salts. Its pharmacological properties 
were studied by Collier end Macauley**'0^ in 1952* This 
compound was first used in clinical anaesthesia by Bodman 
et alia^Q^ in 1952* In the rabbit and the cat, 
laudexluia was more potent; and in the rat and the mouse 
it was less potent than tubocurarine* When tested on the 
sciatic nerve-tibialie muscle preparation of the oat, its 
duration of action was about 50 per cent longer than that 
of tubocurarine* Neuromuscular block was antagonised by
TAO 1neostigmine* and markedly potentiated by ether anaesthesia 
end its cumulative effect was greater than that of tubocur­
arine •
A new series of aliphatic triequaternary ammonium 
compounds (Fig.2 9,P •117)* ia whioh the number of carbon atoms 
between the quaternary nitrogen centres varied from five to 
nine, were prepared and examined for pharmacological 
activity by Kensler et glto3^  in 1954. Two tynes of
activity were observed, namely, the production of
neuromuscular blockade and the inhibition of vagal slowing
of /
117.
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Figure 29m The structural formulas of
A. 5-(4~di©thylaLiinobutyl)~1# 9-bis diethyl amino-
nonane triethobromide (H * * Kg « * 4)
and
Bo Tetrakis-(dimethyl eminomethyl)-meth©ne tetra- 
methobromide (SKP 2091)♦
of the heart* The most potent compound among this series 
was found to he 5 - (4-diethylaminobutyl) - 1,9 - bis 
diethylaminonon&n© triethobromide (444®, Fig*29,A, p.117) 
where R * end n^* 4) which had about 40 per
cent of the activity of galla nine when tes ted by the rabbit 
head drop test* Its mode of neuromuscular blocking action 
was similar to that of gallamine and tubocurarine in that 
in the kitten phrenic nerve-diaphregm preparation its 
paralysing effects were antagonised by edrophonium, ©nd 
it was found to antagonise the stimulant actions of 
acetylcholine on the isolated frog rectus abdominis muscle*
When it was found that bis and tris quaternary
derivatives possessed potent neuromuscular blocking
activity, it was not unnatural to expect s search to be
made for compounds containing even more quaternary nitrogen
atoms* Tetrakis - (dimethylaminomethyl) - methane tetra
aethobromide (SKF 2091), the most potent of the series of
tetraquaternary ammonium aliphatic methonium compounds,
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was examined by Kens-ler et alia* The structural
formula of this conpound is shown in Fig*29,p.117. In th©
kitten phrenic nerve-diaphragm preparation this compound
showed neuromuscular blocking activity of p. type which
resembled that of deermethonium rather than that of 
tubocurarine /
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tubocurarine in that (a) the block vas not sniagonised 
by neostigmine or edrophonium, (b) it produced 
contracture of the isolated rectus abdominis muscle of the 
frog and (c) injection into the chicken produced a spastic 
not e flaccid paralysis*
Although tubocurarine, gallamine, suxamethonium and 
a number of other muscle rejaxantc are being widely used in 
clinical practice end ere in general satisfactory, all of 
them are at times guilty of causing untoward side effects* 
Histamine liberation and ganglion blocking activity are 
shown by tubocux’arine, an inhibitory effect upon the cardiac 
vagus is shown by gsilamine and c lack of suitable 
antidotes is a major disadvantage in the use of decamethon- 
ium and suxamethonium. The search for the ideal muscle 
relaxant can by no means be considered concluded and active 
investigation© are ©till being carried on in this field*
The greatest need is, without doubt, for a short acting 
relaxant which acts by competition with acetylcholine 
because,although suxamethonium is usually satisfactory for 
short surgical procedures, it causes initial stimulation of 
the skeletal muscles, and occasional reports of prolonged
n m F)*7
apnoea have appeared in the literature. *
A /
A series of aliphatic straight chain polymethylene 
ethonium compounds having three and four quaternary centres 
(Figs*3 >,31 and 32, pages 171, 122 and 1^3), which were 
synthesised by Edwards and 3tenlak®^^*^9, have been 
investigated for neuromuscular blocking activity* These 
compounds have more than two quaternary centres and they 
are all ethonium derivatives* This work has been carried 
out for the following reasons. It was hoped to demonstrate 
in this series rioc only neuromuscular blocking activity but 
also ganglion blocking, and in consequence hypotensive, 
activity. uanglion block is not caused by any of the 
compounds which have been investigated, but their neuromusc­
ular blocking properties were so interesting that it was 
thought well worth while pursuing the study of this aspect* 
In some of the trisqusternary compounds the nitrogen atom in 
the centre has been replaced by sulphur or by a non­
ionised sulphone group (Fig* 30,(1) and 31)* The methonium 
analogue of compound dihexasulphonium (Fig*31 (1)) was 
also available*
The work described in this part of the thesis was 
undertaken to investigate the neuromuscular blocking 
activity of these compounds in different species in order 
to correlate the degree and type of muscle relaxant
activity /
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Figure 30* The structure! formulae of dihexona, 
dihexaaeonium, dioeta&sonium and dldeeaaeonltn
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C H j
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Figure 31* 2fhe structural formulae of dihexasulpbon- 
ium trimethiodide9 dipentasulphonium, dihexasulphon- 
ium# dioctasulphonium end didecasulphoniunu
IO *TO  «
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Figure 32• The structural formulae of
A* trishexatetrassonium and B. trisdeoatetragoniuai.
activity with the chemical structure# The relationship 
of pharmacological activity to chemical structure in the 
neuromuscular blocking agent® is a complex subject# An 
apparently small alteration in molecular configuration may 
profoundly change the type of action of a compound end 
cause a large alteration in potency# Pell known
examples of this are the chan.gee in the neuromuscular 
blocking activity brought about by the replacement of 
methyl by ethyl groups on the quaternary nitrogen atom® 
of the neuromuscular blocking agents^vi The
distance between the quaternary centres is also reported to 
be one of the main factors upon which the potency and the 
mechanism of action of the neuromuscular blocking agent® 
depend^*7b*72*115# in this investigation* the
relationship of pharmacological activity to chemical 
structure of some members of the new series of compounds 
has been studied with reference to (a) the influence of 
th® length of the polymethylene chains separating the 
quaternary centres* (b) replacement of the central 
quaternary nitrogen atom by a sulphone (SOg) group or by 
a quaternary sulphonium group and (c) the influence of 
the number of quaternary centres present in the molecules# 
In addition* the activity of these compounds on the cardio~ 
vascular system* on ganglionic transmission and on 
respiration of the cat have been studied /
125#
studied in some detail and comparisons with tubocurarine 
hare been made*
Xhe series of compounds Investigated have now been 
protected by letters patent and one coiapoundf diheaca^  
sulphonium, is undergoing clinical trial*
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0 H A. M B E  II
A* MATERIALS
Throughout this section of the thesis, the names 
of certain drugs have been abbreviated. The list of 
drugs used in this section, together with their 
shortened names, is m  follows*
(1
(2
(3
(4
(5
(6
(7
(8
(9
(10
(11
(12
(13
(14
(15
Acetylcholine chloride is described bb
Atropine sulphate * * *
(*} -Tubocurarine
chloride * * *
(-)-Mrenalihe
hydrochloride * » »
{*-) -Iforadre naline
bitarirate * * *
Histamine acid
phosphate ** * "
5~Kydroxytryptamine
creatinine sulphate * « *
Hemmethonlum bromide
Becamethonium iodide
Neostigmine methyl 
sulphate
Edrophonium chloride 
Eserine salicylate 
Potassium chloride 
Sodium pentobarbitone 
/
acetylcholine, 
atropine.
tubocurarine.
adrenaline *
noradrenaline.
histamine*
5-hydroxy~ 
tryptamine*
hexamethonlua.
decamethonium.
neostigmine, 
edrophonium# 
eserine * 
potassium, 
pentobarbitone «
(15) Ether anaesthetic is described as ether*
The compounds investigated in this section of the 
thesis, together with their shortened names, are shown 
below* Their structural formulae are shown in
Figures 30, 31 and 32, pages 121, 122 and 123.
1* 7*7 -Die thy 1-7 -ass oniat rid e cyleaebig (trie thylemmonium)
triiodide is described as dihexaajsonium# (Fig*30,2A*)
2* 9 * 9-Bi© thyl-9-agoniahep tr.de cylenebis (triethylammoniua)
triiodide is described as dioetaasoniuau (Flg#30,2B*)
3 * 11 tll-Bie thyl«-H**a»oniahene icosylenebis (trtethyl- 
ammonium) triiodide is described as d id e caagonium*
(Fig* 30, 20*)
4* 7 *7114 *14-Tetraetiiyl»7 *14*diagoniaeicoByleneb|g(triw
ethylasimonium) tetr&iodide is described as 
trjeihexatetnagonima* (Fig* 32, A*)
5 • 11 * 11 * 22122-Tetraethy 1~11122-diagoniadotriaeontylene-
bis (triethylammonlum) tetraiodide is described as 
trisdeoatetragonium, (Fig* 32, B.)
6 * 7-Me thyl^7*thionia tridecylenebis (trimethylammonium)
triiodide is described as dihexssulphonium 
trim©thiodide. /
6* /trimethiedide# (fig# 31# (1)*)
7 # 6~Ethyl~6«thicniaunde cylenebig( t ri© thyXammoniua) 
triiodide is described as dipentasulphonium#
(fig# 31# 2k.)
8# 7^ Bthyl*7^thionistrid@oyleaebi» (triethylBSKaoBiuE )
triiodide i© described as dihexasulphoniua#
(fig# 31# 2B.)
9# 9-£ihyl~9~thioniahepi&de cylenebi£( trie thylamstoniusi)
triiodide is described as dioct&sulphonium*
(Pig. 31# 20#)
10 • ll-Bthyl-»ll-»*thi oniahe ne ic osyle nebia (t rie thylammonium)
triiodide is described as didecasulphonium•
(fig. 31# 2D.)
11 • 7-Bioxothiatridecane-l sl3^ bis( trie thy lammonium)
iodide is described a® dihexone # (fig# 30#(1)#)
All the compounds mentioned in this section are 
aliphatic straight chain polymethylene derivatives. Trie- 
hexate trasonium and trisdecatetrasonium each have four 
quaternary nitrogen atoms whereas the others (excepting 
dihexon©) each have three quaternary centres* The 
quat©raary /
quaternary centres in each compound are separated by 
^olymethylene chains of varying lengths (Figs. 30# 31 and 
32> n « 5# 6, 8 or 10), Bihexone is similar in 
structure to dihexausenium and dihexasulphonium except that
4- -b
the central M or $ atom has been replaced by a nonquaternary 
sulphone («*30g) group# Shis compound is therefore a 
bisquaternary derivative* All the compounds described are 
©thonium derivatives with the exception of dihexaaulphonium 
trimethiodide which is the methyl analogue of dihexesulphon- 
ium and is a methonium derivative# All the compounds 
described are freely soluble in water#
The composition and methods of preparation of all 
physiological saline solutions used in this investigation 
are to be found in Appendix I (pages 334 and 336)#
The conventional abbreviations of the metric system 
for volumes and weights are used throughout this thesis#
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C H A P T E R  II
B*
Cat (gastrocnemius Huaele-Sclatio Herre Preparation*
m&m o b *
Gats of either sex# weighing Between 2*0 end 5*0 leg*# 
were anaesthetised by means of an intraperltoneal Injection 
of sodium pentobarbitone* The commercial, solution 
containing 60 mg* per ml# of sodium pentobarbitone 
(Nembutal-Abbott) was employed# A dose of 60 mg* per kg* 
was usually adequate for the production of surgical 
anaesthesia within 10 to 15 minutes*
Having anaesthetised the cat# the external jugular
vein end the trachea were caxmulated in a. manner similar to
that described on pages 11 and 12 of this thesis. Having
completed the cannulotion of the trachea and the external
jugular vein# the left leg m s  prepared for indirect
stimulation of the gastrocnemius muscle via the sciatic
nerve# The gastrocnemius muscle was partially dissected
free from the surrounding tissues# and the aohillee tendon
severed at a point near to it® Insertion into the calcaneus*
A strong linen thread was tied around the free end of the
tendon# The leg was held with its long axis perpendicular 
to /
to the operating table and fixed rigidly by means of two
clamps# one at the knee joint and the other at the ankle
(Fig# 33, p#146)# The thread tied to the achilles tendon
was led over pulleys and attached to a myograph lever# the
writing point of tihioU was adjusted so as to record the
contractions of the muscle upon a moving smoked surface#
By means of an incision made through the skin covering the
lateral aspect of the thigh# the sciatic - nerve was exposed
between the hamstring muscles* It m m  then crushed
proxinmlly between the jaws of a-pair of artery forceps#
and a pair of shielded platinum electrodes were placed
around the nerve distal to this point# The nerve was
stimulated using; single shocks by means of a Bobbie Molnnes
square wave generator at a frequency of 4 to 8 per minute#
at 10 to 20 volts# the pulse width being 2.0 to %0 msec#
In any one experiment frequency# voltage and pulse width
were kept coustaatf but. in some experiments the muscle was
also tetanlsed indirectly by using a frequency of 1#500
impulses per minutes and in ©there the muscle was also
stimulated directly at 40 volts after it had become
unresponsive to indirect stimulation# The tension placed
upon the muscle varied between 0#2 and 0#3 kg## and in any
one experiment tension was kept constant# The tension 
produced /
146 »
Figure 33• Method of recording contractions of the 
gastrocnemius muscle of the cat in response to 
indirect stimulation via the sciatic nerve.
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produced by the contraction of the muscle in response to 
electrical stimulation varied from experiment to 
experiment but usually remained between 0.6 to 0.8 kg.
The drugs used were administered in the form of solutions 
in normal saline* Injection was made into the robber 
connection between the Jugular vein cannula and the 
burette* The solution of the drug was washed by means 
of 4 ml. of saline.
2* The Babbit Head Drop Method.
This method was Introduced by Holaday^* in 1941 but
the procedure was first described in detail by Varney et 
2alia » The procedure followed in the experiment# to b# 
described is a modification of that described by Tarney et 
all*2*
METHOD.
Rabbit# of either sex, weighing between 1.5 and 3*0
kg., we re used. Mne rabbits were used for each drug. The
rabbits were placed into individual wooden bleeding boxes
in such a way that the head protruded through the opening
at the front of the box (I-ig.+34,p.l48). The animals were
allowed to sit quietly in the cages for some time before
the experiment was started. In all cases rabbits which 
had /
146*
Figure 34* Rrbbit Heed Drop Test*
I and II, before injection of drug. 
I l l  and IV, pfter injection of drug*
had not previously been used for experimental purposes 
vers employed* The drugs under test* and tubocurarin© and 
deoamethonium* were diluted with normal saline to give 
solutions with a final drug concentration of 0*05 mg, per 
ml# This was injected through a marginal ear vein* The 
injection was made by means of a Palmer’s slow infusion 
apparatus at a constant rate of 1*4 ml* per minute using a 
50 ml* all glass syringe connected by means of rubber 
tubing to a wHo*12* Record fitting hypodermic needle* The 
needle was inserted into one of the marginal ear veins and 
was held in place by means of a bulldog clip fixed just 
peripherally to the point of puncture* A ©trip of adhesive 
tape was used to fix the rubber tubing firmly to the ear*
The piston of the syringe was lubricated by means of liquid 
paraffin before use* so as to ensure smooth running* After 
making sure that all the air bubbles had been expelled from 
the syringe and the rubber tubing* the needle wa© inserted 
into the vein* the reading of the syringe was noted and the 
apparatus immediately switched on* The rabbit remained 
quiet until © few minutes before the end-point was reached* 
when there was usually a brief period of restlessness*
Soon after this point was reached* the rabbit’s head began 
to fall but the sniaol was still able to raise it voluntarily* 
Infusion /
Infusion was stopped as soon as the muscles of the neck 
were fully relaxed and toneless, and the animal could no 
longer x*oise its head in response to a light tap on the 
mussl©# At this moment the reading of the syringe was 
again noted# The difference between the two reading® 
gave the volume of solution injected# The dose required 
fox* head drop was calculated and expressed in mg# per leg# 
of body weight (See Table 3, p*226). The antagonism of 
neostigmine to the effects of the drugs injected, as well 
as to the effects of tubocurarin© and becamethonium, was 
also Investigated, again using groups of nine rabbits# for 
this purpose, a dose of 0#1 mg# per kg# of neostigmine was 
injected auhcutamecusly into the rabbit 15 minutes before 
the intravenous infusion was started# The ratio * head 
drop dose for the ne os tigmine-t re at e d animals / head drop 
dose for the untreated animals - was determined# If this 
value was greater than unity, this was interpreted as 
evidence of neostigmine antagonism and if less than unity, 
as evidence of potentiation by neostigmine of the 
neuromuscular blocking effects of the compounds under test#
3# Experiments upon Mice#
Estimation of the Approximate Median Paralysing Pegs (KP50)
151*
MEfBOP#
Solution© of drug© were injected intrap©riton©ally 
into mice of either s©x, weighing between 20 and 50 g#
Oroupe of 10 mice were injected at different dose lev©la# 
and were placed on a fine-iussh wire screen inclined at an 
eagle of 50° to the horizontal# fhis method wa® 
originally used by Thomson-^  for the assay of insulin in 
mice• Those mice,which developed a typical skeletal 
muscle paralysis and abruptly ©lid off the screen within a 
half-hour period after drug injection, were considered to 
show a positive reaction# She dose at which 5 out of 10 
Injected mice slid off the screen was considered to be the 
approximate median paralysing dose (PD 50)* This wa© 
expressed in mg* per kg# of the body weight#
4# Experiments upon Chicks,
Pour to eight day old chicks were used in these experiment®• 
Drugs in solution in normal saline were injected intra- 
peri tone ally into groups of six chicks for each compound 
(10 to 40 mg# per kg • )#and the nature and mod© of onset of 
the paralysis which developed was observed#
5# Experiments using the Isolated Eat Phrenic Nerve- 
ITiaph’raCT Fre'paration*
METHOD*
The /
The procedure adopted was essentially that described 
by BfUbxing^* Adult rats of either sox wore killed by a 
blow on the hoed, the throats cut and the blood allowed to 
drain out* The rat wee then laid on its back upon a 
cork-covered dissecting board to which it m s  pinned* The 
skin © rev the cheat m s  removed and the thorax opened 
along the right side of the sternum* The frontal part of 
the right thoracic -wall was removed* the nedlaslinuM 
behind the sternum wee severed, and a cut m s  made just 
above the frontal insertion of the diaphragm* Oar© was 
taken not to damage the phrenic nerve which is s ome times 
attached to the ribs* The frontal part of the left 
thoracic well was then removed and the phrenic nerve exposed* 
loth lobes of the left lung were removed, and the left 
phrenic nerve carefully freed from fat and other tissues I 
the utmost care was taken not to injure it# The left 
abdominal muscles were cut along the costal margin#
Holding the last rib with a pair of forceps, a segment of 
diaphragm was then dissected out* Two converging outs were 
made through the ribs towards the tendinous part of the 
diaphragm* and parallel to the direction of its muscle fibres* 
The outs were mode about 5 mit* to the right end 5 ?mt# to the 
left of the point where the phrenic nerve entered the 
Ciiap&ragB* /
diaphragm* The strip of diaphragm was dissected out 
'beyond its tendinous part with about 5 cm* of phrenic nerve 
attached to it# The final pre arntion m s  fan-shaped, 
being 2 am# ^iae at the tendinous end and about 20 rnm* wide 
at the costal margin# The costal margin of the diaphragm 
segment was fixed to a J-shaped glass rod. by means of 
platinum wires, and a thread was tied around the tendinous 
end. Hie preparation was then set up in a 100 tnl* Organ 
bath (Fig, 35, p *154) containing double glucose Tyro&e*s 
solution* The J-piece held 1lie costal margin of the 
segment in position- at the bottom of the organ bath, while 
the thread tied at the tendinous end was fixed to a light 
isotonic heart lever writing upon a smoked drum surface * 
Tyrode *s solution,containing double the usual amount of 
glucose, was aupplied to the bath from a reservoir via the 
heating coils* The benpe,aature of the bath was maintained 
thermostatically at 29- 0.5°C* A sintered glass 
distribution tube was fixed at the bottom of the bath to 
provide a vigorous supply of oxygen with which the bath 
fluid was aerated in a form of fine bubbles* A thread was 
now tied t© the cut end of the phrenic nerve and, by means 
of a fine needle, about on© cm* of the phrenic nerve was 
drawn into a fluid electrode"'. The fluid electrode 
containing /
_ .. Fresh 
Tyrode's 
Solution
^..Starling Heart 
Lever
Leads to 
Stimulator
Fluid electrode- 
Phrenic nerve- 
Diaphragm----
J '  Piede with 
platinum wire
Fluid-'*'
Heater
-Nerve
-White soft 
paraffin
Sintered Glass 
bubbler
♦Waste Pre-heating 
bottle
figure 55* Diagram of the apparatus used for 
recording contractions of the kitten or rat 
diaphragm produced by electrical stimulation 
of the phrenic nerve.
containing the nerve was filled with double glucose 
Tyrode*s solution and the hole at the bottom of the 
electrode was sealed off with soft paraffin. By this 
arrangement, the fluid surrounding the nerve at the point
of stimulation was not in electrical contact with the 
fluid surrounding the muscle in the bath. The nerve was 
left sufficiently slack to allow for any movement caused 
by the contraction of the diaphragm* Single square wave 
impulses were applied to the nerve by means of a Bobbie 
iielnnes * square wave generator at a frequency of 6 to 10 
per minute, at 8 to 12 volts, the pulse width being 0.5 
to 2.0 rnsecs• In m y  one experiment frequency, voltage 
and width were kept constant.
Drugs (in solution in double glucose Tyrode*a 
solution) were added to the bath by means of a 1 ml. 
tuberculin syringe. The drug was allowed to act for three 
minutes after v&iich the Tyrode*s solution in the bath was 
changed. Between the addition of one dose of the drug 
and the addition of the next, there was an interval of 
about 15 minutes during which the Tyrode *s solution was 
changed several times.
£■
West observed that the preparation gave a constant
response /
response of good magnitude for a longer period, if the 
temperature of the beth was lowered from 37°Q to 20°C.
He also found that the rat© of recoveiy of the muscle 
after the addition of a dose of tubocurarin© was greatly 
accelerated by adding potassium chloride to the bath after 
the tubocurarin© had been washed out* In the present 
series of experiments, it was observed that lowering the 
bath temperature from 37°C to 29°0 without addition of 
potassium chloride gave a satisfactory recovery, and that 
the magnitude of the muscle contraction was maintained in 
a satisfactory manner*
-■ 7Chou , using the phrenic nerre-diaphra gra preparation 
for the assay of curare-like substances, allowed the 
solution of tuboourarine to act for 3 minutes. In the 
experiments described in this section, this feature of 
Chou’s technique was adopted because it was thought that 
if the drug was allowed to act upon the tissue for long 
enough to produce its maximal effect, then so much time 
would b© needed to wash the drug off the receptors that 
few comparisons could be made upon one preparation.
6. Experiments carried out on the Kitten Phrenic Herve-
SiapKra'gm ''F^ eparati6n'/>,w,,^ ..
Details of the relative potency of curare-like
compounds /
compounds and tubocurarin© on the phrenic nerve diephregm 
preparation of different species of animals were 
published by Wien® who found that the triethyl iodide of 
tri (diethylr-ninoe ihoxy) - 1 - 2 - 3  benjsene was equal in 
potency to tubocurarin© on the diaphragm of the rabbit, 
had one-fifth of the potency of tubocurarin© on the 
diaphragm of the kitten, but possessed less than one- 
hundredth of the potency of tubocurarine on the diaphragm 
of the rat* The wide species variations of potency
among neuromuscular blocking agents is one of the striking
8features of this group of compounds* It whs therefore 
decided to observe the effects of these compounds upon 
similar preparations obtained from different species of 
animal* With this object in view, it was decided to use 
the kitten phrenic nerve-diaphragm preparation as well as 
that taken from the rat*
METHOD*
The tils section and method of assembly of the 
preparation was similar to that described for the rat 
phrenic nerve diaphragm preparation (see p*152)*
Kittens of either sex, weighing between 20') and 400 g*,
were used* The muscle was stimulated indirectly via the
phrenic nerve by square wave impulses from v bobble clnne® 
stimulator, /
stimulator (10 volts, 3 per minute, pulse width 1,0 to 
3*0 msees#)*
It was found that this preparation was as satisfactory 
as the rat phrenic nerve diaphragm preparation, althou^i 
Bfflbring* observed that even with single shocks given at 
the slow rate of 5 per minute, the muscle twitches slowly 
declined in magnitude. It wr.s found, however, in this 
investigation that muscle twitch height was uniform and 
the recovery after tubocurarine and other neuromuscular 
blocking agents was satisfactory for many hours, even when 
the rate of stimulation was as much as 10 per minute*
7* Experiments using the Isolated Prog Rectus
Abdominis Muscle*
METHOD*
The preparation was? set up as described in page 33 
of this thesis* Acetylcholine and de came thonium were 
dissolved in frog Ringer1® solution to give the concentrat­
ion required and added to the bath by means of a tuberculin 
syringe fitted with a suitable record fitting needle*
In all experiments at least two uniform submaximal
contractions to the sane dose of either acetylcholine or
decomethonium were obtained before the effects of any of 
the /
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the drags under investigation wore studied* The. tine 
interval between each done of acetylcholine was six 
minutes} the resulting contractions were recorded for 
ninety seconds* In the case of deceraethonium* sufficient 
time (about thirty minutes) was allowed for the muscle 
to regain its original length after the contraction* and 
the contractions were recorded for periods of two to 
three minutes* In each case the drug being investigated 
was added one minute before the addition of acetylcholine 
or d©camethonium* The muscle was washed with fresh frog 
Binder's solution between each dose of acetylcholine or 
de came thonium* Before the next addition of the drug
Under teat* sufficient time was allowed for the muscle to 
regain its original length* Several additions to the bath 
of acetylcholine or decamethonium were needed for complete 
recovery* The length of time taken depended upon the 
sise of the dose of the drug added to the bath* The 
concentrations of stimulant drugs used to produce 
contractions of the muscle were from 0*10 to 0*20 pg* per 
ml# of acetylcholine* and from 1*5 to 2*5 ng* per ml* of 
deeam© thoniuia* The apparatus used for these experiments
is shown in Figure 4* page 35.
0. /
8# Experiments on the Blood Pressure of the 
Anaesthetised Oat*
M^ TBOI)*
Oats of either eex, weighing between 2*0 and 3#5 kg*,
were used* Induction of anaesthesia, dissection and
assembling of the preparation are described on pages 11 to 13 
of this thesis* The blood pressure was recorded from 
the common carotid artery* and drug® were administered via 
the external jugular vein*
9* Experiments on the Kiotitating Membrane of the 
Anaesthetised Oat *
Hkgflop*
Oats of either sex, weighing between 2*0 and 3*5 kg*#
were used* The cat was anaesthetised by mean® of an
intraperit oneel injection of 60 mg* per kg* sodium
pentobarbitone (see page 11*)* The preparation was then
set up in a manner similar to that described on page 36
of this thesis* Hie contraction of the nictitating
membrane was elicited by stimulation of the cervical
sympathetic by means of square impulses at a frequency of
800 to 1,200 per minute, 10 to 12 volte, pulse width 0*5
to 1*5 msec* In any one experiment frequency of
stimulation, voltage and pulee width were cons taut* -The 
nerve /
161.
nerve m e  stimulated at 5 minute intervals for periods 
of 15 to 20 seconds at a time# Haring obtained standard 
reproducible responses of the nictitating membrane by 
stimulating the nerve trunk* drug© were injected into the 
external jugular vein one minute before the next period 
of stimulation* The next injection of drug was not made 
until the contractions of the nictitating membrane had 
regained their original height*
10# Experiment% on the Inspiration of the Anaesthetised
Cat#
MElHOi)*
In those experiments healthy oats of either sex# 
weighing from 1*5 to 2*5 leg## ware used* Anaesthesia was 
induced’by 60 mg* per kg. of sodium pentobarbitone injected 
lnt rape ri tone ally. The external jugular vein and the
trachea were eannulated in a way similar to that described 
in pages 11 and 12. Respiratory movements were recorded by 
mean© of a thread sewn into the skin of the epigastrium# 
This wae led over pulleys and attached to a recording 
lever having a frontal writing point# After obtaining 
a standard record of the respiratory movements for a period 
of about fifteen minutes# the drug solution was infused 
into the external jugular vein at a constant rate of 0*8 
ml* /
1 6 2
ml* per minute from a Palmer*a Blow infusion apparatus*
The drug was in solution in normal sal in® and in all 
eases the strength of solution was 0*2 mg• per ml* The 
infusion was stopped as soon os spontaneous respiration 
ceased* and the volume of the solution which had been 
injected noted* The eat was then placed under 
artificial respiration*
11* Ihcperiiaente on Isolated Perfused Rabbit and 
Kitten Hearts*
method*
The preparation was set up in a manner similar to 
that described on page 20 of this thesis* Drugs 
dissolved in Looks * s solution were injected into the rubber 
tubing attached to the aortic cannula by means'of a one 
ml* tuberculin syringe fitted with a "number 20* record 
fitting needle* The heart rate was counted by 
inspection* and the outflow was measured by collecting the 
perfusate for a period of one minute* at five minute 
intervals* after each injection of the drug* In some 
experiments* the outflow was measured by means of Ga&dum*© 
outflow recorder*
12* Experiments carried out Using the Isolated Rabbit 
Duodenum*
MLfiKXD*
The /
The experimental procedure was similar to that 
described on page 32 of this thesis# The drug, in 
solution in Locke*© solution, m s  added tp the bath by
means of a tuberculin syringe and the effect observed for 
ninety seconds* At the end of this period the fluid 
in the bath was replaced several times by running in 
fresh Locke’s solution#
13* Experiment© parried out Using the Isolated 
guinea Fig ileum*
M&TI10B*
The experimental procedure was similar to that 
described on page 29 of this thesis* The stimulant drug 
used m s  acetylcholine which m s  added at three minute 
interval© and left in contact with the tissue for thirty 
seconds* The drug under teat was added to the bath by 
hand on® minute before the next automatic inflow of 
acetylcholine* The contractions were allowed to return 
to a constant level before the next addition of the drug 
under investigation*
14. Experiment© on the ferfused Eat Hindquarters*
m m m .
The experimental procedure was similar to that 
doscribed /
described on page 26 of this thesis* Drugs dissolved 
in Locke’s solution were injected into the injection 
cannula by means of a tuberculin syringe fitted with
a “number 20“ record fitting hypodermic needle*
15. fxgerl^nta WM.i&SSA
Determination of the Approximate Median 
Lethal Pose*
METHOD*
In these experiments drugs were administered by 
intraperitone 1 injection into groups of ten mice, each 
mouse weighing between 20 and 30 g* The weights of the 
individual members of each group were approximately equal 
to a variation of not more than t o*$ g, - The dose at 
which five out of ten mice died within half-an-hour m e  
taken as the median lethal dose (id) 50) for that 
particular group of mice, and was expressed in tens* of 
mg* per kg# of the body weight*
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C H A P T E R III
RESULTS.
1* Gat Gastrocnemius Masole-Sciatic Berve Preparation*
(A) neuromuscular blocking activity* All of the 
compounds which were tested reduced the twitch height of 
the gastrocnemius muscle in response to indirect 
stimulation via the sciatic nerve * There was incomplete, 
or complete, neuromuscular block depending upon the dose 
administered* The block was completely reversible*
The compounds d ip e at a a ulph onium, dihexasulphonium, 
dihexa&aonium, didecasulphonium and dldecaazonium caused 
about 50 per cent reduction of the amplitude of the muscle 
twitch when doses from 0*13 to 0*20 mg* per kg* were 
injected, whereas 0*30 to 0*35 mg* per kg* was needed to 
cause complete neuromuscular block* The doses needed to 
produce these effects were comparable in magnitude with the 
doses of tubocurarin© required to produce similar effects 
on twitch height•
The compounds dihexasulphonium triaethiodide, diocta- 
sulphoaium, dioctaazoniua, dlhexone and trisdecatetrass onium 
were less potent than tubocurarin©, and in order to produce 
equivalent effects doses, which were from between two to 
eight /
eight times greater than those of tuboeurerine, were 
needed* Trishexatetragonium was about three times more 
potent than tubocursrine and about 0*10 mg* per kg* wae
needed to cause complete block*
The duration of neuromuscular block depended upon the 
magnitude of the dose injected as well as upon the number 
of doses which hod been administered* The bigger the 
dose, the more prolonged was the duration of effect* 
Neuromuscular block was more prolonged following the second 
injection of the same dose than it was following the first 
dose* Block caused by the third and similar dose was 
of longer duration than that following the second dose*
Ihen neuromuscular block following administration of 
any one of the compounds, dipentasulphonium, d ihexa sulphonium 
trimethiodide, dihexasulphonium, dihexaasonium, diocta- 
aulphoaium, dioetasisonium and triehexatetrazoniua, was just 
complete the duration of block was about 30 minutes* The 
maximum degree of neuromuscular block was usually reached 
within 1 to 2 minutes following the injection* In this 
respect all of the compounds referred to behaved in a 
similar way* The type of effect observed resembled that 
produced by an equipotent dose of tubocurarine* Dihexone 
showed /
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showed similar properties hut the duration of effeet was 
a little longer* figures 36. 37 and 38 {pages 169,170 and 
171) illustrated the type of neuromuscular block caused by 
some of 'these compounds*
The duration of block caused by didecasulph onium, 
didecnaaonium and trisdecatetra&oniuia was different from 
that produced by tubocurarin© * If a dose was selected so 
as to produce en approximately 80 per cent block, about one
and a half hours were needed for complete recovery* 
following a subsequent and similar dose of the same drug 
(given after complete recovery), the duration of block was 
much more prolonged* These three compounds appeared to 
possess from two to four times the duration of effect of 
tubocurarlne given in an equinetent dose* The onset of 
neuromuscular block e used by these compounds was gradual 
and the maximum degree of block was usually not reached 
until about lo minutes after the administration of the drug 
(Fig* 38, b and o)*
Potentiation of twitch height was only observed after 
injection of didecaaeonium (Fig* 33,c)* Potentiation of 
twitch height after didecaaaonlum was accompanied by 
generalised fascieulatory movements of the skeletal muscles* 
Although /
Figure 36* Cat gastrocnemiue-sciatic preparation*
Pentobarbitone anaesthesia# Indirect stimulat- 
ion via sciatic nerve. Contraction downwards# 
Drugs administered intravenously.
(a) At A, trishexatetrazoniuni 0.05 mg# per kg.
(b) At B, tubocurarine 0.15 mg# per kg.
(c) At C# dioctaazonium 0.30 rag# per kg.
(d) At £, dihexone 1.50 m g • per kg#
^9999999999151254351
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Figure 37. Cat gastrocnemiua-oelatic preparation# 
Fentobarbitone anaesthesia# Indirect stimulate 
ion via sciatic nerve* Contraction downwards# 
Drugs administered intravenously#
(a) At A, dihex&sulphonium 0#15 mg# per kg#
At B, d ip ontesulph onium 0*15 mg* per kg#
(b) At C, dihexasulphonium 0.50 mg# per kg#
At I), dipentasulphonium 0#50 mg. per kg#
8957
FjUflire 38* Cat g&strocnemius-sciatic preparation* 
Pentobarbitone anaesthesia* Indirect stimulat­
ion via sciatic nerve. Contraction downwards. 
Drugs administered intravenously.
(a) At A, tubocurarin® 0.25 mg* per kg.
(b) At B, dideeasulphonium 0.30 mg. per kg.
(c) At C, didecaass onium 0.25 mg. per kg*
082
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Although there was no increase in twitch height, a similar 
fascicul&tory response was observed following injection of 
didecasulphonium and triad®catetragonium. As a rule, 
muscular fasoiculations were intermittent in nature and 
appeared in a few groups of muscles at a time. When 
bigger doses were need, the muscular movements observed 
were very vigorous. Muscular faseiculation was never 
observed following administration of any of the other 
compounds. The gastrocnemius muscle responded to direct 
electrical stimulation during the period of interruption of 
m rve-impulse transmission* In each case the amplitude 
of the muscle contraction fojlowing direct stimulation 
during complete neuromuscular blockade was lees than that 
obtained following direct stimulation before injection of 
the drug* This indicates some uegree of direct depressant 
action upon the muscle which is also observed when 
tubocurarin® is used. A typical example of this kind of 
effect is shown in Figure 39 § page 173. The amplitude of 
the muscle contraction on direct stimulation after complete 
neuromuscular block was from. 20 to 40 per cent of the 
control height following didecasulphonium and tried®catetre- 
senium, while in the case of the other compounds the 
amplitude varied from 30 to 80 per cent of the value obtained 
before /
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Figure 39* Cat gaetrocnemius-sciatic preparation. 
Pentobarbitone anaesthesia* Indirect stimulation 
via sciatic nerve* Direct stimulation at 40 volts*
Contraction downwards * Drugs administered 
intravenously#
At A# direct stimulation
At 23# indirect stimulation
(a) At C, dipentasulphonium
otn*o mg. per kg
At $# edrophonium o « U1 o mg. per kg
(b) At o# d ihexasulphonium o • VI o mg. per kg
At edrophonium o • o ■i .per kg
(e) At <3, dihexaazonium 0.20 mg •per kg
At edrophonium 0.20 mg. per kg
(d) At c# trishexate traz onium 0.06 mg. per kg
At edrophonium 0.50 per kg
before injection of the drug#
Subsequent doses of the same drug given after complete 
recovery appeared to produce an increased effect* fhis 
effect was demonstrated in the cat gastrocnemius muscle** 
sciatic nerve preparation* and is shown in Figure 40, 
page 175 « A similar effect was seen when tubocurarin*
was used# (Fig#40,a») In this figure, if part b is 
considered, it can be seen that the first dose of 
0*30 mg# per kg* of dioctaazonium reduced the twitch height 
by about 15 per cent and the preparation required 8 minutes 
for recovery| the second and similar dose administered 
10 minutes after the first dose resulted in a depression of 
about 40 per cent and needed 16 minutes for recovery* The 
effect of third injection of a similar done of diocts** 
asonium caused the twitch height to be depressed by about 
90 per cent and required about 30 minutes for complete 
recovery# the effect of the fourth dose can be seen not
to differ significantly from that of the third dose# That 
further cumulation was not taking place suggested that the 
period of 30 minutes between injections allowed s sufficient 
amount of the drug to be eliminated to balancethe effects of 
any dose subsequently given# All the compounds behaved in 
a similar fashion with the exception of dideessulphonium, 
dideoaaeonium /
Figure 40* Cat gsstrocnemlus-sciatic preparation*
Pentobarbitone anaesthesia* Indirect stimulation via 
sciatic nerve* Contraction downwards* Drugs 
administered intravenously*
(a) At A, tubocurarin© 0*075 mg* per kg*
(b) At A9 dioctaazoniura 0*30 iag* per kg*
There was an interval of 40 minutes between (i) and (ii)*
(c) At A# dihexaezonium 0*20 mg* per kg*
There was an Interval of 25 minute® between (i) and (ii)*
0121517215
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dideoaaaonium and triadecat e tr&sonium, which showed Itss 
tendency to produce cumulative effects*
(B) Bffect of Indirect ^etanieotion of the i artially
f g r n a  —  —  I I  n ^ u i i i i . n m m i I IJ     n . u n .  <mnm<    . i n m i ■  i u  ,■ 11   . ' I
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If the muscles partly blocked by tubocurarin* are
1 2tetanised indirectly the tension rapidly wanes * *
Previous tetanisetion decreases the intensity of the 
neuromuscular block produced by tubocurarin© or by other 
drugs having & similar mechanism of action^**, In 
contrast to this, tetaninalion does not affect the intensity 
of a neuromuscular block caused by decmu®thontum ©r other 
depolarising agents, and the tetanus is well maintained in 
cat muscles in which partial neuromuscular block has been 
produced**-^*
ihen the compounds under tost wore used, the effects 
observed were of two distinct types. Some behaved in a 
similar way to tubocurarin©, while others had properties in 
common with de cam© th onium* I’he compounds dipentasulphonium, 
dihexasulphonium trimethiodids# dihexasulphonium, dehexa- 
asonium, dihexona, dioctaazonium, didecasulphoniua and 
trishexBtetrazonium were of the former group and the 
compounds, dioctesulphonium, did©eeasonium and trisdeoa— 
tetraaonium were of the latter. It was observed that the 
tetanic /
tetanic response of a normal muscle was well sustained, i#e> 
the tension did not wane# In Figures 41, 42 and 43,
(pages 178,179 and 180) the results of a typical experiment 
are shown* Figures 41 and 42 show the poorly sustained
i
responses of the muscle, tetanized indirectly via the 
sciotic nerve, when partly blocked by dioctaazonium (Fig«41, 
didecaeulphonium (Fig* 41,b), dihexeazoniuta (Fig* 41,0), 
dihexasulphonium (Fig* 41,e), trishexatetrazonium (Fig.42,b) 
dipentaaulphonium (Fig*42,c) or by dihexone (Fig* 42,d)* 
These effects are compared with those seen in the muscle 
partly blocked by tubocurarin© (Fig* 42,a), decamethonlum 
(Fig* 42,e), and of untreated, muscle (Fig* 41,d)« Figure 
43 shows well sustained tension of the tetnnized muscle 
partly bloeked by dioctaeulphoniurn (Fig* 43,*0, triad© ca«» 
tetrazonium (Fig# 43,b), didecaazonium (Fig* 43,o) and 
decamethonium (Fig# 43,e) which are compered with the well 
sustained tension of normal muscle (Fig* 43,d) during 
Indirect tetanization# Indirect tetanlzation during 
neuromuscular block caused by dideeaazonium, trisdeeatetra~ 
zonium and dldecasulphonium, has no influence on the degree 
of block and is shown in parts b, c, and d of Figure 44 
(page 181)# In contrast to thee© observations, the 
muscle twitch amplitude during neuromuscular block following
the use of dipentaeulphonium, dihexasulphonium trimethlodid© 
dihexasulphonium /
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ffi^ ure 41* Cat gaotroonemlus-aciatio preparation# 
Pentobarbitone anaesthesia# Contraction downwards#
Drugs administered intravenously#
At 2, indirect tetanisation via sciatic nerve* during
(a) partial block following diocta&aontum 0#2Q mg# per kg.
(b) * didecasulphonium G.20 mg# per kg#
(c) * * * dihexaaaonium 0#06 mg* per kg#
(©) * " * dihexasulphonium 0#10 mg# per kg#
(d) no drug administered#
Figure 42» Oat gastrocnemiuB-sciatio preparation.
Pentobarbitone anaesthesia. Contraction downwards. 
Drugs administered intravenously.
At f, indirect tetanization of the gastrocnemius 
(1500 impulses per minute) via the sciatic 
nerve during partial block by
(a) tubocurarlne O.05 mg• per kg.
(b) trishexatetrasonium 0.02 iag. per kg.
(c) dipentasulphonium 0*05 mg. ner kg.
(d) dihexone 1.0 mg. per kg.
(e) dec^methonium 0.02 mg. per kg.
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Piffure 45* Cat gastrocnemius~sciatic preparation* 
Pentobarbitone anaesthesia* Contractions downwards. 
Drugs administered intravenously*
At T, indirect tetanisation via sciatic nerve (1500 
impulses per minute) during partial block by
(a) dioctaeulphoniuia (b) trisdeoatetrazoniua
(c) didecaasonium (e) decnmethonium
and untreated muscle (d).
Figure 44• Oat gastroenemiue-sciatic preparation.
Pentobarbitone anaesthesia. Contraction downwards. 
Drugs administered intravenously.
At T# indirect tetanization of the gastrocnemius 
(1500 impulses per minute) via the sciatic 
nerve during partial block by
(a) dioctaazoniu® 0.10 mg. per kg*
(b) did©caasonium 0.10 " " M
(c) trisdecatetrazon-
iua 0.10 " ”
(d) dideeasulphonium 0*20 * * *
d ih e xas ulph onium, d ih e xa e z oni urn $ dihex one, d i oe t as ulph onium # 
dioetaazonium and trishexatetrazonium is temporarily 
increased (decararisation) by indirect tetanlzatlon* This 
is shown in part of Figure 44 (page 181 )$ whioh 
illustrate© a typical example of this type of effect* 
Although the tension of the tetanised muscle is fairly well 
maintained during block by dioetasulphoniu®, indirect 
tetanlzation produces some degree of temporary deeuraris- 
ation (Fig* 0 $ (a), p#180)#
(C) The Bffect of tuboourarlne* The effect of the 
different competitive neuromuscular blocking agents is 
additive-* and. that of depolarizing agents antagonistic to 
the block produced by them in the cat muscle-nerve 
proparation***^ . In attempting to elucidate the mechanism
of action of new compounds with neuromuscular blocking 
activity# these facte are rexy important and it was there­
fore decided to investigate whether the effects of the 
drug© being studied were additive with or antagonistic to 
tubocurarin®* If these drugs have the same mechanism of 
action as tuhoeurarinef then the neuromuscular blocking 
effects of any one of them would be expected to suminat© with 
that of tubocurarin©• To Investigate this point# s dose of 
one of the new compounds and a dose of tubocurarin© were 
selected /
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selected to produce, tfhen given alone, a measurable but 
not intense neuromuscular depression of comparable degree. 
When the dose of a ny one of the compounds dipent as ulph onium, 
dihexasulphonium trimsthiodide, dihexasulphonium, dihexa- 
asonium, dihexone, dioctssulphonium, dioctaasonium and 
trishexatetrasonium was followed by a selected dose of 
tubocurarine given at the point of maxim©! effect of the 
former agents, the extent ox neuromuscular block was 
further increased, The same end result occurred when the 
order of administration of the two drugs was reversed. 
Figure 45, (page 184), shows typical effect® observed in 
this particular type of experiment. In this figure, the 
dose of dihexasulphonium (0*06 mg. per kg.) and the dose of 
tubocurnrine (0.06 mg. per kg.) were selected to produce a 
neuromuscular block of about 3 • per cent (parts I and II 
of Fig. 45). &hen the dose of dihexasulphonium was 
followed by a dose of tubocurarin© at the point of maximal 
depression, the degree of neuromuscular block was increased 
to about 60 per cent (part III of Fig. 45). Approximately 
the same end result occurred when the order of administrat­
ion of dihexasulphonium and tubocurarin® was reversed 
(part IV of fig. 45). Ihe effect of two consecutive 
injections of either dihexasulphonium or tuhocurarine wee 
in /
Figure 45* Oat gastrocnemius made-sciatic nerve
prepare'sion* Fentobarbi tone anaesthesia* Indirect
stimulation via sciatic nerve* Contraction down- 
wards* Drug® administered intravenously*
At Af ' dihexasulphonium 0*06 mg* per kg*
At B# tuboeursrine 0*06 mg* per kg*
At Cfi edrophonium G#f>0 ng* per kg*
6
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in no way different from the mixed responses (parts V and 
VI of fig. 45). This effect was typical of those 
observed with dipentasulphonium, dihexasulphoniu® trim© th- 
iodide * dihexr.sulphcnium* dihexa&aonlum* dihexone.* diocta- 
eulphonium* dioetaasonlum and trishexatetragoniun. all of 
which had additive effects with tubocurarin© as well as 
with one another. The effects of dideo&eulphoniua* dideca- 
asonium and trlsdecatetrasonium, when given in sequence with 
tubocurarin© wcne different. This is illustrated in 
Figures 46 and 47* pages 186 and 187 • In part b of Figure 
46* a. dose of didecasulphonium (0.50 mg. per kg.) and a 
dee© of tubocurarin© (0.25 sag. per kg.) were selected to 
produce incomplete but measurable neuromuscular blocking 
effects. hhen the close of didecasulphonium had produced 
its maximum depressant effect* it was followed by the dose 
of tubocurarin® and the extent of the neuromuscular block 
was further increased. On the other hand when the dose 
of tubocurarin® was followed by the dose of dideoaeulphoiiiuJi* 
at the point of maximal depression caused by tubocurarin© 
the twitch height was increased instead of being further 
depressed (Fig* 47* part a)* an offset which would not be 
expected if both drugs possessed the same mechanism of 
action. isidecaaaonium and triad©catetragonium behaved in 
a /
Figure 46♦ Cat gastrocnemius-sciatic preparation* 
Pentobarbitone anaesthesia* Indirect stimulation 
via sciatic nerve• Contraction downwards. Drugs 
administered intravenously*
(a) At k9 trisdeoate tra &onlum 0*50 rag. per kg*
at B# trisdecatetrasoniua 0*75 mg. per kg*
At 0, tubocurarin® 0*20 mg* per kg*
(b) At kg dldecasulphonium 0.50 sag. per kg*
At Bf tubocurarin® 0.25 tag* per kg.
Figure 47. Gat gastrocnemius-seiatic preparation. 
Dent obsrbitone anaesthesia. Indirect stimulation
via sciatic nerve. Contraction downwards.
Drugs administered intravenously.
(a) At A# tubocurarine 0.15 mg* per kg.
At B, dideeaaj&onium 0.50 mg. per kg.
At C, tubocurarin© 0.10 mg. per kg.
At D# didec&sulphoniura 0.30 mg. per kg.
(b) At B# tubocurarin© 0.1? mg. per kg.
At F, triadecntetmEonium 0,70 mg. per kg.
^//A 8548^1582^
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a similar way to d id e e a aulphonium (Figs. 46 and 47)%
'&hen the earn® experiment was done using didecasulphonium, 
dldecaesonium or trdLedeeatetroBonium with dec&methoniu®, 
the effect observed was an additive one irrespective of 
whether the dose of decpmethonium employed was followed, 
or -oreeeded by the dose of didecasulphonium, didee aaeonium 
or trlsdeoetetraeonlum (Flits# 60 and 62, cages 213 and 217
■twwjww, "f 1 <»t* "■ v  ■
These drugs bad mutually additive effects* This feature 
of the actions of didecasulphonium, dldeea&sonium and 
trig&ecatetrasonium is shared with decamethonium rather 
thsn with tubocurarine*
( T j )  Effect of ether anaesthesia* Ether anaesthesia
has been reported to increase the effects of competitive
3 8neuromuscular blocking agents" , where®s the neuromuscular 
block caused by depolarising agents is either unaffected 
or antagonised by this agent^* This point was investigated
with respect to each member of the group of compounds 
listed la pages 141 and 142 « A dose was selected which
produced a measurable neuromuscular block (about 20 to $0 
per cent)* The same dose was repeated in the presence of 
ether anaesthesia* Immediately after injection of the 
drug, ether vapour was administered for a period of ten 
minutes to the pentobarbitone—anaesthetised cat from a 
bottle /
bottle connected to the artificial respiration pump* The 
degree of Inhibition of the muscle twitch by the ease dose 
of the drug injected before and during ether anaesthesia
was compared# The effects of all the compcunds,exoept 
dideeasulphonium, didecaazonlum and triadecatetrasonium, 
were potentiated and prolonged by ether anaesthesia# The 
effect of didec&sulnhonium was slightly potentiated by 
ether anaesthesia# The effects of ether anaesthesia upon 
the effects of dideeaa&onium and triadecatetrasonium could 
not he investigated clue to the very prolonged effect of 
these compound® and incomplete recovery* Some typical 
tracings obtained from these experiments are shown in 
Figures 48 and 49, pages 190 and 191*
(1) Studies on drug antagonism* The neuromuscular 
block produced by tubocurarin© or other substances having 
the same mechanism of action is antagonised by depolarising 
drugs^*^*^, anticholinesterase©^, edrophonium^* ^ , 
adrenaline^* and potassium ion©^# Anticholinesterases 
Increase the neuromuscular blocking activity of depolarising
a g e n t s ^ Edrophonium has either no effect on or
10 18potentiates a depolarization block * * Neostigmine,
eeerlne, edrophonium, deems®thonium, adrenaline and 
potassium chloride were used for the studies on drug 
antagonisms /
Figure 48» Cat gastroenemius-eciatie px'eparation* 
Pentobarbitone anaesthesia# Indirect stimulation
via sciatic nerve* Contraction downwards*
Drugs administered intravenously*
(a) At A, trishexatetrasonium 0*05 nig* per kg*
At V-$ trianexatetrasonium 0.03 rag* er kg*
with ether anaes­
thesia.
26 minutes elapsed between (i) and (ii) and
90 minutes between (ii) and (ili).
(b) At A$ dihexaazonium 0*06 mg# per kg*
At B, dihexaa zoniun 0*06 tag* per kg#
with ether anaes­
thesia*
10 minutes elapsed between (i) and (ii)*
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jfteure, .49,# Cat gastrocnemiuff-aciatic preparation* 
Pentobarbitone anaesthesia* Indirect stimulation 
.Tt& sciatic nerve* Contract ion downwards*
Dru s administered intravenously*
(«) At A# dioctaaaonium 0*0? mg* per kg*
-At B# diocinagonium 0.07 mg. per kg. with
ether anaesthesia*
130 minutes elapsed between (:i) and (ii).
(d) At Ag dioc tesulpkcmium 0*20 rug. per kg*
At Bg dloetasulphonium 0*20 mg* per kg* with
ether anaesthesia*
30 minutes ©lapsed between (i) and (ii) 
and 80 minutes between (ii) end (iii).
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antagonisms which are described in this section* The 
antagonists were injected into the cat at the point of 
maximal neuromuscular block or at the point where recovery
was beginning* The extent of the recovexy caused by the 
antagonist was compared with that of the control* The 
effects of the antagonists are described separately*
(i) Edrophonium?
Partial or complete neuromuscular block produced by 
dipentasulphonium, dlhexasulphonium trimethiodide , 
dihexasulphonlum, dihexaazoniom, dioctaazonium and trig- 
hexatetrazonium was rapidly and completely reversed by the 
intravenous injection of edrophonium in a done range of 
0*20 to 1*0 mg* per kg* (Figs* 50 and 51, pages 193 and 194)* 
After a suitable dose of edrophonium, the muscle twitch 
rapidly gained its original height (sometimes within less 
than one minute)* This effect was similar to that 
observed when tubocurarin© was used (Fig*51,b)* The 
effect of edrophonium appeared to be short-lived because.
If after complete recovery of the twitch height following 
edrophonium a second and similar dose of the drug was 
given inside a period of about ten minutes, the neuro- 
muscular block was of approximately similar intensity to 
that obtained before edrophonium was administered* This 
effect /
Figure 50* Cat gastrocnemius-sciatic preparation* 
Pentobarbitone anaesthesia* Indirect stimulation 
via sciatic nerve* Contraction downwards*
Drugs administered intravenously*
(a) At A, dipentasulphonium 0*50 mg. per kg*
At B, edrophonium 0.30 mg* per kg*
(b) At Af diootaazonium 0*20 mg* per kg.
At B, edrophonium 0.50 mg. per kg.
At C, edrophonium 1*0 mg. per kg.
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Fixture 51# Cat gastrocnemius-eeiatic preparation#
Pentobarbitone anaesthesia# Indirect stimulation via 
sciatic nerve# Contraction downwards# Drugs 
administered intravenously#
(a) At A# t ri shexat e t rag onium 0#07 mg# per kg.
At B# edrophonium 0#70 mg# per kg#
(b) At A, tuboeurarine 0#10 tag# per kg#
At B# edrophonium 0*50 mg# per kg#
(c) At A| dihexaass onium 0.40 mg# per kg#
At Bt edrophonium 0*40 mg# per kg#
^1^119149549
effect is also observed when tubocurarin© is used to 
cause neuromuscular block# A typical experiment is shown 
in part ’a* of Figure 52 (page 196).
The effect of edrophonium on the neuromuscular block 
caused by dihexone end dioctasulphonium m s  not so 
striking as that seen when the other compounds wore used• 
There was antagonism but bigger doses (1.0 to 2#0 mg# per 
kg#) were needed, and the recovery was gradual and 
incomplete# The antagonistic effect of edrophonium on 
the neuromuscular block c used by dioctasulphonium and 
dihexone has been shown in Figure 53 (page 197)•
Didecasulphonium, didecaasonium and trisdecatetragonium 
on the other hand had entirely different effects# 
Heuromuscular block caused by didecasulphonlum was either 
unaffected or slightly reduced by edrophonium in the dose 
range of 0*5 to 2.0 mg* per kg# The effect of dideca- 
aaonium and trisdecatetrnsonium was actually potentiated 
when 0*5 to 2*0 mg# per kg* of edrophonium was injected at 
the point of maximal depression# These effects are 
Illustrated in Figure 54 (page 198).
(ii) Heostigmines
The antagonistic effect shown by neostigmine to the 
ne uromuscular /
Figure 52. Cat gastrocnemius-nsciatic preparation.
Pentobarbitone anaesthesia. Indirect stimulation via 
sciatic nerve. Contraction downwards. 2>rugs 
administered intravenously.
(a) At A and at 0$ trishexatetragonium 0.10 mg. per kg.
At B* edrophonium 0.5 mg. per kg.
(b) At A and at 0$ dihexasulphonium 0.50 mg. per kg.
At B# neostigmine .06 mg. per kg.
^19191
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Figure 53. Cat gastrocne®±tts«*eciatto preparation# 
Pentobarbitone anaesthesia# Indirect stimulation 
via sciatic nerve* Contraction downwards#
Drugs administered intravenously*
(a) At A# diocteeulphonium 0*30 mg. per kg#
At B* edrophonium 1*0 mg* per kg#
At G* edrophonium 0#73 mg# per kg.
(b) At A* dihexone 1#50 mg# per kg.
At B# edrophonium 0.50 mg. per kg.
At 0$ edrophonium 0.75 mg# per kg.
Figure 54* Cat gastrocnemius-sciatic preparation. 
Pentobarbitone anaesthesia. Indirect stimulation 
via sciatic nerve. Contraction downwards.
Drugs administered intravenously*
(a) At A# didecaasonlum 0.20 mg# per kg
At B# edrophonium 0.08 mg# per kg
(b) At A# triadscatetraa onium 0*20 mg# per kg
At B, edrophonium 1.0 mg# per kg
(c) At A, dldeoasulphonium 0*30 mg# per kg
At B# edrophonium 0.50 mg. per kg
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neuromuscular block caused by different types of muscle
relaxants is one of the major differentiating factors in
the determination of their mechanism of action* Heostig-
mine antagonises the block caused by the competitive type
11 IQof neuromuscular blocking agent * $ n&ile it has a
potentiating effect upon the effects of the depolarizing
OQ
drugs • The effect of this drug on the neuromuscular 
block caused by the compounds was studied by injecting 
neostigmine at the point of maximal neuromuscular 
depression and the recovery of the twitch height was 
compared with that of the control.
Partial or complete neuromuscular block caused by 
dihexasulphonium trine thiodide, dipentasulphonium^ 
dihoxasulphoniu\ i# d ihexaazonium and trishexatetzmzonium 
was completely antagonized by neostigmine although the 
process of antagonism was not so rapid as that seen 
following edrophonium* I'eostigmine was injected in a dose 
range of 0*05 to 0.10 mg* per kg* and an effective 
antagonism to the characteristic effects of the©© four 
compounds was observed* The muscle twitch began to 
increase in amplitude within about 10 to 15 seconds after 
intravenous administration of neostigmine at the point of 
maximum depression of the twitch height. The twitch 
regained /
regained its original height in about 2 to 5 minutes 
depending upon the magnitude of the dose of neostigmine 
employed* The antagonistic effects of neostigmine to 
the neuromuscular block ceased by trishexatetrazonium» 
dihexaazonium and dlhexasulphonium are shown in parte b, 
e and d of figure 55* page 201* in which the effect of 
neostigmine upon the block caused by tubocurarin® is also 
shown (Fig* 55,a).
lidecaoulph onium, didecaazonium and trisde catetrazon­
ium had different properties in this respect# 0*05 to
0*50 iag* per kg# neostigmine did not show any antagonism to 
the neuromuscular blocking effects of didecaazonlum and 
tried©catetragonlum whether the block was partial or 
complete* These two compounds share this property with 
deeamethonium* Neostigmine at dose levels of 0*05 to 
0#50 mg* per kg# showed either no effect or slight 
antagonism to dldecesulph onium (Fig* 56,a, p#202)o
Neostigmine in similar doses reversed the neuromuscular 
block caused by dihexone, dioctasulphonium and diocta~ 
azonium, but the reversal m s  not so complete as that 
observed in the cases of dipentasulphonium, dlhexasulphonium, 
dihexaazonium and trishexatetrazonium* This is shown in 
figure 56, /
201.
ffi&ure 55* Cat gastroenendus~sciatic preparation* 
Pentobarbitone anaesthesia* Indirect stimulation 
Tin sciatic nerve* Contraction downwards*
Drugs administered intravenously*
(a) At A9 tubocurarine 0.20 mg. per leg
At B# neostigmine o • H O mg* per kg
(b) At A# trishexatetragonium 0.05 mg. per kg
At B# neostigmine o * £ o mg* per kg
(c) At A# dihexaazonium 0.20 mg. per kg
At B# neostigmine 0*05 mg* per kg
(d) At A, dihexasulphonium 0.50 mg. per kg
At B, neostigmine 0.06 mg. per kg
Figure 56. Oat gastraenexnius~soiatic preparation# 
Pentobarbitone anaesthesia. Indirect stimulation 
via sciatic nerve. Contraction downward®.
Drugs administered intravenously.
(a) At A# didecasulphonium 0*50 mg. per kg.
At B# neostigmine 0.075 mg. per kg<
(b) At A, dioctasulphonium 0.30 mg. per kg.
At B* neostigmine 0.10 mg. per kg.
(o) At A* diootaaaonium 0.15 mg. per kg.
At Bt neostigmine 0.10 mg. per kg.
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figure 56, b and 0* &ven with a dose of neostigmine as 
large as 0*50 mg* per kg*, the recovery of the muscle 
twitch amplitude depressed by dihexone, dioetrsulph onium 
or dioot&asonium we© only alight compared with 100 per 
cent recovery when 0*05 to 0*10 mg* per kg * neostigmine 
was injected at the point of Maximal block caused by 
dihexasulphonium, dihexnaeonium, triaheaatetrazonium or 
tubocurarin© (Fig* 55, p*201).
fh© antagonism shown by neostigmine is a fairly 
prolonged one and its effects persisted for about 30 
minutes or more, aa shown by the observation that a second 
dose of dipent asulphonium, dihexasulphonium, dihexaaaonium 
or trishexatetragonium given within a thirty minute 
interval produced very little effect {Fig* 52, part b* 
page 196).
(iii) Kserin©%
i‘he effect of ©serine on the neuromuscular block 
caused by the compound© investigated was essentially 
similar to that observed with neostigmine but was less 
marked* Effective and prolonged antagonism to the 
neuromuscular block caused by dipentasulphonium, dihexa- 
sulphonium irimethioaide, dihexasulph onium, dihexaaeonium 
and /
204.
and triahexat etx&mniurn was shown by ©serine in the dose 
range of 0*50 to 1*0 mg.* per kg* Figure 57 (p*205) 
shows si typical example of eserine antagonism to the effect 
of these drugs*
1serine caused only a alight reversal of the neuro* 
muscular block produced by dihexone, dioctasulphonium 
and dioctaas onium, even when the dose of e serine given was 
as groat as 2*0 mg* pur kg*
neuromuscular block caused by did©casulphonium, 
diaeca&zonium and triodecatetrassonium was not affected by 
eserine in the dose range of 1*0 to 2*0 mg# per kg*
Be came th onium i
Be came tli onium ie & typical depolarising neuromuscular 
blocking agent* line effect of decamethonium is additive 
with those agents having a similar mechanism of action , 
while it antagonises the effects of tubocurarin® or other 
competitive neuromuscular blocking agents^*
22Baton and Raimis observed that the injection of a 
small dose of tubocurarin© rendered decamethonium less 
effective aa a neuromuscular blocking agent in the cat.
This observation has been confirmed by Macfarlane jjt alla*^ 
in /
Figure 57* Oat gast rocnemius-seiatic preparation*
Pentobarbitone anaesthesia* Indirect stimulation 
via sciatic nerve* Contraction downwards*
Drugs administered intravenously.
(a) At A, dipentasulphonium 0*20 mg* per kg*
At B# eserlne 0*50 mg. per kg*
(b) At A, dihexasulphonium 0.25 mg* per kg*
At B* ©serin© 0*75 mg* per kg*
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In man# Baton and Zaimis~ also found that whan 
decamethoniua was given before tubocurarine it did not 
greatly modify the m ur omuseular blocking activity of the 
alkaloid# Bepierre*^, however, observed a reciprocal 
antagonism be two a galIamine, a competitive neuromuscular 
blocking agent, and decamethonium# flutter and Pasco©** 
showed that suitable doses of do camethonium were able to 
restore neuromuscular transmission after it had been 
blocked by tubocurarin©« The reverse phenomenon, namely 
the antagonistic effect of tubocurarin© to the neuromuscular 
block produced by de cantothonium, was observed by 
Ballemagne and Philippot^# In all cases the observations 
were made using cate bb the experimental animals •
Became th onium antagonism to the effects of the new 
compounds which have been investigated was studied on the 
cat*& nerve-mueole preparation* in an attempt to gain more 
information shout their mechanism of action# fhe nature 
of the investigat ions and the results are described under 
the following different headst
(a) Effects of decamethonium administered following a 
dose of one of the new compounds#
(b) Effects of the new compound administered following 
a dose of de came thonium•
(cj /
(c) Effects of became thonium given at the point of 
maximal neuromuscular depression caused by the 
new compound#
(d) Effects of the new compound given at the point 
of maximal neuromuscular depression caused by 
deemae thoniuau
(a) fhm previous injection of a email dose of dipenta­
sulphonium, dihexasulphonium iri aethiodide, dlhexaeulphonium 
diliexaasonium* dihexone, dioctasulphonium, dioetaazonium 
or triahexatetraaonium modified the effects of later 
administ ration of deeawethonium# A dose of 0#Q2 to 0#03 
mg* per kg# doeMacthoniurn, when given alone, produced 
approximately 70 to 90 per cent neuromuscular block# A 
second and similar dose of deeamcthonium, given after 
complete recovery from the neuromuscular block caused by a 
small dose of any one of the new compounds, produced either 
no depression of the twitch height or only a slight 
depression# A. similar effect was observed by Paton and 
Zaimis^ and Koppe^ who showed that a doe© of decantsthonium 
which when given alone produced neuromuscular block, was 
without effect in cat and dog aerve«4&usele preparations 
which had just recovered from th© effects of a small dose 
of tubocurarin©• A typical experiment is shown in Figure 
58, part *af (page 208)* At A, the first dose of 
decamethonium /
.gigure.. 58* Cat gastrocnemus-eciatie preparation* 
Pentobarbitone anaesthesia* Indirect stimulation 
via the sciatic nerve* Contraction downwards* 
Drugs administered intravenously*
(a) At A, decamethoniua 0*02 mg* per kg*
At B, trishexatetrasonium 0*04 mg* per kg*
(b) At A, dihexaeulphoniua 0*50 mg* per kg.
At B, decamethonium 0*06 mg* per kg*
At B$ ©serine 0.50 mg* per kg*
1075
decam©thonium, 0*02 mg* per kg*, reduces the twitch height 
by about 70 per cent wherers the second and same dose of 
decame thonium at A, given after a dose of triahexatetragon- 
ium (0*04 rag* per kg*), does not reduce the twitch height*
The effect of d e e a me thonium given after a. dose of 
didecasulphonium, did©caazonium or trisdecatetragoniura was 
different* The effect of a second and similar dose of 
decame thonium, given after a small paralysing dose of one 
of the compounds, was about the same as that caused by 
the first dose*
(b) fhe previous administration of a paralysing dose of 
decamethonium did not greatly modify the neuromuscular 
blocking properties of any of the new compounds* This 
effect was expected when dideca aulphoniurn, didecaazonium 
or triadecatetrazonium was given after decmae thonium, as 
the effect of decamethonium Itself was not modified by 
th® prior a&ministr tion of any one of these three 
compounds* ihe observation that the effect of the later 
administration of any of the other compounds following a 
paralysing dose of decnmethonium was practically unaltered, 
was rather unexpected but was similar to the effect observed 
by Baton and 2aimis22 when they administered a dose of 
tubocurarin© /
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tubocurarin© following a previous injection of deoamethonium 
in the cat nerve-muscle preparation* A typical experiment 
is shown in Figure 58, part b, c and d# page 208*
(c) Neuromuscular block, par tial or complete, caused by 
dipeniasulphonium, dihex&sulphonium trinethiodide, dihexa- 
sulphonium, dihexaazonium, dihexone, dioetosulphonium, diocta- 
asonium or triahexatetrazonium was rapidly and completely 
reversed by decrmiethonium injected during the block* The 
dose of decamethonium required was roughly about one-fourth 
of the dose of the compound used to cause paralysis• Immed­
iately after injection of decam©thonium at the point of maximal 
neuromuscular depression, the muscle twitch began to increase 
in amplitude and if the dose was correctly gi/en, complete 
reversal was effected within 2 to 5 minutes and the twitch 
amplitude re '.slued steady at the control level* If the dose 
of dedamethoniurn given was bigger, there was a sharp increase 
of the amplitude of the muscle twitch which immediately after­
wards began to decline in amplitude, rapidly causing a 
neuromuscular block which was more intense than that caused by 
the compound itself* This secondary block was perhaps due 
to the effect of deeamethoniua itself which was present in 
quantities more than were needed to counteract the effect of the 
other drug causing the initial neuromuscular depression*
If /
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If, on the other hand, the dose of deearn©thoniura chosen 
is lose than optimal there is an increase of twitch height, 
but complete recovery is not observed* Hutter and Pascoe^
found that dee ante thonium, in suitable doses, would restore 
neuromuscular transmission after neuromuscular block 
caused by tuboeurarine * In Figure 59 (p*2l2) an example 
of decamethonium antagonism is shown*
The effect of decame thonium given during maximal 
depression of neuromuscular transmission caused by dideca- 
sulphonium, didecaasonium or triede cate t ra sonium was 
completely different* Bocame thonium, instead of decreasing 
the block, actually increased its intensity as if another 
dose of the same drag had been given* Phis effect is 
shown in Figure 60, page 213.
(d) It has been shown by Ballemagne and Philippot^ 
that wfoen given in suitable doses tubocurarin© can rapidly 
and completely reverse a neuromuscular block caused by 
deoamethonium* The magnitude of the dose of tubocurarine 
needed has been shown to be critical, and must be very 
accurately gauged*
I© investigate this particular point, partial or 
complete neuromuscular block was produced by giving a suit­
able /
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figure 59 . Cat gastrocnemius-sciatie preparation#
Pentobarbitone anaesthesia. Indirect stimulation 
via sciatic nerye. Contraction downwards•
Drugs administered intravenously#
(a) At A# dipentasulphonium 0*50 mg. per kg.
At Bj decamethonium 0.15 mg. per kg.
(b) At Cf dioctasulphonium 0.15 mg. per kg.
At D# decamethonium 0.0? mg. per kg.
(c) At B# dihexone 0.40 mg. per kg.
At P# deeamethonium 0.06 mg. per kg.
(d) At A, tubocurarin* 0.08 mg. per kg.
At B# deoame thonium
o♦o mg. per kg.
(«) At C, trishexatetragcmlua o . o Gs mg. per kg.
At D# decamethonium 0.06 mg. per kg.
Figure 60* Cat gastrocneraius^seiat ic preparation*
P e nt obar b it one anaesthesia* Indirect stimulation
via sciatic nerve* Contraction downwards*
Drugs administered intravenously*
(a) At A, tri£decatetra»oniua 0*10 mg* per kg,
At B# decamefhonlum 0*04 mg* per kg.
M At k$ d ide casulph onium 0*10 mg* per kg
At B# decamethonium 0*05 mg* per kg
(<*) At A, didecaasonium 0*05 mg* per kg
At Bf decamethonium 0*02 mg* per kg
suitable dose of deoamethonium* fuboour&rina or one of 
the new compounds was injected at the region of maximal 
neuromuscular depression coused by decamethoniua* and the
recovery of the muscle twitch height was observed* All 
of the compound a tea ted * excepting d ;i d e c a au X ph o ni um $ 
dideosasonium end triad© cate tragi oniuia« reversed the block 
caused by decamethoniura• fhe reversal was rapid and
complete following the administration of dipentasulphonium* 
dlhexasulphonium* dihexasulphonium trimsthiodide * 
ciilaexaasoniurn* diootaaeonium end triahexatetrassonium but 
the antagonism shown by dihexone and dioctasulphonium was 
not very well narked* and complete reversal of the 
deeamethoniuiii block was not obtained* A typical experi­
ment is shown in figure 61* page 215.
If the dose of any one of the compounds employed to 
diminish the neuromuscular block caused by decamethonlum 
was slightly larger than that actually needed* then there 
was an immediate increase in the intensity of the block 
already caused by decamethonlum* If the dose was 
insufficient* the decaiaethoniura block either remained 
unaffected or there was on incomplete reversal*
■The effect of didecasulphoniura* didecaasonium or
trie dec ate trasoniuia on the neuromuscular block caused by 
decome thonium /
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Figure 61* Cat aastrocnemius-seiatlc preparation* 
Pentobarbitone anaesthesia* Indirect stimulation 
yia sciatic nerve* Contraction downwards*
Drugs administered intravenously*
(a) At A* de camethonium 0.025 iflg* P®~ kg.
At B, tubocurarin© 0*125 mg. per kg.
(b) At 0* de came thonium 0.04 Big* per kg.
At D* dihexaaxonium 0.20 mg* per kg*
(o) At A# dec arae th onium 0.025 mg* per kg
At B* trishexatetrMoniua 0.10 mg* per kg*
(d) At C* decamethonium 0*05 mg. per kg*
At Dg dihexasulphonium 0*30 mg* per kg.
decerns thcnliiin m m  an additive one* Then any one of these 
three compound© were given (0*5 Mr-# to 1*0 sag# per kg#) 
at the point of maximal depression caused by decani©thonium# 
the muscle twitch either remained maffected or was reduced 
in raegnlttide depending upon the magnitude of the dose of 
dldecasulphonlum# dldeeeaftonlum or trisdeeate trasonlum* 
Becamethonluca block was never antagonised by these three 
compounds* A typical experiment is shown in Figure 62* 
page 217.
(v) Potassium chloridei
The potassium ion has been shown t© antagonise 
neuromuscular block caused by tubocurarlne^but deoamethon- 
turn block la very little affected***^ # It was of interest, 
therefore# to investigate the effect of potassium chloride 
on the neurovascular block caused by those new synthetic 
compound** It m s  observed that the block caused by all 
the compounds (excepting didecasulphonium# didecaasoniuia 
and trisdecate trasoni um) was reversed by intravenous 
injection of 15 to 2h mg# par kg# of potassium chloride*
The reversal m m  usualiy incomplete and did not persist 
(Pig* 63# p*218). This effect was similar to that 
observed with tubocurarin© • Dideoasulphontum# did©©*- 
aaonium and t riadeoate t r tusoaiusu on the other hazid# had 
different /
Fi.mre 62 . Cat gastrocnemius-® ciatic preparation*
Pentobarbitone anaesthesia. Indirect stimulation via 
sciatic nerve* Contraction downwards• Drugs 
administered intravenously*
(a) At A# decamethonium 10.0 |*g. per kg.
At B, dideeasulphonium 0.10 mg. per kg.
At C, tubocurarin© 0.10 mg. per kg.
(b) At A# dscamethonium 10.0 pg. per kg.
At B# didecaasonium 0.10 mg. per kg.
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ffi&ure 63* Gat gastroenemius-Hsciatie preparation* 
Pentobarbitone anaesthesia* Indirect stimulation via 
©ci&tie nerve* Contraction downwards* Drugs
administered intravenously*
(a) At A, trishexatetraaonium 0*10 mg* per kg*
At B, adrenalins 0*05 mg* per kg*
At 0# potass ion chloride 20*0 m* per kg*
0>) At A, dihexone 0*40 mg* per kg*
At B, potassium chloride • 20*0 mg* par kg*
At c. adrenalins 0 *’.33 *lg* per kg.
(c) At A, dloctaasonium 0 * 07 mg• per kg.
At 3, adrenaline 0*05 mg* per k.g*
At c, potassium chloride 15.0 w$* per kg.
(4) At A# d ihe xaa z onium 0*40 mg* per kg.
At B# potassium chloride 20*0 mg* per kg*
At 0# adrenaline 0*10 mg* per kg.
At adrenalin© 0*05 mg* per kg.
different effects* Potassium chloride when injected 
in doses of from 15 to 20 mg* per kg. had either no effect 
on* or caused slight reversal of the neuromuscular block 
produced by these compounds (Fig* 64, a and c, p.220).
o <• ’
A similar effect was observed when decmnethonium was used 
(Fig. 64,b).
(vi) Adrenaline:
fhe decurari^ing effects of adrenaline were first
observed by Panella^ and were later investigated by 
Camus and ?orak^# Rosenblueth ei^  alia*^  also showed the 
antagonistic effects of adrenaline to the neuromuscular 
block caused by tubocurnrine in the cat nerve-muscle 
preparation* On 1 he other hand, Prton and Zaimis^ 
observed that adrenaline had no effect upon the block 
produced by decrmethoniurn in the sane preparation* As the 
effects of adrenaline on the neuromuscular block caused by 
tubocurarine and dec°methonium were reported to be different, 
it was decided to investigate the effect of adrenaline on 
the block caused by the new synthetic compounds (see 
pages 189 and 192 0
Adrenaline in doses ranging from 0.05 to 0.10 mg. per
kg* caused a rapid but short Ip sting reversal of the block 
caused /
fflj-jiiye 64* Gat gastrocnemius-Hssciatic preparation*
Pentobarbitone anaesthesia# Indirect stimulation 
via sciatic nerve* Contraction downward®* Drugs 
administered intravenously*
(a) At A, did® casulphonium 0 * j>0 mg* per kg
At »# potassium chloride 20.0 mg* per kg
<b) At A$ decamethonium 0*05 jag* per kg
At B, potassium chloride 20*0 mg. per kg
(e) At At didecaaaonium 0*20 mg* per kg
At B, potassium chloride 13*0 mg* per kg
0 16
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eeased by nil compounds. In some onses the twitch 
amplitude became almost normal within a few minutes* but 
soon declined again to the level it had attained when the 
adrenaline vao injected. Adrenaline had a, similar effect 
when injected into the cat during neuromuscular blockade 
caused b y tubocurarine and decrmethonium* although Pat on 
and Zaimicf^ observed that adrenaline was ineffective in 
reversing the neuromuscular block caused by dec^methonium.
A typical experiment is shown in Figures 63 and 65* pages 
218 and 222.
(rii) TIexamethoniura t
Paton and Znimie* have investigated the antagonism 
between hexamethonium and dec arse thorium in the cat end 
rabbit. They observed that hexamethoniurn not only 
showed no antagonism to tubocurarine but actually 
potentiated its action to a small extent. When the effects 
of hexanethonium upon the neuromuscular blocking activity 
of the new series of compounds were investigated* it was 
found that dipentasulphonium* dihexasulphoniuin trimeth- 
iodide* dihex as ulphonium* dihexaassonium* dihexone* 
dioctasulphonium, diocteafconium and trishexatotrazonium 
had properties similar to those of tubocurarine. while 
didecasulphonium* didecaazonium and trlsdecatetrazonimn 
had /
Figure 65. Cat gastrocnemius-aoiatic preparation. 
Pentobarbitone anaesthesia. Indirect stimulation 
via sciatic nerve. Contraction downwards.
Drugs administered intravenously.
(a) At k9 decamethonium 0.04 rag. per kg.
At B* adrenaline 0.02 sag. per kg.
(b) At A9 didecasulphonium 0.50 mg. per kg.
At B# adrenaline 0.07 mg. per kg.
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hnd dQCRsiethonium-lilre properties* The neuromuscular 
block produced by the compounds of the former groups was 
cither unaffected or potentiated by an infravenous 
Injection of 2 to 5 mg. per I:.;* of hexanethonium. The 
compound® in the latter group bed properties different 
from those of the first group in this respect. Hcxaneth- 
onln i either slightly increased the twitch height of the 
partially blocked muscle or hod no affect upon it.
The properties of these compounds on the cat gastro­
cnemius 'made-sciatic nerve preparation are summarised 
in Table 2, pages 224 and 225.
2m (A) add) ft Head Prop Test.
The nean herd drop doses etc. of the new compounds 
as well as of tubocurarine end decrmethonium are shown in 
Tables 5 ana 4, pages 226, 227 and 228. Groups of
9 rabbits were injected in each test. The duration of 
head drop caused by dlpentasulphonium* diliexas ilphoniuia* 
dihoxasaoniuni, dihexone and trshexatetragoniua varied 
from 10 to 15 minutes* and complete recovery from paralysis 
usually occurred within 30 minutes. 60 to 90 per cent 
of the rabbits used survived the administration of head 
drop doses of these 5 compounds* whereas when tubocurarine 
was /
A Tabular Comparison of the Properties of Bipentasulphonium* Bihexasulphoniam, Dihexa 
salphoniuai trinethiodide, I)ihexaazonium, Bi oc tasulphonium, Bioetaazonium, Bideca- 
sulphonium, Bideeaazoniuia, Bihexone, Trishexatetrazoniurn and Trisdec at e tra zonium with 
Tubocurarine and Be came th onium on the Cat Gastrocnemius-seiatic preparation*
Tubo­
curar­
ine
Bipenta- 
sulphon­
ium
Bihexa-
sulph-
onium
Bihexa- 
sulphon­
ium t ri­
me thiod-
ide
Bihexa- 
az on­
ium
Biocta-
sulph-
onium
Biocta- 
az on­
ium
Bihex­
one
Tris- 
Hexa- 
Tetra- 
zonium
Be can- 
eth on­
ium
Dideca-
sulph-
onium
Bideca- 
az onium
Tris- 
deea- 
tetra- 
z onium
Neuromus cular
blocking
activity
(a) Time of 
onset of 
maximum 
paralysis 
(minutes) 1 - 3 1 - 3 1 - 3
*
1 - 3 1 - 3 1 - 3 1 - 3 1 - 3 1 - 3 1 - 3 5 -10 5 -10 5 - 1 0
(b) Buration 
of paral­
ysis
(minutes) 20 -30 20-30 20-30 15-25 20 -30 20 -30 20 -30 30—40 20 -30 15- 25 50 -120 90 -120 90 -120
(c) Potency 
(tubocur­
arine —5100 ) 100 95 95 20 100 33 5 0 12 300 1000 100 100 50
Preliminary 
excitation of 
skeletal muscle none none none none none
*
none none none none twitch­
ing and 
fascic- 
ulation
fascic­
ule t ion
twitch­
ing and 
fascic- 
ulation
fascic-
ulation
Effect of tubo­
curarine on 
block addit­
ive
addit­
ive
addit­
ive
addit­
ive
addit­
ive
addit­
ive
addit­
ive
addit­
ive
addit­
ive
antag­
onist­
ic
addit­
ive
addit­
ive
additive
Effect on tubo­
curarine block do. do. do.
.
do* do. do. do* do* do. do. antag­
onist­
ic
antag­
onist­
ic
antagon­
istic
/continued *
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T A I> U I; 2 (continued)*
Tubo­
curar­
in©
lipenta- 
sulphon­
ium
Dihexa-
sulphon-
ium
lihexa- 
eulphon­
ium tri- 
nic tni od— 
ide
Dihex- 
aazon­
ium
I-iocta- 
aulph-
onium
liocia- 
asonium
Eihex-
one
gris- 
aexa- 
tetru­
ss onium
leoam- 
ethon­
ium
lidcoa-
sulph-
oniira
Ildecs— 
azonium
Tria­
ds ca- 
tetra-
zonium
Effect of de ca­
me thonium on 
block
antag­
onist­
ic
antagon­
istic
antagon­
istic
antagon­
istic
antagon­
istic
antagon­
istic
antagon­
istic
antag­
onistic
antagon­
istic
addit­
ive
addit­
ive
addit­
ive
addit­
ive
Effect on deca­
me thonliu block do# do# do# do# do* do# do# do# do* do# dO# do* do*
Effect on the 
block of
*
(a) i^ eostigiaine antag­
onism
antagon­
ism
antagon­
ism
antagon­
ism
antagon­
ism
antagcar-
ism
.antag­
onism
antag­
onism
anta goa~
ism
m
antag­
onism
no
antag­
onism
no antag­
onism
* no antag­
onism
(b) 1serine do# do# do# do# do# do# do* do* do# do# do# do# do*
(c) Edrophon­
ium
(d) Adrenaline
do#
do#
do#
do#
do#
do#
do#
do*
do*
do*
do#
do#
do#
do*
do*
do#
do* 
do* .
Potent- 
iation
antag­
onism
no
antag­
onist
antag­
onism
Potent­
iation
antag­
onism
Potentiat­
ion
antagon­
ism
(©.) Potassium 
chloride
do. do# do# do* do* do# do* do# do* no
antag­
onism
no
antag­
onism
no
antag­
onism
no antag­
onism
(f) Ether 
anaesthesia
(g) Indirect 
tetanization
addit­
ive & 
prolong­
ed
an & Qg*** 
onism
auditive 
U pro­
longed
antagon­
ism
additive 
& pro­
longed
antagon­
ism
additive
& pro­
longed
antagon­
ism
additive 
& pro­
longed
antagon­
ism
additive
& pro­
longed
antag­
onism
additive 
& pro­
longed
antag­
onism
additive 
& pro­
longed
antag­
onism
additive
& pro­
longed
nut a g- 
onism
Ifo eff­
ect or 
antag­
onism
no
effect
no
effect
no
effect
no
effect
no effect
Kesponge of part­
ly blocked muscle 
to indirect 
tetanus
pearly
S  US®
tained 
con­
tra© cion
poorly
S v£l J-xl—
ed con­
traction
poorly
sustained
contract­
ion
sustain­
ed con-
CX*ti0 tiXOfi
poorly 
sustain­
ed con­
traction
well 
sustain­
ed con­
tract ion
poorly 
sustain­
ed con­
traction
poorly 
sustain­
ed con- 
tr-etiar
poorly
BU8-
teined
con­
traction
i
well 
s us-brin­
ed con­
traction
poorly
anstain­
ed con­
traction
well 
sustain­
ed con­
traction
well
sustained
contract­
ion
* Could not be investlooted aae to very prolonged effect#
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T A B L E  3»
Individual and Mean Head Drop Doses of Dipentasulphonium, 
Dihexasulphonium, Bihexaazonium, Dioctasulphonium, Diocta- 
azonium, Bidecasulphonium, Didecaazonium, Dihexone, Tris- 
hexatetrazonium, Trisdecatetrazonium, Decamethonium and
Tubocurarine in the rabbit.
HiiAD DROP DOSES (HDD)
Compound
Cndivid- 
ial (mg.per 
cg»)
Mean ± s.e, 
(mg.per kg.)
Ho.Died
Ho.inject-
ed.
Potency 
(tubocur­
arine SB 
100 )
Dipentasul-
phonium
0.43, 0.42,
0.30, 0.37, 
0.38, 0.40, 
0.35, 0.40, 
0.37.
0.38 + 0.014 2/9 29
Dihexasul- 
phonium
0.42, 0.27, 
0.38, 0.40, 
0.35, 0.40, 
0.35, 0.35, 
0.30.
0.36 t 0.071 3/9 30
Dihexaazon­
ium
0.57, 0.47, 
0.77, 0.60, 
0.58, 0.40, 
0.38, 0.40, 
0.45.
0.51 t 0.057 2/9 21
Dioctasulph-
onium
0.26, 0.25, 
0.22, 0.30, 
0.25, 0.30, 
0.20, 0.20, 
0.23
0.24 i 0.013 9/9 46
Dioctaazon­
ium
.......... .....
0.25, 0.25, 
0.28, 0.30, 
0.25, 0.25, 
0.26, 0.25, 
0.28.
0.26 ± 0.014
..-......... -  .
9/9
i
J.
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T A B L E  3 (continued)*
Compound
fiEAS"pkoF l6SB£ (hW T
Individual 
(mg.per kg.)
■lean i s*e. 
(rag.per kg.)
No.died 
3fo .Inject* 
ed.
Potency
(tubo­
curarine
Didecasul-
phoniuia
Didecaaz­
onium
Dihexone
Trishexa- 
ieTraz on­
ium
Trisdeca­
te tras on­
ium
Be came th on­
ium
Tubocur­
arine
0.13, 0.29, 0.21 t 0.023
0.25, 0.18,
0.16, 0.20,
0.20, 0.23,
0.25
0.19, 0.26, 0.28 t 0.017
0.30, 0.30,
0.30, o .30,
0.25, 0.34,
0.33.
0.30, 0.4 0, 0.39 ± 0.017
0.38, 0.43,
0.43, 0.40,
0.40, 0.36,
0.40.
0 .21, 0.21, 0.19 ± 0.014
0.21, 0.23,
0.20, 0.18,
0.16, 0.12,
0.20.
0.25, 0.50,
0.0 t 0.024
0.35, 0.50,
0.32, 0.45
0.38, 0,40,
0.45.
0.20, 0,18, 0.16 4 0.008
0.17, 0.14,
0.13, 0.15,
C.15, 0.18,
0.18.
0.10, 0.09, 0.11 4 0.01
C.10, 0.15,
0.11, 0.12,
0.10, 0.12,
0.12.
9/9
9/9
1/9
3/9
9/9
3/9
6/9
52
39
28
58
28
69
100
228.
T A r L E 4.
Head drop ; -oaea of 7)ipent as uluhoniurn, Nihexasulphoniua, 
Dihexaaz onium, iootaaaiphoniun, Bioctaazonium, Jideca- 
3ulphoniu:n, Bidecan zoniun, .ihexene, Triahexatetrazonium, 
Triedec g tetrad onium. reermcthonium r.nd Tubocurarin® in 
lili© Rabbit Before and Aftrr ctnent with TRsosiigmine 
and the ratios 'Ldj (';eo^ tl,>-nrie ;r ated)/ 'T"< (Control).
Compound
Been Bead 1 rop lose (HDI)) 
per kc*)
*
Neostigmine
Batio*
controlControl Neostigmine% 0 «1J ‘j.r. * PCI
k >  subcut*) 
treated*
Dipenta- 0*38 + 0.014 0,57 t 0.014 1.50 (?« < 0.01)
sulphoniura
Dihexasul-
phonium 0.36 t 0,071 0.59 - 0.071 1.64 (P* <  0.01}
Mhexaaz on­
ium 0.51 t 0,057 0.81 ± 0.057 i.56 o.oi)
Dioctasul- J
phonium 0.24 i 0.013 0.25 - 0.013 1.04 (P= >0.90)
Bioctaazon­
ium 0.26 ± 0.014 0.33 ± 0.014 1,27 (r= < o.oi)
Didecaaul-
ph onium 0.21 ± 0. !23 0.23 ± 0.023 1.30 (P« >  0.05)
Eidecaasofc -
ium 0.28 t 0.017 0.29 t 0.017 1.00
Dihexone 0.39 ± 0,017 0.44 i 0.017 1,12 (P- >0.40)
Trishexafceti-
azonium 0.19 i 0.314 0,31 t0.0141.63 (P«< 0.01)
rrijjde cate tr­
ass onium C ,40 t0,0240.33 ± 0.024 0.82
leer: me th on­
ium 0.16 ± 0.008 0,15 i 0.003 0.93
Tubocurarine 0.11 + 0.01 0.30 ± 0.01 2.72 (P= <  0.01)
512-3.
was used 66 per cent died following a head drop dose 
(Table 3 #pog@o 226 ??nd 227 )# Death In each case was 
Irvariably due to respiratory paralysis*
The duration of paralysis caused by did© caaulphonium* 
didoeaasoniuza* dioctasulphonium* diocteazonium and 
trlade cate trazonium was more prolonged than that caused 
by the compounds of the former group. All of the rabbits 
which had received head drop doses of the compounds of 
the latter group died within 10 to 30 Minutes (Table 3) •
The potency of the new compounds together with that 
of tubocurarine and decamethonium as estimated by this 
test is shown in Table 3 • All of the compounds were 
found to be less potent then tubocurarine. Pictures of 
the rabbit head drop are shown in Figure 34* page 148*
2# (B) The Effect of neostigmine upon the Magnitude
of the Head Drop Dose.
If 0*10 mg* per kg. of neostigmine was injected sub- 
cutaneously 15 minutes before the drug infusion was 
started then there was In some cases a change in the 
magnitude of the head drop dose# The doses of dipenta- 
sulph onium* dihexasulphoniura* dihexaajzoniuai and tris- 
hexatetrasoniuxa were found to be appreciably raised* 
whereas /
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whereas those of did©csaionium* dioetesulphonium and 
tried®catetrazonium remained eithe r unaltered or reduced 
(Table 4 *p#228)# This property of di&ecaas onium* 
dioo t a □ ulphonium and tried© oatetraeonlua m s  shared with 
deeamoth onium and that of the former group was shared with 
tubocurarine# the head drop doses after prior treatment 
with xioostigTaine* together with the ratio* head drop dost 
for the neostigmine pro treated rabbits/head drop dose for 
the untreated rabbits* are shown in Table*4*
3* Mouse Test#
Median .Paralysing hose (PBisn)*
Five to ten minutes after intraperitoneal Injection 
into mice* all of the new compounds caused increased 
movement and restlessness* These symptom appeared at 
the was* time as symptoms of respiratory embarrassment 
became apparent# The mice then became quiet and began 
suddenly to lose their ability to retain their position 
on the inclined screen and slid abruptly backwards off 
it* heoovery from paralysis was usually complete in 15 
to 20 minutes end the mice had completely recovered in 
30 to 45 minutes# The time of onset of action and the 
period required for recovery from paralysis were greater 
for dideeaeulphonium* didecaaasonium and trigdeoatetraz oniua* 
The /
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the median paralysing doses (PDcjq) of the compounds 
studied are shown In Table 5* peg© 232* The relative 
potency has been determined in terms of tubocurarin© ** 100 
and is shown in the same t^bie• It was observed
that the compounds dioetasulphonium and trisdecatetrag^ 
onium were the most patent (2*5 times 4ore potent than 
tubocurarine) and dihexaaaonium wns the least potent*
4* Chick Paralysis Test*
It is well known that competitive neuromuscular 
blocking agents cruse a flaccid paralysis in birds* 
whereas depolarising agents cause a typical spastic para­
lysis?#^* It was of interest* therefore* to see the 
type of paralysis produced in chicks by the new compounds *
Following an intraporitoneal injection of from 10 
to 40 mg* per kg* of dipentasulphpnium* dihexasulphonium* 
dihexaazonium* dioctasulphonium* dioctaazonium* dihexone 
or trishexate trazoniuin* a typical toboeurar ine-like 
flaccid paralysis was seen in chicks* lidecasulphonium* 
dideoaasonium* dihexasulphonium trimethi odide and tria­
ds cate trasoniuia* caused different effects in chicks# 
lideoasulpbonium* didecanzonium and dihexasulphonium 
trim©thiodid© in the dose range of from 1 to 40 mg* per 
k«. /
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T A P L E 5
A Comparison of the Potency and Toxicity of Lipenta- 
sulphonium* Bihexasulphonium, Pihexaagonium, Liocta- 
suiphonium, jDioeta&gonium, Didecasulphonium, Lideca- 
azonium, Lihexone, rishexatotraaonium and Triadeca- 
tetraaoniu?a with Tubocurarine and Be eauieth onium in mice*
Compound
Approx­
imate 
Median 
Paralys­
ing dose 
(mg.per kg*)
Approx­
imate 
Median 
Le thal 
Bose
{mg.per kg.)
Paral­
ysing 
Potency 
(tubo- 
eurarine 
* 100 )
Median 
Le thal 
Dose 
?fedian 
Paral­
ysing 
Lose.
Lipentasul-
ph onium 0.70 1.33 / 28 1.9
Lihexasul-
ph onium 0.80 1.20 25 1.5
Diliexaaa on­
ium X.20 2.25 17 1.9
Bioctasul-
phonium 0.08 0.40 250 ' 5.0
Lioctaasson­
ium 0.10 0.40 200 4.0
Lidecasul-
phonium 0.10 0.20 200 2.0
Bid eeaass on­
ium 0.16 0.18 125 1.15
Lihexone 0.60 2.30 33 3.8
Trishexatetrn- 
zonium 0.40 0.75 50 1.9
Triedocate t ra­
sa Onium 0.08 0.10 250 1.25
i)e cainc th onium 3.65 4.10 5.4 1.12
Tubocurarine 0.20 0.28 100 1.4
kg# produced an initial decani©thonium-like spastic 
paralysis with extension of the legs and retraction of the 
head, hut within a few minutes the paralysis became 
flaccid in nature* This type of paralysis was observed 
in chicks following an injection of the bisquaternary 
methonium compound, tridecaaet'honium^#
Triadecatetrasonium at dose levels of from 10 to 20 
mg* per kg* caused a flaccid paralysis, but when the dose 
waa increased to 30 to 40 mg# per kg* an initial spastic 
paralysis was seen idilcfc rapidly became flaccid in nature#
Kesults of these experiments are summarised in 
Table 6, page 234*
3# Activity on the Bat Phrenic i?erye«4)iaghr&&ai Preparation*
All of the compounds tested in the dose range of 
0*05 to 0*2 mg# per ml* reduced the twitch height of the 
diaphragm caused by indirect stimulation via the phrenic 
nerve* The effect was always reversible on washing# 
Tubocurarine was many times more potent on this 
preparation than the most potent of the new compounds#
A typical experiment is shown in figure 66, page 235* 
Tubocurarine was about 50 to 100 times more potent than 
dipentasulphonium /
234.
Type of Paralysis in Chioka
Compound
Type of paralysis 
observed*
Bipent as ulphonium flaccid
nhexasulphonlum flaccid
Bihexasulphonium 
triiaeth iodide Spastic — ^ flaccid
Bihexaaz onium flaccid
lioctaeulphonium flaccid
Bioctaasonium flaccid
Bide casulph onium Spastic — ^ flaccid
Bideeaasonium Spastic — flaccid
Bihexone flaccid
Triehexatetrag onium flaccid
Trtedeoatetrazonium (Flaccid in smaller dose 
(Spastic in larger dose
Tubocurarine Flaccid
Becameth onium Spastic
235 •
Figure 66* Isolated rat phrenic nerve-diaphrag®
preparation* Indirect stimulation via phrenic nerve 
at 10 volts* pulse width 1*5 ®secs*# B impulses per
minute W «» wash out*
(a) At A tubocurarin® 3*0 pg* per ml*
At B dioctasulphonium 100*0 |ig* per ml*
At C dioctaas onium 100*0 pg* per ml.
At B triedecatetrazonium 100*0 pg* per ml*
0»)
At K tubocurarine 2*0 pg. per ml*
At A tubocurarine 3*0 p.g* per ml*
At B trlshexatetrasoniuia 100*0 p.g* per ml*
At C dihexasulphoniu® 200*0 pg. per ml.
(o) At A dlhexaasonium 30*0 tig* per ml*
At B dihexaaxonium 100*0 pg* per ml.
At C tubocurarine 2.0 pg. per ml*
At D did©oasulphonium 100.0 pg. per ml*
dlpentaaulphonium, dihexmsenium, dihexsusulphonium, 
dide casulphonium or di&eca&sonium, while trtBhexatetrsBw 
Oiiiusit . tarladc oate t msontoa , d i oetasuIphonium and dioeta- 
aaonium were about 30 to 50 times and dihexone about 150 
times lose potent than tubocurarine*
6*.. Activity on the Kitten Phrenic Herve-Bianhram
Preparation*
This preparation m e  many times more sensitive to
the neuromascular blocking activity of the compounds under 
investigation than the rat diaphragm preparation* All 
the compounds tested reduced the height of the indirectly 
induced twitch, and the effect was always reversible on 
washing* There m s  no initial potentiation of twitch 
height* Although dipentasaXphoniura and dlhexa82 onium 
were omnipotent and dioetasulphonium and dioctaasonium 
were less potent than tubocurarine on the oat gastrocnem­
ius muscle-sciatic nerve preparation, these compounds were 
more potent on this preparation* Poses required to 
reduce the twitch height of the diaphragm by 50 per cent 
in three minutes varied very much from preparation to 
preparation and were usually between 0*01 to 0*1 rag* per 
ml* The results of seme typical experiments are shown 
la figure 67, page 237 ♦ In some experiments complete 
block /
■Ill
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Figaro 61. Isolated kitten phrenic nerve-diaphragm 
preparation* Indirect stimulation via phrenic 
nerve at 12 volts# pulse width 2*0 mseca*, 8 
impulses per minute * w m  Wash out*
(a) At A * dihexasulphonium 30 per ml*
At B, tubocurarine 30 |ig per ml •
At o, trishexatetragon!am 
d ioc t asulph onium
10 per ml*
At D, 15 per ml*
(b) At A* tubocurarine 4 Hg per ml*
At b ; didecaazonlum 60 per ml*
At c, didecas ulphonium 65 ,per ml*
(c) At A# tubocurarine 20 per ml*
At tubocurarine 10 per ml*
At »# dihexaa sonima 10 Pg per ml*
At C, dihexaazoniua 5 pg per ml*
At D, d the xasulphoniua 5 per ml*
At B# dihexasuIphonium 10 m per ml*
At dihexasulphonium 20 per ml.
At n. dipent asulphonium 10 f*g per ml*
At i# dipentasulphonium 5 |Ag per ml*
233 #
block was produced at do@e levels of 0*015 to 0*1 mg# 
per ml* in 5 to 7 minutes# There was complete reeo?oi7 
of the twitch height on washing# This type of experiment
is shown in Figure 68, page 239# The approximate
potency of the compounds expressed in terms of tubocurajv 
ine is shown in Table 7# page 240#
7* The Frog Rectus Abdominis .Muscle#
Hone of the new compounds had any diroot stimulant 
effect on this preparation at doses of up to 25 |ig« per
ml* A H  of them in the dose range of 0*5 to 2*5 US# per 
ml# caused graded inhibition of contractions induced by 
0*10 to 0*25 per ml# of acetylcholine or 1#5 to 2*5 
IMS* per ml* of dec&methaniua (Figs* 89 mid 70, pages 241 
and 242 )# In this respect all of the compounds showed 
properties similar to those of tubocurarine* The potency 
of these compounds as measured by the degree of inhibition 
of acetylcholine induced contractions is shown in Table 8, 
page 243.
Antagonism by some of those compounds to acetylcholine 
and dse&sethanium induced contractions of the frog rectus 
abdominis muscle is shown in Figures 71 and 72, pages 244 
and 245.
The /
239#
Figure 68* Isolated kitten phrenic nerve-diaphraga 
preparation* Indirect stimulation via phrenic 
nerve at 10 volts, pulse width 1*5 maeos*, 8 
impulses per minute*
At A, dihexaasonium 15 pg* per ml*
At B, dipentasulphonium 30 ^g* per ml*
At W# wash out*
4910
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T A B L E  7
The relative potencies of d ip e n t as ulph oni u n , dihexa- 
suiphoniusa, dihexaazonium, dioctasulphonium, diocta- 
aaonium, didecaeulphonium, & ide cansonium, dihexone, 
triahexatetrasonium, trisdecatetrasonium and 
tubocurarine on the kitten phrenic nerve-diaphragm
preparation*
Compound Potency in terus of tubocurarine * 100
Lipentflsulphonium 200
Bihexae u Iph onium 100
Dihexaaz onium 300
Bioctasulphonium 200
Bioetaazonium 150
Bidecasulphonium 15
Bidecaaeonium 15
Dihexone 7
Triahexatetragonium 300
Trisdecatetrazoniuia # ■ ■
Tubocurarine 100
Be c axne thonlua 75
* could not be compared*
o didecaazonium 
• tubocurarine 
x dipentasulphonium
100
80
60
4 0
20
0 21 O 1
Log dose £ug per ml)
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IlffiMPi 69. Isolated frog rsotus abdoaiaio auscls. 
Relation of leg dose of dldeeaasoaiaa, taboaiixfcrino 
•ad dlpentaeulpboniua (abaoiesa) to the yorsoatago 
rsduotioa (ordinate) of ths height of ooatvaetimt 
produced by the same dose of acetylcholine*
•  didecaazonium  
° ^r/shcxatetrazonium
glgiirt 70. Isolated frog rootue abdominis ousels, 
Belotion of log does of dideeossonlua and 
trlehe»tetga»onlua (ahseisos) to tho poroontago 
vaduotlea (ordinate) of tho height of eontr&otloa 
produced bjr tho ease dooo of dooaatothoniuau
243*
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Comparison of the potency of the compounds, dipenta- 
sulphonium, dihexa sulphonium, dthexa,azonium, diocta- 
sulphonium, dioctaazonium, didecasulph onium, dideca~ 
azonium, dihexone, trishexatetrazonium, trisdeoa- 
tetr&zonium, with tubocurarine on the frog reetue 
abdominis muscle*
Compound
Potency in terms of 
tubocurarine « 100
Dipentasulphonium 25
Bihexasulphonium 25 «
Bihe xaa z onium 50
I)i oc t as ulphonium 10
Bioctaezonium 20
Bidecasulphoniuta 10
Didecaazonium 10
Dihexone 2
f rishexate traz onium 50
Triedecatetrazonium 20
figure 71* Isolated frog rectus ab&cminie muscle#
(a) All contractions were due to 0#20 pig# per 
ml# acetylcholine acting for 1*5 minutes# 
labelled contractions were preceded one 
minute earlier by
At A*B and C, didecaaionium 5*10 and 15 pig# per ml*
respectively#
At BtE and tubocurarine 1* 1*5 and 0#75 pg*par ml#
respectively#
At CrfH and I# dideoasulphonium 5$ 5 and 20 pig# per ml*
respectively#
(b) All contractions were due to 0#10 pg« per ml# 
acetylcholine acting for 1*9 minutes*
Labelled contractions were preceded one 
minute earlier by
At AfB*C and I) 0 dipent as ulphonium 5* 2#5# 1 and 0*5 pg* per
ml* respectively*
At DfF and 0* tubocurarine 0*5* 0*25 and 1 pg# per ml*
respectively#
ffi&ure 72* Isolated frog rectus abdominis muscle#
(a) All contractions produced by deeameih onium 
2*5 |sg# per ml# acting for 2 minutes# fhe 
addition of becamethonium was preceded one
minute earlier by
At A* B and Ct dideeaasonium 10* 5 and 2*5 t*g* per ml*
respectively*
(b) All contractions produced by became th onium 
2*0 pg* per ml* acting for 2 minutes* She 
addition of decsmeth onium was preceded one 
minute earlier by
At A and 2* trishexntetrasonium 2*5 end 1*25 tig* per ml#
respectively#
At B and 0* dioetaazonium 2 #5 and 1*25 tig* per ml*
respectively#
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The neuromuscular blocking potency of these compounds 
in different species Is colored with that of tubocurarine 
and is shown in fable ^
®* Effects upon the Blood Pressure of the Anaesthetised 
Cat*
fuhocuraxine in doses of 0*1 to 1*0 mg* per kg* caused 
a fall of blood pressure of varying intensity In 
anaesthetised eats and dogs^* The fall in blood pressure 
which follows administration of tubocurarine is probably 
due to blockade of transmission of sympathetic vase* 
constrictor impulses at the ganglion synapse* It may 
also be partly due to liberation of hist a m i n e * In 
order to investigate whether the new compounds resembled 
tubocurarine in this respect$ their effects upon the blood 
pressure of anaesthetised cats were studied* Bone of the 
compounds caused a significant rise or fall in the blood 
pressure when administered in doses ranging from 0*5 to 
2*0 mg* per kg* excepting trigdeeatetrassoniua which 
always caused the blood pressure to fall when given at 
doses of from 0*5 to 1*0 mg* per' kg* (Figs* 73*0 and 
pages 248 and 249 )• A moderate fall of blood
pressure was observed in one cat following 0*4 mg. per kg* 
of dideca&sonium (Xrig#74*b)* tubocurarine (0*5 to 1*0 
/
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SLAJLLEJL
Comparison of Potency of Bipentaeulphonium, Dihexaeulphon- 
ium, Dihexaeulph onium trimoth iodide, Dihexaasonium*
Idoctasulphonium, Dioctaasenium, Bidee&sulphonium, l-ideca- 
azGnium, Dihexone, Trlghexatetragonium and ^risdeoate tra- 
aonium with Tubocurarine taken as 100 in different species*
0 A * HAT RABBIT MOtlHE m m
Compound Gastro-
cnemius-
sciatic
Ihrehic
diaph­
ragm
ffirenlc
Diaph­
ragm
ilead Drop 
Dose
Approx­
imate
median
paral­
ysing
dose
Acetyl­
choline
antag­
onism*
Bipentasul-
phonium 95 200 1-2 29 28 25
Dihexasul­
ph onium 95 100 1-2 30 25 25
lihexaazon­
ium 100 300 1—2 21 17 50
Dioctasul- 
ph onium 33 200 2 46 250 10
1)1 oc tea z on­
ium 50 150 2 42 200 20
Bide cas ulph - 
onium 100 15 1-2 52 200 10
Bideoaazon­
ium 100 15 1-2 39 125 10
Dihexone 12 7 0*6 28 33 2
Trishexatetr­
agon ium 300 300 2 53 50 50
Trisdeoatetr-
azonium 50 2 28 250 20
Tubocurarine 100 100 100 100 100 100
De c arae tfc onium 1000 75 69
. ..
5.4 contract­
ure
243.
a.
b
c
Figure 75. Cat. Pentobarbitone anaesthesia* Blood 
pressure record from common carotid artery. Brags
administered intravenously and followed by 4 ml. 
saline in each case.
(a) At A# dipentasulphonium 0.50 mg. per kg.
At B# dihexaeulphonium 0.50 mg. per kg*
At U$ saline 4 ml.
At tubocurarine 0.50 mg. per kg.
(b) At A# adrenaline 1.0 tig. per kg.
At B# aiftexaa ionium 1.0 mg. per kg*
At C, diliexaasonium 2.0 mg. per kg.
At S, saline 4 ml.
At B# dioct&aulphonium 2.0 mg. per kg.
At ^ 0 tubocurarine 1.0 mg. per kg.
At £# trtshexatetraaonium 2.0 mg. per kg.
At F, didecas ulpb oniua 2.0 mg* per kg*
At Q, dihexone 2.0 mg. per kg.
(c) At A* triadeoatetraaonium 1.0 mg. per kg.
At B* t rishemt e tragonium 1.0 mg. per kg.
At C# dideoaasonium 1.0 mg. per kg.
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fimre 74. Cat. Pentobarbitone anaesthesia, Blood 
pressure reoord taken from the common carotid 
artery. Drugs administered intravenously and 
followed by 4 ml, saline in each ease.
(a) At kt trisdeoatetrasoniuni 1,0 mg, per kg.
At S# saline 4 ml.
At Bf
11118 1,0 mg, per kg.
At $# tubocurarine 1,0 mg, per kg.
(b) At S# saline 4 ml.
At A, dideoaasonium 0,40 mg, per kg.
At didecasulphonium 0,40 mg, per kg*
kg,) usually caused & well-marked fall of blood pressure 
in tho anaesthetised cat. In some oats there was slight 
initial fall followed bjr a well-marked rise, and in seme 
oats a well-marked rise and then a fall in the bleed 
pressure level were seen following the injection of 
tubocurarine (Fig, 73 ,b and c), These effects of 
tubocurarine and the effects of some of the other compounds 
on the blood pressure of the anaesthetised cat are shown 
in Figures 73 and 74*
9, dan&lion Blocking Activity,
In order to study the ganglion blocking activity of 
the compounds under investigation, their effects were 
studied on the response of the nictitating membrane to 
stimulation of the preganglionic fibres of the cervical 
sympathetic, There was a slight reduction of the height 
of contraction of the nictitating membrane following the 
injection of 0,5 to 1*0 mg# per k doses of compounds, 
dips nt a sulphonium and dihexaaaonium (Fig# 75# page 251}*
'Whereas dihexas ulph onium. trimsthiodide* dihexaascn—
*
iuua# diootasulphonium# dioctaascmlum# dideeas alph onium# 
dihexone, triahexatetrazonium and triadecatetra­
ss onium at doses of up to 3.0 mg, per kg, showed no 
activity /
Figure 75, Cat gastrocneiaius-aclatlc preparation. 
Pentobarbitone anaesthesia. Contractions of 
nictitating membrane elicited at 3 minute intervals 
by preganglionic stimulation at a frequency of 
1*000 impulses per minute# 10 volts* 0,5 msec, for 
15 seconds, Drugs administered Intravenously one
minute before the stimulation.
At A* dihexasulphoniura 1,0 mg. per kg.
At B* " 0,50 mg. per kg.
At 0* dlpentasulphonium 0,50 mg. per kg.
At D* tubocurarine 0.50 mg, per kg.
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activity# did© cans onium exhibited a. stimulant effect. 
Following the administration of dideoaaaonium in the doe© 
range of 0.25 to 1.0 mgt per kg.# there was a 
significant contraction of the nictitating membrane 
and the effect was a, long lasting one (Fig. 76# p,253).
In contrast to these compounds* tubocurarine in doses m  
low as 0.2 mg, per kg, always caused m marked reduction 
of the amplitude of the contraction of the nictitating 
membrane» Some typical effects are shown in Figures 
75# 76 and 77* pages 251* 253 and 254.
10. The Effect on the lies plrpt ion of the Anaesthetised
......Cat .....    ' .....
The continuous intravenous infusion of the new 
compound investigated* as well as of tubocurarine and 
decamethonium* always resulted in respiratory paralysis 
in the pentobarbitone-anaesthetised cat. If administrat­
ion of the drug was stopped immediately upon cessation 
of the respiration* spontaneous respiration began again 
in a certain proportion of animals. As a rule# 
artificial respiration had to be gi/en until spontaneous 
respiration begem again. This always produced complete 
recovery. The doe© required to cause respiratory 
paralysis was always higher than the dose required to 
cause /
ffi&ure 76* Cat# Pentobarbitone anaesthesia#
(a) At Af contract lone of nictitating membrane
elicited by preganglionic stimulation at
12 volts* 1*000 impulses per minute* puls#
width 1*0 msec* for 15 seconds#
At B* didecaazonium 0*50 mg# per kg# intra­
venously.
(b) At A* contractions of nictitating membrane 
elicited by preganglionic stimulation at 
15 volts* 800 Impulses per minute* pulse
width 1*5 msec# for 15 seconds#
At B* infusion of dideoaasonium (0*20 mg# per 
ml*) at 1die rate of 0*80 ml* per minute for 
10 minutes*
254.
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cause complete neuromuscular paralysis in the eat n e m *  
muscle preparation* The respiratory paralysing dose 
as well as the potency in terms of tubocurarine taken as 
100 are shown in Table 10, page 256 „
Tubocurarine was more potent than any of the compounds 
tested* excepting trishexatetraaonium* This compound
was slightly more potent in paralysing respiration but was 
3 times as potent as tubocurarine in causing neuromuscular 
block in the cat, Figure 73, page 257 shows respiratory 
paralysis due to trishexatetrasonium, dioctasulphonium 
and didecaazonium#
11* Experimenta on isolated Perfused Rabbit and
Kitten Hearts*
Hone of the new compounds in doses of up to 1*0 mg# 
had any depressant effect upon this preparation* A 
slight increase in the rate and amplitude of the heart 
beat was observed; and the outflow of the heart was 
slightly increased *
12* Experiments Carried Out Using the Isolated
Rabbit iiuodenum*
All the compounds showed stimulant properties on this
preparation in dose range of 10 to 20 p,g# per ml* This
effect /
T A E Ii £ 10 256*
Cooipariaon of the Respiratory Paralysing Potency of 
Dipent as ulph onium* Blhexasulph onium* Bihexaasonium# 
Moctasulph onium# Bioetaajsonium* Bidecaeulphonlum# 
Pideeaazonium, Bihexone# frlshexate trass onium, Trig* 
dsMtetrazonium and Be came thonium with Tubocurarine 
indicating; the Individual and Average Respiratory 
Paralysing Boses in the Anaesthetised Cat#
Compound
Respiratory Paralysing
_ jDqs©
(lae, per kg.) (ag* per kg,)
Potency 
(tubocurar­
ine - 100)
Mpentasul-' 
ph onium 0*72* 0.80* 0.76 0.76
Bihexssul*-
phoaium 1.20* 1.15* 0.86 1*0?
Dihexaason-*
ium 1.0* 1.60* 0.96 0.85
Bioctasul-
phonium 1.10* 1.0* 0.68 0.93
Biocteas&on-
ium 1*40 * 1.08* 1.25 1*24
Bideeasul* 
ph onium 1.28* 0.90* 1.40 1.19
Bidecaason*
ium 0.64* 0.60* 0.48 0.5?
Dihexone 1.12* 2.0* 2.0 1.70
Trishexatet*
rs&onium 0.30* 0.28# 0.48 0.35
frisdecatet- 
razonium &
Be c a Dieth on­
ium 0.15* 0.12* 0.17 0*15
Tubocurarine o .40 * 0.56* 0.50 0*48
65
45
56
51
58
40
84
28
157
520
100
* i;o estimate could be made due to violent muscular
movements•
Figure 78. Cat. Pentobarbitone anaesthesia. 
Record of respiratory movements of the 
epigastrium. Intravenous infusion of drug at 
the rate of 0*80 ml* per minute. Concentration 
of the drug* 0*20 mg. per ml*
(a) At A, infusion of trishexatetrazonium
(b) At A, ** ” dioctasulphonium
(c) At A* 1 ” didecaazonium.
effect was effectively abolished by atropine (0.O02 to 
0*004 |Ag* per ml.)* In some preparations dihexaasonium# 
dihexasulphoniura# dioe taeulphonium and dioctaass onium
showed no stimulant effect at these dose levels* 
Tubocurarine (10 to 20 us* per ml*) had no stimulant 
properties in any of the preparations* lone of the 
c ompounds (10 to 2D ug* per ml*) had any observable effect 
on the peristaltic movements of the duodenum* Some of 
these results are shown in Figure 79 (page 259).
13* Rxperliaents using Preparations of Isolated Guinea
Fig Ileum*
Dipentasulph onium# dihexasulphonium# dioctasulphonium 
and diootaazonium in closes up to 0*2 mg* per ml* had 
little or no stimulant effect© upon this preparation*
Thee© compounds in doses of 0,10 to 0,20 mg# per ml* 
antagonised the contractions induced by 0*10 to 0,5 >g.per 
ml* of acetylcholine* Tubocurarin© at similar dose 
levels had similar effects•
Mhexs&zoniuia# dihexone# trishexatetrazonium* dideca- 
sulphonium, didecaazonium and trisdecatetrazonlum showed 
direct stimulant effects at dose© of from 0,10 to 0*20 
mg* per ml* The stimulant properties of these compounds
were /
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Figure 79. Isolated rabbit duodenum.
(a) At A, trighexatetrassonlum 10,0 ug. per ml.
At B, dihexaazoniua 10,0 ug. per ml.
At C, dibexaBulphonium 10.0 ug. par ml.
At AS,atropine 0,002 ug. per ml.
(b) At A, dideeaaulphoaium 10.0 ug. per ml.
At B# JSifideeatetraaonlua 20,0 us. per ml.
At C, acetylcholine 0,02 ug. per ml.
At I), dldecaaaonium 20.0 ug. per ml.
At AS,atropine 0.004 ug. per ml.
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were blocked by atropine (0.002 per ml.)* Although 
they ell showed stimulant properties, all of them 
antagonised acetylcholine-induced contractions of the 
guinea pig ileum when used in doses of 0*10 to 0*20 
Ug* per ml* Some typical results are shown in Figure 
30 (page 261).
24* Isolated 'Perfumed Hat Kind quarters.
frisdecatetraaonium (0.20 to 1.0 mg.) caused 
constriction of the isolated perfused blood vessels of 
the hindquarters of the rat. Other compounds in the 
does range of 0*25 to 1.0 mg. did not cause any 
significant alteration in the outflow of the perfusion 
fluid* Tubocurarin© usually causes constriction of the 
blood vessels in this dose range• A typical experiment 
is shown in Figure 31 (page 262).
15• Mouse feet.
Median Lethal Lose (LD50)
The median lethal doses (LB50) 1» &ic© following 
intraperitoneal injection of the compound© investigated, 
as well as of tubocurarin© and decamethoniuia, are shown 
in Table 5,p.232. Following an intraperitone© 1 Injection 
of /
Figure 80. Isolated guinea pig ileum.
(a) Unlabelled contractions caused by acetyl­
choline 0.02 pg. per ml.
At A, trisdeoatetrasonium 10 pg. per ml*
At AT, atropine 0.03 ftg.per ml.
(b) All contractions caused by acetylcholine 
0.2 Q jig* per ml. Addition of acetylchol­
ine was preceded one minute earlier by*
At A, dihexasulphonium 0.20 mg* per ml.
At B, dihexasulphonium 0*10 mg. per ml.
At 0, dipentasulphonium 0.10 mg. per ml.
At B, dipentasulphonium 0.15 mg* per ml.
At E, dipentasulphonium 0.20 mg. per ml.
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gjgure 81* Parfujsien if isolated rat hind^uartars *
> ’ * V ' f f *■
tfpetroka indicates vasoconstriction*
(a) ft A# trisdeeatetragonlum 1*0 mg*
At B, tubocurarin© 1*0 mg*
At o# triadeeatc traaonium 0*20 mg*
At tubocurarin© 0*50 mg*
(b) At A, dipentasulphonium 1*0 mg*
At B# tubocurarin® 1*0 mg*
At dihexasulphonium 1*0 mg*
At !>• tubocurarin© 0*20 mg*
of a minimal lethal dose of all the compounds (excepting 
didecaaulphonium, didec&aaoniuia and t£isdeoatetrazoniua) # 
there was a rapid development of a typical flaccid 
paralysis# This was followed by failure of respiration 
which was the apparent cause of death because the heart 
continued to beat for some time after the respiration 
had ceased*
11th didecasulphoniujaf dldecaazonium and triedeea— 
tetrasenium some stimulant properties were noticed#
These accompanied the onset of paralysis# The mice had 
clonic convulsions and there was extensor spasm of the 
hindlegs before death*
the ratio of LB$q to P£§q as shown in Table 5, p.232 
was highest for dioetasulphoniua, whereas that of dideca~ 
aaonium was the lowest*
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DISCUSS101
$h© compounds investigated have been shorn to 
possess neuromuscular blocking activity when tested upon 
different experimental preparations and intact animals#
In the Oat gastrocnemius muscle-sciatic nerve 
preparation* dipentasulphonium* dihexasulphonium* 
dihexaasonium, di&ecaasonium and dideeasulphonium are 
about omnipotent with tubocurarin©• Trishexatetrasoniuai 
is three times more potent than tubocurarin®, Whereas 
dioetaasonium, dioctasalphonium, dihexone and trio- 
decatetrasonium are about one half, one third, one eighth 
and one half as potent as tubocurarine respectively# 
Dihexasulphonium triaethiodide, the methyl analogue of 
dihexasulplioniurn,is about one fifth as potent as the 
parent compound# In general, the potency of the 
trissulohoniua compounds appears to be a little less than 
that of the corresponding trisasonium compounds when 
compared upon cat nerve«muscle preparations, although it 
is of interest that in the isolated kitten phrenic nerve** 
diaphragm preparation, dihexaasonium is about three times 
as potent a® dihexasulphonium* The duration of the 
neuromuscular block in the cat gastrocnemius muscle** 
sciatic /
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sciatic nerve preparation, caused by didecasulphonium, 
di&e©aa»©aium and trtsdecatetrasonium - the compound 
In which the polymethylene chains separating the 
quaternary centres each consist of ten units - is from 
two to four times as long as the effect of tubocurarine 
given in equipotent doses# 1‘he other compounds appear 
to have approximately the same duration of effect as 
that seen with equipotent doses of tubocurarine# fhC 
reversibility of the neuromuscular block caused by the 
three compounds in which a dec a methylene chain has been 
interposed between the quaternary centres was very often 
observed to be incomplete, but that obtained following 
the use of the other compounds was, like that following 
tubocurarine, completely reversible » even after the 
dose had been repeated several times*
the character of the neuromuscular block, produced 
by the individual members of this series of compounds 
in the cat, was not uniform# that the block caused by 
dipentasulphonium, dihexaasonium, dihexasulphonium and 
tricdecatetragonium is entirely tubocurarine-like is 
shown by the following observation©*
(1) Prior to depression of twitch height, there is
no /
m  evidence of muscular fasoieuXation or of potentiation 
of the muscle twitch amplitude *
(t) The block is effectively antagonised by 
edrophonium, neostigmine, ©serine and decsmethonlum*
(3) Temporary but well««narked antagonism to the 
blockade is shown by adrenaline, potassium Chloride and 
indirect tetaniEation of the muscle*
(4) The block In intents if led by he xame th onium, easier 
and ti&oour&rlm*«
(5) The tension of a tetanus in the partly blocked 
muscle is poorly sustained#
(6) There Is no evidence of a direct stimulant 
effect on the isolated rectus aM©minis muscle Of the 
frog,and antagonism is shown to acetylcholine Or' M^v 
decsmethcnium^lndueed con tractions of the rectus*
C7) A typical flaccid paralysis is seen when theii'* 
compounds are Injected into chicks*
The characteristics of the neuromuscular block 
produced in the eat by didee&sulphonium, dideca&zonium and 
triad©cate t rasonlum are different from tho*se described
above /
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above*
(1) Neuromuscular block Is el ways preceded by 
twitching and muscular faseleulation* and in the caee of 
dideoasaonium there Is on increase in the twit eh height*
(2) Edrophonium* neostigmine and ©serine do not 
antagonise block due to these three compounds! 
edrophonium actually intensifies the block caused by 
dideeaaaonium and trtsdeeatetrasonium*
(5) Potassium chloride and indirect tetanisation 
have no effect upon the intensity of the block*
(4) The block is reversed by hexametheniu® and 
intensified by decamethonium*
(§} The tension of a tetanus is well maintained 
(except in the case of didecasulphonium where the tension 
is poorly maintained}*
(6) Tubocurarin© block is partially reversed by all 
of these compounds*
(7) An initial d©camethonium-like contractural mt 
spastic paralysis is seen in the chick*
In /
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In the characteristics outlined above 
dideeasulphonium* didecaasonium end triadscatetrasoniua 
show typical decsmethonium-like depolarising properties. 
But in the isolated frog rectus abdominis muscle* these 
three compounds do not show any direct stimulant effects 
and all of them antagonise acetylcholine or decamethoniua- 
induced contractions. When it can be demonstrated that 
thee® compounds possess all of the other typical 
depolarising properties* lack of stimulant activity on 
the isolated frog rectus abdominis muscle is rather 
difficult to explain. Becamethonium which causes a 
marked nicotine-like contracture of the frog rectus 
has a much weaker stimulant effect than these compounds 
on the isolated rabbit duodenum and guinea pig ileum.
Mootssulphonium* dloctaassonium and dihexone have
what appear to be predominantly tubocurarins*»lite 
properties and are similar to dipentasulphonium* 
dihexasulphonium* dihexaasonlum and trishexstetrazoniuia* 
whose quaternary centres are separated by polymethylens 
Chains each consisting of five or six units. On the 
other hand* neuromuscular block caused by these compounds 
is not well antagonised by neostigmine and the tension 
of an indirect tetanus in the muscle* partly blocked 
by /
by dioctaEUlphonium, is well sustained «* a d© cam©thonium** 
like effect*
Became thonium and auxamethonium, and tubocurarin©
and gall&mine all cause neuromuscular block, yet they 
bring about their effects by mechanisms which appear 
to be of two quite distinct types* Three of these 
compound® possess two quaternary centres, while 
galiamine has three* Be came th onium, suxamethonium sand
tubocurarin© are methoniura derivatives; galiamine is 
an ethonium compound# It has been suggested that the 
distance between the quaternary centres is critical 
and should be within the range of 12 to 14 Angstrom units* 
The function of the groups on the quaternary nitrogen 
atoms is less clear* It is tempting to suggest that 
me thonium compounds are predominantly depolarizing and 
ethonium compounds have competitive (i*e* tubocurarin©** 
like) properties,but tubocurarin©, a hi©methonium compound, 
causes neuromuscular block by competition, and some of 
th© ©thonium compounds described in this thesis cause 
block by depolarization in the cat* Several 
investigators have attempted to analyse what appears to 
be an important relationship between the ability to cause 
excitation /
excitation and the presence of methyl groupings* The 
early observations of B u m and Bale* revealed that a 
lose of excitatory properties,as well os the appearance
of ganglion blocking activity,were associated with the 
replacement by ethyl groups of the methyl groups of 
the te t raise thylam monium ion# The effect upon the 
mechanism of action of several series of neuromuscular 
blocking agents of ethyl substitution on the quaternary 
cent re s, as compared with that of methyl substitution* 
has been investigated by a number of workers^
Hiker and Wescoe8 observed that replacement by methyl 
groups of the ethyl groups in the quaternary nitrogsn 
centres of gallamine resulted in a loss of potency* 
but that this loss did not appear to be associated with 
a change in the basic mechanism of action* A 
significant loss of neuromuscular blocking potency did 
not take place until at least two of the ethyl groups 
upon each of the quaternary nitrogen atoms of g&llamlne 
had been replaced by methyl groups* Accordingly, the 
trie (diethylmethylaminoethoxy-) derivative, when tested 
upon the nerve muscle preparation of the cat, closely 
resembled gallamin© in its neuromuscular blocking 
activity, whereas the trig (trime thylaminoethoxy-) 
derivative /
derivative had approximately one-fourth of the 
neuromuscular blocking potency of gallamins* respite 
the alterations in potency produced by these changed*
. all of the compounds tested continued to exhibit
(when given in appropriate doses) neuromuscular blocking 
activity indistinguishable in type from that shown by 
gallamine*
In another series of trisquaternary ammonium 
compounds* Kensler et alia^ reported that the me thonium 
derivatives were less potent than the ethonium 
derivatives* but did not observe any change from a 
uniform tuboeurarine-like mechanism of neuromuscular 
blocking action to an effect resembling decsmethonium* 
the ethonium derivative of benssoquinonium has been 
reported by Hoppe et alia11 to be tubooursrlne-like in 
Its mechanism of action* whereas in the cat the ms thonium 
derivative was found to possess striking de came thonium- 
like properties*
In the polrae thyl: neb is quat e rrmry ammonium series* 
the effects of replacement of the methyl groups on the 
quaternary nitrogen atoms by ethyl groups were studied 
on the chicken nerve muscle preparation by fhesleff and 
Uana7 /
VnmJ $ and on th© rat diaphragm and rabbit nervo-muscl© 
preparation by Barlow* Robert a and Eeid^, llies© 
investigate13 observed a reduction of potency as well as
a ahange 'in laechanism of action when the methyl groups 
on the quaternary nitrogen atoms of do cam© thonium were 
replaced by ethyl groups*
In th© series of polyethylene trisquaternary
derivatives which th© author of this thesis has 
investigated* the methyl analogue of dihexasulphonium 
was tested for neuromuscular blocking activity# while 
dihexasulphonium was found to be equipotent with 
tubocurarin© on the cat* dihexasulphonium trimethiodide* 
the me thonium analogue* was only one-fifth as potent as 
the parent compound or tubocurarin© but th© mechanism 
of action remained unaltered# fhia observation,Which 
also shows that a striking change csn take place in th© 
properties of a neuromuscular blocking agent following 
an alteration in the nature of the substituents on th© 
quaternary nitrogen atoms* I© similar to that seen with 
gallamins and its methyl analogue but is contrary to 
that observed with the de came thy lens bis trimethyl and 
triethyl compounds (de came th onium end decae thonium) of 
Barlow /
Barlow and his colleague*
In the polymethylene bisquaternary series studied 
by Thecleff and UhnsJ and Wien et a l i a ^ » hexaethoniuia baa 
been shown to have weak neuromuscular blocking activity 
shea tested on the chicken gastrocnemius muscle-sciatie 
nerve preparation* and on the isolated rabbit phrenic 
aerve-diaphragm preparation* Shis compound has only weak 
ganglion blocking activity3*2# hen the ethyl groups m  
the nitrogen atoms are replaced by methyl groups* the 
neuromuscular blocking activity is further reduced 
although the compound now becomes a potent ganglion blocking 
agent3*2 • The molecules of dihexasulphonium and 
dihexasulphonium trimethiodide may be considered to be made 
up of two hexae thonium and two hexamethonium residue® 
respectively* which are linked together through a 
sulphur atoxi* 2ihe reduction in the neuromuscular blocking 
potency of dihexasulphonium trimethiodide* the methyl 
analogue of dihexasulphonium* appears to be related to that 
observed when hexame thonium and hexaethonium are compared* 
although the absolute lack of ganglion blocking activity 
shown by dihexasulphonium trim© th iodide (see page 250) 
is in sharp contrast to the potent ganglion blocking 
activity /
activity of hexamethonium#
In the polymethylene bisguaternary ammonium eerie® 
the influence on th© neuromuscular blocking potency of the 
length of the polymethylene chain separating the nitrogen 
atom® m e  studied by Barlow and Ing3*^ * Baton and Zaimis3^ * ^ *  
and fheeleff and tfnna^ using the rabbit head drop method 
and th© chicken and cat gastrocnemius muscle-sciatic 
nerve preparation# These workers observed that in the 
bisque ternary me thonium aeries maximum potency was 
obtained with de came thonium# In the M a t  r ie thy 1 ammonium 
series Barlow and Ing3*^  also observed that the activity 
gradually rose and was maximum in the compound having 
thirteen carbon atoms in the polymethylene chain# That 
the type of activity in the neuromuscular blocking agents 
is also influenced by the length of the polymethylexie 
chains separating the quaternary centres was shown by Baton 
and Zaimis3^  in the cot* and by Thesleff and IFnna^  in the 
chicken gastrocnemius muscle-sciatic nerve preparation*
They observed that pen tame thonium and he same thonium had 
tubocurarin©-like activity* while dec. me thonium caused 
neuromubcular block by producing depolarisation# A large 
series of bisquinoline and bis isoquinoline derivatives in
which the nitrogen atoms were linked by a decamethylene
chain /
chain has been studied by Collier and Taylor3*** and Taylor 
and Collier3*?# A study of the effects of altering tha 
length of the polymethylen© chain between the nitrogen 
atoms in the 6* 7-dimethoxy and 6 *7* 8-trimethoxy 
derivatives revealed that in rabbits and mice maximum 
neuromuscular blocking activity was obtained with the dees 
and undecm m thylene members3*^ # These compounds had a 
tubocurarin©-like mechanism of action3^ * In the trig- 
eulphoniuta compounds, dipentasulphonium and dihexasulphonium* 
in which the quaternary centres are separated by polymethyl­
ene chains of five and six units respectively, both the 
mechanism of action and the potency are the same as those 
of tubocurarin© in the cat* Y/hen each of the polymethylene 
chains is increased so i s to contain eight units (as in 
dioctasulphonium) the compound still has predominantly 
tubocurarin©-like properties, but a few transitional 
properties are seen* On the other hand the potency ie 
diminished threefold when this compound is compared with 
compound© having five and six methylene unite in between 
the two quaternary centres* then the polymethylene ohaina 
are further increased so that each contain© ten unite (as in 
didecasulphonium)* the potency remains unaltered and ie 
comparable with that of compounds having five and six 
ssembered /
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member^ci polymethylene chains in between the quaternary 
centres# but the mechanism of action becomes entirely 
different# neuromuscular block produced by these 
compounds in the cat is very similar to that caused by 
deoamethonium except that the tension of an Indirect 
tetanus in the partly blocked muscle is poorly maintained 
* a property shared with tubocurarin© • In the
trisag onium compounds a similar sequence of ©rents takes 
place when the polymethylen© chains separating the 
quaternary nitrogen atoms are increased in length* In 
dihexaazonium where the polymethylen© chains each consist 
of six units, both th© potency and mode of action are 
similar to those of tubocurarin© * In dioctaneonium 
where the polymethylene chains each consist of eight units, 
the properties are similar to those of tubocurarin© except 
that the block is not so well antagonised by neostigmine#
On the other hand potency is reduced to about half of that 
of dihexaasonium • In did©eaagonium, where the polymsthyl~
ene chains are increased to contain ten units in each, the 
neuromuscular blocking activity is decamethonium-like *
The potency, however, rises again and this compound ie 
equipotent with th© compounds which have five and six 
polymethylene units separating the quaternary centree#
In /
In the case of the compounds containing four
nitrogen atoms similar phenomena can be observed when the
polymethylen© chain length is increased* Trishexatetra-
senium has properties in the cat which are similar to
those of tubocurarin©, but is about three times more
potent* This compound has polymethylen© chains which
consist of six units in etch* Triedecate t rr« zonium •
another tetrazonium' compound in which the quaternary nitrogen
atoms are separated by pclymethylene chains each consisting
of ten units - has properties which are entirely different
from those of tubocurarin© and in the cat closely resembles
d© came thonium* The potency of this compound is about one
half of that of tubocurerine* This difference in
mechanism of action and potency in the trie and tetra~
quaternary compounds appears to be due to the alteration in
th© length of the polymethylene chains between the nitrogen
atoms* Whereas in the bistrlethyl and bis trimethyl
ammonium series, the potency increases from th© compounds
whibh have five or six memb©red polymethylene chains to
reach a 'maximum in the compounds having ten (in the
me thonium series) and thirteen (in the e thonium series)
13 15carbon atoms separating the quaternary nitrogens * t in
the trie and tetr&qaatemary compounds which have been 
investigated, /
investigated, it has been observed that there is a 
decrease in potency with increase in chain length* Thi® 
is apparently not in agreement with observation® made in 
either the me thonium or e thonium compounds of the 
bigquatarnary aerier^*^# She change in the mechanism
of notion which ie seen in the transition from the 
hexamethylene compound to th® decant©thylen* compound in 
the trisquaternary series is similar to that observed in 
the transition from hexauethonium to decam© thonium in 
the polymethylen© biaquaternary trinethyl amonium series^* 
The appearance of some transitional properties in 
dioetas ulphonium and dioctaazonium - which have polymethyl- 
ene chains of eight units - ib a phenomenon similar to 
that observed in hepta- and oc tame thonium* In the hi®** 
triethyl ammonium series, however, the mechanism of action 
remain® unaltered# Both hexame thonium and decata© thonium 
posses® tubocurarin©-like properties# Since the compounds 
studied in this investigation were all ethonium derivative®, 
the type of activity was expected to remain unaltered in 
much the same way as in th® bis trie thyl eerie®, and not 
to alter in th® way observed in th© hi®trimethyl aerie®
Of Barlow and Xng^ and Pat on and Zairais^*
These /
These properties e*n be explained if it is
assumed that the type of activity - decamethonium-lllcs*
transitional or tubocurar ine-like ~ depends not so much
on chain length or on the nature of the substituents on
the quaternary nitrogen atoms as on the firmness with
^dieh the molecules are adsorbed on to the receptor
surface* If depolarising activity ie associated with
very firm adsorption* then compounds with several
adsorbing groups might be expected to show decamelhoziltxtt*
like activity* while compounds with fewer strongly
adsorbing groups should have tabocurarine-like activity*
Even this theory does not explain everything but if m
further assumption is made that the receptors on the post
synaptic membrane are of two types, (a) of a strongly
adsorbing type (S) and (b) of a less strongly adsorbing
type (W), and that these follow a regular pattern then it
Is possible to speculate a little further* Supposing that
o
the strongly adsorbing receptors are about 14 A apart 
and that the less strongly adsorbing receptors be about 
midway between a group of four of the former arranged la 
a pattern as follows«*
and that this pattern is reproducible indefinitely at the 
end-plate region* A compound like hexane thonium or 
hexaethonium might combine with one (S) and one (1)*
( (S) - (W) ), - not a very strong adsorption end likely 
to be easily reversible* lecamethonium on the other hand 
should combine with two (3), ( (S) - (S) ), and so be 
firmly held to the receptor surface* The deca methylene 
compound with four quaternary nitrogen atoms would 
combine with four (S) receptors, ( (S) - (S) - (S) * (S). )* 
The hexamethylene compound with four quaternary nitrogen 
atom® should combine with two (S) receptors and two {W) 
receptors, ( (s} - (W) - (s) - (W) ) and would be more 
weakly held*
The functional relationship of tuboeurarine to 
acetylcholine has focused attention upon the role played 
by the quaternary ©entree in the neuromuscular blocking 
agents* /s haa been mentioned in the introductory 
section many drugs such as atropine, quinine, strychnine 
etc* show a marked increase in neuromuscular blocking 
activity when their nitrogen atoms are quaterniised* On 
the other hand, m-ny nonq.uaternary (tertiary) ammonium 
compounds such as quinine, nicotine, erythroidine 
derivatives /
derivatives eto# have neuromuscular blocking activity* 
fhe occurrence of potent neuromuscular blocking activity 
in tertiaiy ammonium bo see such as p-erytljroidine* 
dibydro-p-erytbroidine and the dieappearance of this 
activity in p~erythroidin© methiodide - the quaternary 
methonlim ©alt of p-erythroidine - show that although the 
presence of quaternary centres in the molecule is often 
necessary for the neuromuscular blocking activity* their 
presence is not essential in every class of compound# 
while certain monoquaternary compounds (sueh as the 
O~toxiferines) can bo shorn to posses© neuromuscular 
blocking activity* compounds having two quaternary ©entree 
have aroused the moat interest in the study ©f the 
neuromuscular blocking agents* home of the import eat 
compounds in this group (such as the straight chain 
compounds* quinoline and isoquinoline derivatives and others) 
have already been described in the introductory chapter 
of this section of the thesis#
A number of compounds with three and four quaternary 
centres and having neuromuscular blocking activity have 
been investigated* but all of the clinically useful 
neuromuscular blocking agent® possess two quaternary eentree 
(excepting /
{excepting gallsmine which has three}# Pecamethonium* 
suxamethonium* bensoquinonium - all of vfeieh contain two 
quaternary nitrogens - are much more potent than gallamin* 
which ha© three quaternary nitrogen atoms # Other 
compounds having three and four quaternary centres 
(sec pages 116 and 117 ) have been examined only in expert* 
mental animals and found to be much less potent than 
tubocux\arine• From these observations it is rather 
difficult to understand the role of the actual number of 
quaternary centres in neuromuscular blocking potency* On 
the other hand* when the number of quaternary centres la 
a particular aeries of compounds la increased there appears 
to be a definite relationship between the potency and the 
number of quaternary .-toms in the molecule# fhus a series 
of ethers of {Miydroxyetbyltrlethyl ammonium* F.2512* 
f *2557 and f.2553 (gallamin*) (Fig.82, page 287) 
having one, two and three quaternary centres respectively 
were shown by Bulb ring and lepierre" to possess 
neuromuscular blocking activity in the rat phrenic nerve* 
diaphragm preporalion in the ratio of 2i 201 100* i#e* 
in this series there is an increase in potency with 
increase in the number of quaternary centres. In the 
series of compounds which have been investigated in this 
section /
o (cH2) n (c2H5)3 o (CH2)2 t^5'2H5^ 3 
o(ch2)2n (^2^ 5)3
B. F 2557
o(CH2)2N (^2 8 5 )3 
' 0 ( C H 2) 2  N ( c 2 8 5 ) 3
o (ch2)2 n ( c2H5)3 
c . F 2 5 5 9  (G allam ine)
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Figure 82# The structural formulae of f #2512* 
F#2557 and F#2559*
section of the thesis* the relationship between the 
number of quaternary centres and the neuromuscular blocking 
potency is not clear# In the hexamethylen© members of 
the series* dlhexonc (a bisqua ternary derivative with a 
sulphone (-SOg) group in the centre) is about one-eighth 
as potent as tubocurarin© in the cat* when the (-SOg)
4* -f.
group is replaced by - s ~ or - 1 - * dihexasulphoniua 
or dihexaasonium are produced respectively* both of which 
contain three quaternary centres and have a potency equal 
to that of tubocurerine in the cat# Further* when the 
overall chain length is increased so as to interpose 
another quaternary nitrogen atom, triahexatetrazonlurn is 
produced# This conpound is three times as potent as 
tubocurarin© in th© cat# It has been shown that in the 
compounds dihexone, dihexaszonium end trishexatetrazonium 
(having two* three end four quaternary centres respectively)* 
the ratio of neuromuscular blocking potency is of the order 
of 1* 81 24* which is similar to that observed in the 
compounds F.2512* 1.2557 and F.2559 (gellamin©)# On the 
other hand* in the decamethylene members of the present 
series trisdeoatetrasonium - which has four quaternary 
nitrogen atoms - is only one half as potent in the cat as 
didecaasonium* a compound with three quaternary nitrogen 
centres*/
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centres* When the potency does appear to he related to 
the number of quaternary atoms as in the hexaaethylene 
members of the series* it is rather difficult to explain 
why it should not also hold true for the deoamsthylene 
members *
The replacement of the central quaternary nitrogen 
atom in dihexaazonium# dioctaazonium and dideoaazonluia 
by a quaternary sulphur atom appears to have some slight 
i nfluence on the neuromuscular blocking potency of these 
compounds* In the cat dihexasulphonium appears to be 
slightly less potent than dihexaazoniumf it is more potent 
in the rabbit and mouse (fable 9* page 247)*
In the octamethylene compounds* the trissulphonium 
derivative# dioctasulphoniu t* is also slightly less potent 
in the cat than the trisnitro/^ en derivative# diocteazcniura# 
but is more potent in the rabbit and mouse (see 
Table 9)* In addition# the well-maintained tension
of a tetanus in the partly blocked muscle* and the 
less well-marked antagonism by neostigmine seen in 
dioctasulphonium may be due to the replacement of the 
quaternary nitrogen atoms by quaternary sulphur atoms* In 
the case of the decamethylene compounds# the trissulphonium 
compound# did©oasulpbonium* has some properties which enable 
it /
it to be distinguished from the trigazonium compound* 
didecaazonium* In the first place* following 
administration of didecasulphonium# there was no initial 
potentiation of the twitch height of the gastrocnemius 
muscle of'the cat in response to indirect stimulation Via 
the sciatic nerve# which was usually observed in the case 
of didecaazonium* Secondly* the tension of a tetanus in 
the muscle partly blocked by didecasulphonium was poorly 
sustained* This was in contrast to the well-maintained
tension of a tetanus of the partly blocked muscle 
following administration of didecaazoniunu Thirdly# the 
neuromuscular block caused by didecasulphonium was either 
slightly reversed or not influenced by the administration 
of neostigmine or edrophonium# whereas neostigmine had no 
effect upon# - and edrophonium intensified the neuromuscular 
block caused by didecaazonium* Further* di&ecasulphon- 
ium was equipotent with didecaazonium in the eat* 
but slightly more potent in the rabbit and mouse (Table 9# 
page 247)* These differences in the properties of
dldecasulphoniuza and didecaazonium appear to be due to the 
replacement of the central nitrogen atom by a sulphur atom# 
because the two compounds are otherwise structurally 
identical* The observed change in potency of the trie- 
sulphonium /
triesulphonium and trisazonlum compound® # although only 
slight in different species# is not in entire agreement 
with the observation of Walker2^ who# using the rabbit 
head drop test# found a reduction in neuromuscular 
blocking potency by replacing the quaternary nitrogen atom 
in decsmeth onium by a quaternary sulphonlum atom*
Other factors may come into play and it is possible 
that the degree of solvation of the quaternary centres is 
Important in determining both potency and type of effect* 
tfnfortunately# no data is yet available but it seems 
possible that a cationic group which carries a large number 
of molecules of water is likely to be held lees firmly to 
the receptor surface than one which has a small "solvation 
shell"*
From a pharmacological standpoint an ideal drug is 
one which exerts a specific effect upon a given organ or 
system without producing other effects in other parts of 
the body* Many compounds have been described which poesees 
considerable neuromuscular blocking potency but# in most 
instances# they lack specificity of action* They may# 
for example# block nerve impulse transmission in the 
autonomic nervous system either at the ganglia or at the 
periphery* /
periphery# and they may cause liberation of histamine or 
have a marked depressant effect upon respiration* In 
some instances these secondary effects are of sufficient 
intensity to cause inconvenience in the routine clinical 
application of the drugs* Lack of complete specificity 
of neuromuscular blocking activity among the competitive 
type of neuromuscular blocking agents is illustrated by the 
fact that tubocurarin© possesses not inconsiderable
op
ganglion blocking activity-~ together with the capacity to
liberate hist&mine^^ *^ * These properties are quite
marked in dimethyl tubocurarin©, although they are less
noticeable than in tub sourerine ^  ^  • Although
laudexium shows little clinical evidence of any histamine
28release and ganglion blockade * its neuromuscular blocking 
effect is more prolonged th**n that caused by tubocurerine^* 
end neostigmine even in excessive doses is a less effective 
antagonist^®. Gr&llciaine# although lacking the properties 
which cause release of histamine^ and ganglion blocksde^^# 
has the disadvantage of causing sinus tachycardia due to 
its selective atropine-like parasympatholytic action on the 
cardiac vagus^2* ^* ^ .  Beeernethonium possesses no 
significant ganglion blocking^ or histamine liberating 
activity^ /
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activity-*-* at therapeutic dose levels, but it cannot be 
considered to be an ideal neuromuscular blocking agent due 
to its depolarising action^ and the lack of suitable 
antagonists or antidotes* Of the compounds investigated 
in this section none shows ganglion blocking activity as 
measured by the response of the nictitating membrane of 
the cat, even when given in doses more than five times 
those needed to or us e complete neuromuscular block*
1id©caaaonium, however, causes a contraction of the 
nictitating membrane* Eidecaazonium and triedecatetragon- 
iua cause a foil in the blood pressure level of the 
pentobarbitone-anaesthetised cat in a similar way to that 
observed when tubocurarin® is used* Other compounds have 
no significant effects upon the blood pressure,even when 
doses many times more than those needed to produce complete 
paralysis in the cat1® nerve -muscle preparation are used*
A f 11 of blood pressure following tubocurarin® is believed 
to be due to its histamine liberating property and also to 
its inhibitory effect on sympathetic ganglionic transmiss- 
ion24*25*56.
Compounds having the following properties appear to 
be suitable for further investigation and clinical trial*
(1) Those /
(1) Those with potent tuboeur&rine-like neuromuscular 
blocking activity*
(2) Those which do not appreciably raise or lower 
the blood pressure level*
(3) Those which do not alter the heart rate*
(4) Those which do not cause histamine release*
(5) Those with less respiratory paralysing effects 
than tubocurarin© •
Some of the compounds investigated, namely, dipentaeulphon­
ium, dihexasulphonium, dihexaass onium and triehexatetrasonium, 
the properties of which have been reported in this thesis 
appear to possess, in the cat, certain desirable features*
On the other hand, the species variations in potency seen 
in the neuromuscular blocking agents^ ±8 a complicating 
factor, and their potency in man cannot be assumed from 
that obtained by experiments on animal* Species 
variations among the competitive neuromuscular blocking 
agents is relatively smaller than that found with 
depolarising agents* There is, in addition, a considerable 
variation in the sensitivity of various muscles of the 
same species to the action of both competitive and 
depolarising /
depolarising neuro muscular blocking agents^•
The considerable species variations in potency 
among the new compounds investigated and described in this 
thesis is shared with the other neuromuscular blocking 
agents (see fable 9 , p* 247 )• Of these compounds, 
only dihexasulphonium has been studied on dog nerve-"muscle 
preparation by Forrester and his colleagues*^ who reported 
it to be omnipotent with tubocurarin® • Although this 
observation is similar to that found in the oat, recent 
clinical trials and trials upon human volunteers have 
shorn dihexasulphonium to be much less potent than 
tubocurarin®^* It, therefore, appears that the final 
answer with respect to potency of 'these compounds in «**> 
can only be obtained by careful evaluation in man himself*
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In the introductory chapter of this section of the 
thesis* the history* sources* pharmacological properties 
and clinical uses of the alkaloids of curare hare been 
described*
’X'he mechanisms of neuromuscular block and the 
classifieation of the naturally occurring and synthetic 
neuromuscular blocking agents have bean briefly reviewed#
A short account of the properties of the clinically 
useful neuromuscular blocking agents is also given#
fhe chemical structures of a new aeries of tris- 
quaternary and tetraquatemery ethoniua compounds# the 
properties of which have been investigated in this thesis* 
are also described.
In Chapter II of this section# the various experiment** 
al procedures used in the investigation of the properties of 
these new compounds are described# fhese involve the use 
of anaesthetised and conscious animals#as well as isolated 
tissues#
In Chapter III of this section# the results of an 
invoa tigstion/
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investigation of the properties of the new triequatemary 
and tetraquateraary compounds are described.
It has been shown that all of the compounds possess 
neuromuscular blocking activity on the cat* as well as 
on other preparations. Borne of them possess a potency 
equal to* or greater than# that of tubocurarin© itself*
hile some of the compounds investigated shared the 
properties of tubocurarin©# others showed typical 
decasaethonium-like activity.
hike other neuromuscular blocking agents# the 
compounds investigated showed wide species variations in 
their activity.
In Chapter I¥ of this section# the influence of the 
length of the polymethylene chain separating the quaternary 
atoms* the effect of multiplication of the number of 
quaternary centres# and the effect of substitution of ethyl 
groups for methyl groups on these# is discussed. The 
effects of these changes and mechanism of action of these 
new compounds is also discussed and comparisons made with 
other series of compounds.
It has been shown that an increase in chain length
in /
in the trisquaternary and tetraquateraary compounds 
investigated decreases the potency and alters their type 
of activity from being tubocurarine-OLik© to being 
deesmeihonium^like»
The only methonium compound investigated# the methyl 
analogue of dihex&sulph onium# shows less activity than the 
ethonium analogue# althou^i the type of activity remains 
unaltered.
DERIVATIVES
XiifEOiJi/CfXO??
The compounds I and II (Mg*83* I and II# p.305) 
were synthesised by Jeffreys^ during studies on the 
constitution of the ditertiary alkaloid isochondrodenflrtne 
(Fig«83,IXI)* These compounds are related chemically 
to armepavine^ (pig*83# 17)* coelaurine-* (Fig*83#V)# 
isococlaurine^ (Fi.>83# 71)* and magnocurarine* (Fig#83*VII). 
Iaococlaurine and magnocurarine have been reported to 
possess some curare-like neuromuscular blocking activity# 
Coclaurine is inactive* Compounds I and II are possible 
degradation products of isochondrodendrine which is 
chemically somewhat similar to tubocurarin© (a bis- 
quaternary base)* It was thought worthwhile to test 
these compounds for curare-like activity# and also to 
test the corresponding quaternary salts# especially since 
magnocurarin©# which is a quaternary base# ha© been 
reported to posses© some neuromuscular blocking activity*# 
Some comparisons have been made with tubocurarin© and with 
a borberiae-like compound (fig#83* VIII) which* like 
tubocurarin©* contains an isoquinoline ring system^*
OH OH Cf^ ?
H£-
I
W  V VI
CHjOfXXpL cXpNH
oh2 ch2
OH OH
vn vnr
Figure 85* 3?he structural formula© of I, compound Ij 
II, compound II} III, isochondrodsndrlnst IV, arme- 
pavinef V, coclaurincj VI, isococlaurln®}
VII, mgaocurarin© and ¥111, compound VIII*
The systematic chemical names of Compounds I, II and 
VIII are given on pages 307 and 308*
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Drugs used in the investigation described 1st this 
section of the thesis, together with their shortened 
ne&M* were m  follows t~
(1) Acetylcholine 
chloride ie described m ao©tylcholine
(2} («»)«ddr*mlln* 
hydrochloride n t* m
( 3 )  ( ~Wfaradreiaali&e 
hydroenloride » e ' m noradrenaline
(4) (•► Muboourarine
chloride * « * tubocurarin*
(5) Ifeeaiaethmlu*
iodide n * • d*eac»thoniua
( 6 )  KiatMlas acid
phosphate ft «• « hieteain*
(7) 5-*hydrojsyt*3^ t^
. amine creatinine 
sulphate ft m « S^ydraaytryptamin*
( 8 )  Pheatol&mine » » • phentolctntlne
(9) Blbenamine n m » dibemtmine
(10) Hydergine i * m i t hydergin#.
The jgotuiaollne compounds investigated werot»
(e) (i) (&)«4i^4^4iydTC3y1mieyl}w&^
ethoxy /
«thoxy-l i 2 i J i 4 * tetrabyaro~igeguinolin»
(Pig.83,1, p.305). fhlo is deaeribed 8S
f V*
Compound I*
(ii) The dextrorotatory Isomer of Compound I la 
described as Compound ID*
(ill) The laevorotatory isomer of Compound I le 
described as Compound XL*
(iv) The quaternary derivative (aethochloride) of 
Compound I is described ae Compound XQ*
(b) (i) *hydroxybemyl) «* 2 «* methyl «* 7 **
methoxy «* 6 — ethoxy - 1 t 2 t 3 f 4 <* tetrahydro-* 
isoquinoline (fig* 83,IX, p*305) i« described
as Compound IX*
(ii) The Xaevorotatory isomer of Compound XX is 
described as Compound XXL*
(ill) The quaternary derivative (methoohloride) «f 
Compound IX is described as XIQ#
Co) A compound related to tetrahydroworenine $ 5 t 6 I
15 t 13a «• tetrahy&ro « 2 t J i 10 » 31 • tets*&yd*!Oxy~ 
®  ** dlbem© •* (a, g) ** jyridocholine hydrochloride 
(Fig*83,mx, p*305) /
is described m  Compound Till*
the tertiary compounds are insoluble to water hut 
m m  be dissolved to dilute hydrochloric acid at about
yS I* The corresponding quaternary derivatives art 
freely soluble to water*
The composition of the different physiologies! 
saline solutions used is shown to fable 12, page 336*
1* frog Rectus Abdominis. .Muscle*
The experimental procedure was similar to that 
described on page 33 of this thesis* Reproducible 
subamximal contrac tions were obtained to acetylcholine 
(0*10 to 0*20 p,g* per al*)f and to decarnethonium 
(2*0 to 2*5 tig# per ml*) added at five minute intervals 
and left to contact with the tissue for 1*5 minutes#
Drugs under investigation in doses of 12*5 to 250 pg* per 
ml* were added a half-minute before the next addition of 
acetylcholine or decamethoniom# and left in contact with 
the tissue for two minutes* The next addition of the 
drug m e  not made until the response of the muscle to a 
similar /
b* gjMatxrareift
similar dose of acetylcholine or deeamethonium had 
regained its original magnitude *
2* Ttqk Sartorius Muscle^lschiad Nerve Preparation*
w m m *
fh© sartorlus muscle of the frog lies Immediately 
under the skin covering the ventral aspect of the thigh*
Frogs of either sex m m  decapitated* pithed and 
pinned in the supine position upon a dissecting board# 
ihe skin over both thighs m s  removed and the rectus 
abdominis muscles carefully freed at their points of 
insertion into the pelvis* Having thus exposed the upper 
tendinous attachments of the ssrtorius muscles* a blunt 
seeker was used to free both the proximal and distal 
attachments of the muscle from the underlying tissues# 
Cotton thread© were tied around both ends of the muscle 
which was then cut free from its attachments to the femur 
and the pelvic girdle* A slight tension was applied to 
the muscle by means of the thread© tied. at each end#
At this stage of the dissection* the muscle remained 
attached to the underlying tissues by virtue of the ©oft 
connective tissues running along it© longitudinal axil*
Using the blunt dissection technique# the main body of
the /
the rausele was freed from the underlying maaolss in the 
leg, except for the bridge of connective tissue in which 
rune the thread-lltce ioChiad nerve#
The isehi&d nerve enters the aartoriua muscle 
roughly midway between the two tendinous attachments of 
the latter vsdth the femur and pelvic girdle# Having 
freed and then tied the ends of the muscle* the path of 
the nerve from the muscle to its Junction with the 
sciatic nerve was traced* At this point* a fine cotton 
thread was tied around the nerve which was then very 
gently freed from the connective tissue surrounding it* 
When the nerve had been freed* the preparation 
removed from the leg* By means of a fine needle attached 
to the thread at its proximal end# about one cm* of the 
nerve was drawn through a rubber membrane into a J-sh&ped 
fluid electrode (Fig*84,p*312) filled with double 
glucose frog Kinger’s solution (page 336)# One end of 
the muscle was attached to an oxygen delivery tube* the 
other to a Starling-*type heart lover fitted m  as to 
record the contraction of the muscle upon m smoked 
surface* The completed preparation was then lowered 
into a bath (F.ig*84,P*312) containing 80 ml* of double ♦ 
glucose frog Binger's solution at room temperature# The 
muscle /
c -S ta r lin g  Heart Lever
L eads from stim ulator—
-Oxygen delivery tu b e  
S a r to r iu s  m u sc le
Thread tied to isch iad  
n erv e  '
Fluid e lec tr o d e  -- Isch ia d  n e r v e
R u b b er  m em b r a n e
Frog Ringeris Solution
Fresh Frog Ringeris Solution.
Figure 84s Diagram of the apparatus used for 
recording contractions of the frog sartorius 
muscle produced by electrical stimulation of 
the ischiad nerve.
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muscle was stimulated indirectly through its nerve, and 
also directly by means of a Bobbie rfolnnes square tots 
stimulator delivering 12! impulses per minute# The 
duration and voltage of the impulses were 1*0 msec* and 
10 to 15 volte respectively* One terminal of the 
stimulator was connected to an electrode immersed in the 
bath fluid, the other to the fluid electrode* It was 
found that this preparation could be stimulated 
continuously for up to 6 hours without any signs of 
fatigue becoming evident*
When the twitch height of the muscle in response to 
indirect stimulation was uniform, the drug tinder 
investigation or tubocurarin© (in the appropriate dilution 
with the frog Ringer’s solution) was added to the bath 
and the effects observed for a period of three minutes* 
The fluid in the bath was then replaced several times by 
fresh frog Ringerfs solution from the reservoir#
Sufficient time was allowed for the twitch height of the 
muscle to regain its original magnitude before the next 
addition of the drug* In any one experiment the voltage, 
pulse width and frequency of stimulation were constant*
5* Hat Phrenic irerve^Biaphram Preparation*
The /
The experimental procedure wee similar to that 
described on page 152 of this thesis* The bath solution 
was gassed with a mixture of 35 per cent oxygen and 5 
per cent carbon dioxide* The muscle was stimulated 
indirectly using square pulses at a frequency of 6 per 
minute at 12 volts} pulse width 1*0 msec* Drugs were 
added to the bath and kept in contact with the muscle 
for three minutes*
4* Isolated Perfused Kitten Heart*
The preparation was set up in a manner similar to 
that described on page 20 of this thesis* Drug© dissolved 
in Locke’s solution were injected into the rubber tubing 
attached to the aortic cannula* The heart rate was 
counted by direct visual observation, and the outflow was 
measured by collecting the perfusate for a period of one 
minute at five minute intervals after addition of the 
drug.
5* Outoea.-glg Ileum*
The preparation was set up in a manner similar to 
that described on page 29 of this thesis* About four cm* 
of the terminal ileum was suspended in a four ml* hath 
containing oxygenated Tyrode’s solution at 31°C* 
Eeproducible /
Reproducible eubmaxliaal contractions were obtained by 
adding acetylcholine (0.05 to 0.20 \ig, per ml.) or 
histamine (0,05 to 0,20 jig, per ml*) at three minute 
intervals and leaving them in contact with the tissue for 
ninety seconds* Drugs were added either thirty or 
sixty seconds before the next addition of acetylcholine 
or histamine* The total time of contact of drug with 
tissue was sixty or ninety seconds*
6* Cat Oaatrocnemius Muscle-Sei&tie Herve 
Preparation*
The preparation was set up in a manner similar to 
that described on page 144 of this thesis* Anaesthesia 
was induced by ether and maintained by intravenous 
chloralose (80 mg* per kg*)* Stimulation of the sciatic 
nerve was by means of square pulses at a frequency of 
6 per minute at 12 volts} pulse width 2*5 msecs*
7* Cat Blood Pressure*
In cats weighing 2*0 to 5*5 kg* anaesthesia was 
induced by ether and maintained by Intravenous chloralose 
(80 mg* per kg*)* The preparation was set up in a 
meaner similar to that described on page 11 of this thesis* 
The blood pressure was recorded from the common carotid 
artery, and drugs were administered via the cannulated 
external /
external jugular rein# In some experiments, spinal 
eats were used (see page 17 )•
8* louse Test*
Drugs were given by intraperitoneal injection into 
groups of mice weighing from 40 to 50 g# (see also 
page 164 of this thesis)#
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1# Frog Kectua Abdominis l&tsele#
All the compounds tested in doses of from 1£#5 to 
250 pg# per ml# showed antagonism to acetylcholine^ 
induced contractions of the rectus, and a graded effect 
was seen (see Figs# 85 and 86, pages 318 and 319)#
The potency of the compounds, as compared with that of 
tubocurarine, is shown in Table 11, page 320.
Hone of the compounds tested had any direct 
stimulant effeots upon the rectus muscle# All of them 
antagonised contractions induced by decamethonium, but 
high doses of the order of C4Q5 to G#1 mg# per al* were 
needed# The effeots were additive with those of 
tubocurarine#
j
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Figure 85. Isolated frog rectus abdominis muscle.
(a) At A, B and C Compound VIII 100, 50 and 25
pg* per ml* respectively.
At £ and K tubocurarine 0.6 and 1*0 pg.
per ml. respectively.
(b) At A and B Compound II 100 and 200 pg.
per ml. respectively*
At C end £ tubocurarine 0.4 and 0.25 pg.
per ml. respectively*
(c) At A* B and 0 Compound I 25, 50 end 37.5 pg.
per ml* respectively.
• Compound I 
o Compound YU 
x Tubocurarine
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Log dose (/uq per ml)
yifiurt 86# Isolated frog roetus abdominis musels* 
Eolation of log doss of compounds I, YII and 
tubocurarin* (abscissa) to ths percentage 
reduction (ordinate) of the height of eontnaetlon 
produced by the eaae doe* of aoetyloholine •
920*
Tha Helativa Potencies of Compounds!. tL. IP. XQ. XI. 
III». XIQ anfl VIII and Tubocurarin* on tha 
grog Reotua Abdominis Muaela
Compound
Potency in terms of 
tubocurarine * 100
X 2.0
III 0.25
ID 0.25
IQ 5.53
II 0.25
III 0.25
IIQ 2.0
Till 1.0
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2. frog Sartorlua Wm m r m
Only Geapeanda I* XX sad fill were tested ©a this 
preparation. These three compounds inhibited the 
response of the ^uacls to indirect st isolation. They
were smeli less potent th.an tubocurarine# After 
washing, there m m  complete recovery of the twitch 
height (Fig*87, p*322).
0® this preparation, ths oesipeunds tested bad ©sly 
very weak enrsrs^liks neuromuscular blocking activity. 
Compounds IQ and TIQ, the quaternary salts of Centpowsds 
I ami II, were about 5 tires acre potent than the tertiary 
bases from which they were prepared# Template 
neureisuseuisr block could he produced, but high doeea of 
shout 0*25 eg. per ml* hat to he used. After the resncmse 
te indirect etlnulablea bed failed, the nasal* still 
re.spond*d to direst stimula tlcm* The tertiary boss* were 
about 790 times less potest (Fig. SB,. f.323-} am#
€ ^ 0011* fll bed about ea*<«d*vt&*th of the potency of 
tubocurarine (fig* 89> iM
i. /
322 #
Time interval £mmut<z 1-1-1
Figure 87. Isolated frog sartorius muscle-ischiad 
nerve preparation. Contractions due to indixeot 
stimulation via the isohiad nerve at 12 volts, 
pulse width 0.5 msec., 12 impulses per minute.
At A, Compound II, 62.5 Pg» P®r 
At W, Wash out.
A W B W C  W B W
ffi&ure 88# Isolated rat phrenic nerve-diaphragm 
preparation# Contractions due to indirect 
stimulation via the phrenic nerve at 12 volts, 
pulse width 1 msec*, 6 Impulses per minute*
At A, tubocurarine 2*5 pg* per ml*
At B, tubocurarine 3*0 pg* per ml*
At Cf Compound I 0*60 mg* per ml*
At 1g fash out*
WA W A W B W A WA,  W B, W
irigure 89» Isolated rat phrenic nerve-diaphragm 
preparation* Contractions due to indirect 
stimulation via the phrenic nerve at 12 volts, 
pulse width 1 msec*, 6 impulses per minute*
At A, tubocurarine 5 pg* per ml*
At A^# tubocurarine 10 pg* per ml*
At B, Compound II 0*30 mg* per ml*
Compound II 0*25 rag* per ml*
At 1* lash out*
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4* Isolated Perfused Kitten Heart*
10 to 20 tig* of Compound IIL Increased the rate 
and amplitude of the heart $ 20 p>g* of Compound II had
a similar effect* These effects were reversible*
Compounds II and VIII had no effects in doses of up to 
0*3 mg*
5* Guinea Pig Ileum*
All of the compounds tested inhibited contractions 
of the ileum Induced by acetylcholine or histamine, but 
doses of the order of 0*15 to 0*3 mg* per ml* were 
needed and a graded antagonism was not seen* Wo direct 
stimulant or depressant effects upon the ileum were seen*
6* Cat Gastrocnemius iiusole-Seiatic fferve 
Preparation* " ~"TTr" ~......
The quaternary bases (IQ and II0) at doses of 1 to 
2 mg* per kg* did not depress the response of the muscle 
to Indirect stimulation* Similarly, the tertiary bases 
(I, II and VIII) at 1 to 4 mg* per kg* had no 
neuromuscular blocking activity* In eveiy case there was, 
however, some spontaneous muscular twitching following 
drug administration*
7. /
7* Cat Hood Pressure.
Compound I in doses of from 1*0' to 2*0 mg* per kg*
always caused a diphasic de p re asor-pre &sor response•
The fall in blood pressure was marked but the ensuing rise
was small* (fig*90, p*327). Compound ID and II* showed
qualitatively similar effects, but both depressor and
prose or components were less* vhen Compound I wee given
after bilateral aid-cervical vagotomy, the depressor
component wee lost and only a rise in blood pressure was
seen (?ig*90, p.327}* in a few experiments Compound
II* caused only a rise in the blood pressure* Compound
IQ (0*5 to 1*0 mg* per kg*) caused a. rise in blood
pressure- (Fig*91, p.328)# Compounds II and III*., at does
level® of 1*0 to 2.0 mg* per kg*, caused respectively a
©light rise in blood pressure, and a biphasie depressor-
pressor effect* Compound I IQ (0.5 to 1.0 mg. per kg.)
also caused a rise in blood pressure (fi.g*9i, p*328).
Compound fill (1*0 to 2.0 ag* per kg.) had no effects on
the blood pressure level* Ihe pressor responses were
not blocked by phentola&ine (up to 5 mg. per kg*),
dibeaaalaft (up to 25 ag* per kg.) or hydergine (up to 0*4
mg. per kg*). These compounds did not ant agonise the
characteristic effects on the blood pressure of acetyl­
choline /
Figure 90» Cat* Cfoloralose anaesthesia# Blood
pressure recorded from common carotid artery# 
Drugs administered intravenously followed by 
4 ml* saline in each case#
At A, Compound I 0.80 mg. per kg.
At V, bilateral mideervioal vagotomy.
*B
Figure 91• Oat* Chlorelose anaesthesia* Blood 
pressure record from common carotid artery* Drugs 
administered intrarenously followed by 4 ml• saline 
in each case®
At A, noradrenaline 0*20 \lg* per kg*
At B# Compound IQ, 0.20 mg. per kg.
At G, Compound IIQ, 0*50 mg. per kg*
acetylcholine (0*5 to 1*0 |*g* per kg*), histamine 
(0*5 to 1*0 pg* per kg*), adx^naline (1*0 to 2*0 pg* per 
kg*) or 5-hydroxytryptaiaino (1*0 to 2*0 pg* per kg*)*
Higher doses when given repeatedly to anaesthetised 
cats caused respiration to stop, and artificial 
respiration had to be given*
When doses of 1*0 :a.~* per kg* or more were given 
to an&esthetiaed or spinal cats at intervals of one 
quarter to one half of an hoar, convulsions were caused* 
Convulsant activity was not shown following the first 
dose, hut on repeated administration of each drug 
convulsant activity become apparent* This appeared to 
be a cumulative effect* Convulsions were preceded by 
twitching movements which later became clonic convulsions* 
There were periods of quiet between the convulsions*
8* Mouse feat*
In mice Compounds X, XX and VXXX showed potent 
convulsant activity* These compounds were roughly 
omnipotent with leptasol* The mice showed tonio^clonlc
convulsions with maximal hindleg extensor spasm*
£X3Ct?38I0B
The compounds investigated in this section show 
little or no neuromuscular blocking activity in the oat 
gastrocnemius muscle-sciatic nerve preparation, but 
they block neuromuscular transmission in the isolated rat 
diaphragm and frog sartorius preparations, although the 
potency is very low. The lack of neuromuscular blocking 
activity in the cat may be a manifestation of the species 
variation in sensitivity which is so common in the 
neuromuscular blocking agents4***. (This is discussed in 
Chapter IV,page 294 of this thesis#) The preparation 
of the quaternary salts of Compounds I and II increased 
their potency on the rat diaphragm and frog rectus muscle, 
end showed that qua te miration of the tertiary bases had 
increased the neuromuscular blocking potency. Compound 
II is less potent than Compound I which would indicate 
that transposition of the ethoxy and methoxy group® had 
altered activity.
All the tertiary bases were convulsant® and had 
convulsant activity in mice,as well as in anaesthetised 
and spinal cats. The quaternary derivatives also 
showed /
showed convulsant activity in anaesthetised and spinal 
oats (the convulsant activity of the quaternary salts 
could not be tested in mice due to insufficient supplies 
of the compounds). From the observation that the spinal 
cat had convulsions following the administration of these 
drugs, the site of convulsant action seems likely to he 
the spinal cord.
The chemical relationship between these compound® and 
tubocurarine and isochon&rodendrine made it worth while 
investigating them lor neuromuscular blocking activity* 
Some of them can ie looked upon as being halved molecules 
of tubocurarine. In addition, they are monotertiary 
or monoquateranry bases, and it was of interest to see if 
these had any tubocurarine—like activity. On 
investigation no neuromuscular blocking activity to® found 
in the oat nerve-Biuscle preparation* It seems that in 
these compounds one tertiary nitrogen or one quaternary 
nitrogen is not sufficient to confer neuromuscular 
blocking activity, but these compounds are convulsant® 
and show some nicotine—like activity *
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(± )<^( 4^ <-0Iy&roxybenzyl (^ ~me thyl~6~m© th oxy~7^th©xy**l I 
21 3f 4^tetrahydro~isoq.uiiiol£ne and its dextrorotatory « M  
laevorotatory isomers and ;ethoehloride # (2;)~1~(4^ «** 
hydroocybenayl)-.2^eth3rl*-7-»aiethoxy-*6--<jthoxy--l* 2s 3t 4- 
tetrahydro*»igQquinoline # its laevorotatory isomer and 
methochlortde and a berberine-like compound related to 
tetrahydroworenine have been tested for curare~ll&e 
activity# Little activity m s  noted# but on th© rat 
diaphragm and frog rectus muscle qimternis&tioa of the 
raeemio coiapounds increased this. fhe tertiary bases 
possessed potent convulsant properties#
4 S' S V t n T Y T lift A
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In fable 12 (p#336) are given the formulae of the 
physiological saline solutions used in the experimental 
work described in this thesis* All the chemicals used 
were of "Analar11 quality and only glass distilled water 
was used# In sone cases aqueous stock solutions of 
certain salts were prepared to facilitate the rapid 
preparation of a oaline solution* With the exception 
of sodium bicarbonate solution, these stock solutions could 
be used for at least two weeks after their preparation# 
Sodium bicarbonate stock solution was freshly prepared 
every three or four days# Glucose was added in the 
solid form to each batch of saline#
Preparation of Solutions of Eescinnamine from the Solid*
The rescimmiaine was dissolved in a tew drop© of 
glacial acetic acid and sufficient distilled water added 
to give a final concentration of 2 mg# per ml# fhe pH 
of a solution of resciimamine prepared in this way was 
about 3*0# Further dilution was mde by the addition 
of the appropriate volume of physiological offline 
immediately before use#
fhe control solution, was prepared by adding the same 
volume /
volume of saline to the same volume of glacial acetic 
acid# $he pH of the control solution was always checked 
and if necessary adjusted so as to correspond to that of 
the rescinnamine solution#
All other drugs and fine chemicals used were of the 
purest standard available from commercial sources#
Formulae of Physiological Saline Solutiona
Salts (g* for 
1 litre)
Frog
Ringer’s
Solution
'I’yro&e’s
Solution
Locke’s
Solution
Sodium chloride 6*50 8.00 9.00
Potasslum chloride 0.14 0.20 0.42
Calcium chloride 
(Anhydrous) 0.12 0.20 0.24
Sodium dihydrogen 
Phosphate (dihyd- 
rate) - 0.05 mu
Sodium bioarbonate 0.20 1.00 0.50
Magnesium chloride m 0.10
ulueoee 1.00 1.00 1.00

Agpimix xx
TheBlectrlcal Controlling Mechanism of the Semi-automatic
Isolated Or&an Bath*
The apparatus used was a modification of that 
suggested by aaddum and Dembeck^*
The flow of solutions into the isolated organ hath 
was regulated by two modified electro-magnetic relay 
switches (l*ig*92, p*338)* Solutions flowed only whan 
these were activated* The remainder of the equipment 
which is illustrated diagraminaticelly in Figure 92 
served to control the activation of the relay switches in 
a predetermined time cycle•
The time cycle m s  controlled by a Palmer time clock* 
supplied with a 60 volt B*0* input* The clock activated 
a switch relay* and thus the driving magnets of a 
uniselector* at 5 seconds intervals* The sweeper arms 
of the uniselect02? which were in t?*o halves* thus giving 
a continuous activation over the semicircular bank of 
contacts* advanced one contact every 5 seconds* Two 
banks of contacts with 25 terminals in each* were 
connected and the opposite halves of the upper and lower 
sweeper arm© were removed* so that the upper bank was 
activated /
Wfcuvder Plugs
|A B
1st BANK
2nd BANK
U n ise le c to r  Switch
Palm er Time Clock.
+ i i-
60v D.C.
ftsure 92. Circuit diagram of the electrical
equipment ueed to control the sesti*auf emtio 
ieolated organ bath (aee fig. 3, page 30).
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activated for half a revolution of the sweeper arm, while 
the second bank was activated for the next half of a 
revolution. The two banks thus served effectively as one 
complete circle of 50 contacts. To obtain a complete 
revolution of the sweeper arms in 3 minutes, 14 contacts 
in one bank were short circuited as illustrcfeed in 
Figure 92. Then the first bank sweeper arm reached 
contact A, positive current was fed through the uniselector 
switch (which was closed) to the driving magnets of the 
uniselector and moved the wiper arm, at the same time 
opening the uniselector switch. The first bank sweeper 
arm was moved to contact E and the process was repeated. 
This sequence of events was repeated very rapidly until 
the sweeper arm reached contact C (covering 14 terminals). 
At this stage, iue sweeper arm of xhe second hank had 
reached point D. Thus 14 contacts were effectively 
removed from the circuit since, in practice, the time 
taken for the sweeper arm to pass from point A to C on the 
first bank was only h fraction of a second.
Certain contacts on both banks were connected to 
wander plugs. negative current was led to the two 
modified relay switches md two indicator lights. Each 
was fitted with a connection to the wander plug board. By 
placing /
placing thee© plugs into the appropriate socket* (which 
were fed with negative current via the contact* of the 
uniselector), the event© in the three minute cycle could
be pre-set# The plug© were connected a© follows*
Wander plug number J, m e  connected to an indicator 
lidbt which lit 5 seconds before the inflow of a 
stimulant drug solution.
Wander plug number 2 was connected to a li^it 
indicating the time for addition of an antagonist#
Wander plug nuuber £ was connected to the relay 
switch controlling the inflow of fresh physiological 
©aline# This could be prefect to take place 15# tO* 
30, 45, 60 or 90 seconds after the inflow of a 
stimulant drug#
Wander plug number £  was connected to the relay 
switch controlling the inflow of a ettealaat drug#
1* Cted&oa, 3» H., and Lwabeek, {1949)»
Brit* J. Fhemaool., 491#
fat«® e.rt t - s e r t M  us Ab j t c sI'i. St:;,
iawWiic 4?»
these m m  described i& Appendix ill 
end Appendix XT*

APPENDIX III
I S  f E 9 H  C 1 I 0 1
fhe influence of changes in the hydrogen tea
concentration of the bath fluid upon the reactions t©
drugs of preparations of smooth muscle is of much
interest and has been studied in some detail* In 19&3
1Brans and Underhill 9 using preparations taken from the 
Intestine and uterus of the guinea pig* rabbit and eat* 
shoved that the addition of dilute acid to the bath 
fluid always caused relaxation and the addition of 
alkali contraction* fhey also showed that the response 
of intestinal and uterine smooth muscle to stimulant 
drugs was reduced in a bath fluid of acid reaction and 
was abolished at pH 6* Haskell^ and Baylise^ 
investigated the reaction of vascular smooth muscle to 
small changes of pH and observed vasodilatation in the 
frog following the use of a dilute solution of lac tie 
acid* and constriction with alkali©^* Bixon^ 
investigated the reaction of intestinal smooth muscle over 
a greater range of pH values and s t a t ed that dilute laotie 
acid solutions produced relaxation of frog stomach*
Fordon^ oba orved that in preparations of the rcastmaliasi. 
uterus the presence of alkali augmented tonus and caused
ft diminution of the magnitude and frequency of the 
spontaneous contraction® • wild and PXatt^ found that 
acidity caused vasoconstriction in the frog but that 
very dilute acid sometimes caused a preliminary 
dilatation* Pie is eh ^ perfusing the hind limb of the
frog confirmed that treatment with very dilute acid® 
caused the arterial smooth muscle to relax and that the 
us® of a stronger solution caused it to contract*
Hooker^ observed ’rhythmic’ intestinal muscle and ’non* 
rhythmic1 vascular muscle to relax when treated with acid, 
while • non~rhytimie1 intestinal muscle was found to 
contract when treated with alkali* .Hmt acids a® well 
ft® alkali® can cause vasoconstriction was shown by
Ishikawa^ who used the perfused hindquarters of the frog#
"1 /*>
and Prank®1 and Moritaxu showed that smooth muscle always 
contract® when trooted with alkali, while there was 
usually a relaxation when acid was used* "cBwinoy and 
Newton^* using preparations of the stomachs of rats* 
rabbit© ant! cats -showed that (a) moderate changes of the 
pH of the physiological saline solution towards the acid 
side (from pH 7*5 to pH 5*9) caused relaxation, and that 
with a further decrease in the pH to 2*4 there was 
contraction and finally relaxation, (b) moderate and
larger changes towards the alkaline side from pH 7#f to 
pH 11*5 caused contraction and a further increase in pH 
was followed by relaxation*
fhese studies clearly indicate that the reaction 
of intestinal and vascular smooth uuscle is very much 
Influenced by changes in the hydrogen ion concentration 
of the bath fluid or perfusion fluid* While it is 
clear that the response of preparations of smooth muscle 
varies with the pH of the physiologies! saline solutions 
used, it is also to be expected that the response of 
those preparation© to different drugs will be modified 
by changes in the alkalinity or the acidity of the perfus­
ion fluid* Although it has been shown that the response 
of intestinal uterine and smooch muscle to pilocarpine 
and to histamine was reduced or abolished*** according to 
the degree of acidity of the bath fluid yet there appears 
to be little or no published work upon this particular
to
aspect of the mode of action of drugs* decently G i l l i e 0 
during studies on the mode of action of reeerpine on the 
guinea pig ileum, noticed that the response of the tissue
to various stimulant drugs was modified by the addition 
of the drug in an acid solution (pH 4)* -he reaction of 
the solution of reeerpine which he used was also on the
acid side of neutrality# It seemed necesaaxy* there* 
fore,to investigate the response of smooth muscle 
preparations* especially those of the guinea pig ileum* 
to stimulant drugs such as acetylcholine , histamine etc# 
at different pH values# As a preliminary study it was 
deoicied to investigate the effect of acetylcholine and 
histamine on the guinea pig ileum in bath fluids having 
both acid and alkaline reactions#
fhis investigation was carried out as a preliminary
to studies on the properties of reseimmmlne and to aid
in the interpretation of the results obtained by dillis 
13and Lewis J using reserpin®» It seeraed necessary to 
carry out this work since there was an obvious and
significant variation in the response of the guinea pig 
ileum seen when reaorpine and roserpine antagonists were 
used in more acid solution* It was noted for example 
that certain resorpine antagonist® were rendered more 
potent when applied in a more acid solution* Biis 
effect might be due to potentiation of the response of 
the preparation to the stimulant drug or it mi-ht be 
due to an effect upon ionisation* since it is well known 
that the non-ionisod form of drugs are able to penetrate 
tissue better than the ionised ones* If increased
• '%
acidity suppressed ionisation* then the effect of the 
antagonist might he explained in this way*
I&ethode and Materials*
A piece of terminal guinea pig ileum was set up in 
a 2 or 5 ml* bath in a manner similar to that described 
on page 29 of this thesis* The perfusion fluid used 
was lyrode’s solution (see Appendix I* page 336)* the pH 
of which was from 7*7 to 8*0* and this solution is 
referred to*for convenience* as "normal" Tyrode *s solution* 
In order to alter the pH of the "normal11 Tyrode*a solution* 
hydrochloric acid (H/lO* M or 5N solution) or sodium 
hydroxide (N solution or fused pellets) were used* fhe 
pH of the solution was adjusted to the required value by 
adding the minimum amount of acid or alkali and cheeked 
against a glass electrode using a , luirhead pH meter*
3?he stimulant drugs used in these experiment* were 
acetylcholine chloride (acetylcholine) and histamine 
acid phosphate (histamine) and were employed in the dose 
range of from 0*01 to 0*20 ^g* per ml# and the antagonists
were atropine sulphate (atropine) and mepyramine maleat© 
(mepyromine)* used in the dose range of from 0*0001 to 
0.005 {*£• Per ^1* Acetylcholine and histamine wort
added /
added to the hath at three minute Intervale from a semi* 
automatic apparatus (see Appendix II, page 337 ) and the 
bath fluid containing the drug was replaced and the tissue 
washed by means of "normal15 Tyrode5s solution thirty 
seconds after the drug solution was added to the bath# 
Solutions of atropine and mepyramine were added one minute 
before the inflow of the solutions of acetylcholine or 
histamine•
Standard reproducible contractions of the ileum 
were obtained to acetylcholine or histamine in "normal* 
fyrode’s solution# Tyrode*a solution containing the same 
concentration of the drug but adjusted to different pH 
levels was then allowed to run into the bath and the 
experiment repeated at the new pH# The pH of the Tyrode*s 
solution used to wash out the bath was within the "normal* 
range (7*>7 to 8*0), but in some cases the pH was adjusted 
to that of the acid pr alkaline Tyrode*a solution 
containing the drug#
Demonstration of Drug Antagonisms and the Influence 
of pH Changes upon These#
Standard reproducible submaxiraal contractions of the 
ileum were obtained to acetylcholine or histamine (0#0X to 
0#10 jig# per ml.) using unormal” Tyrode5© solution and
atropine antagonism or mepyramine antagonism was demonstrate 
sd in the conventional way* Antagonists were added to 
the hath one minute before the inflow of Tyrode * e solution 
containing acetylcholine or histamine* The experiments 
were then repeated in an exactly similar manner* but using 
Tyrode*3 solution at different pH values*
In some experiments doae-response curves were 
obtained* Drugs at different dose levels (acetylcholine 
or histamine) were added at three ruinate intervals to the 
bath containing the modified Tyrodete solution by means of 
& tuberculin syringe* Hespouses were observed for thirty
seconds after which the tissue was washed with Tyrode*e 
solution having the same pH as that used to dissolve the 
drug*
The effect of alterations of bath fluid pH without 
addition of drug was also studied* The tissue was allowed 
to remain in contact with the Tyrode *® solution at 
different pH values for varying periods of time (two t# 
ten minutes) and the response was observed#
s a  /
A# Acetylcholine*
(1) Rffects of Altering the pH from normal
(7#7 to 8 * 0 )  to a Range of Values
- k i w i  n rmmmmmmmmmrnmanm
Between pH 2*1 and pH 7*5 or From nH 
8*2 to pH 9*6*
(a) Raising the pH (Increased Alkalinity)* As a
rule the height of the contractions was increased (Mgi 93*
p*350) but once or twice no modification from the normal
was observed* This increase in magnitude was seen at all 
levels of pH from 7*3 to 9*6* The effects were reversible
(b) lowering the pH (Increased Acidity)* When the 
pH was lowered gradually from normal (pH 7*7 to 8*0) to
pH 5*8* the height of the contraction was usually increased 
and it was observed to remain steady at the new level 
(Figs. 94 and 95* pages 351 and 352 )# when the pH was
further reduced to values of from pH 5*8 to pH 5*1# the 
first few contractions were greater than the control 
contractions but gradually the height was decreased and 
ultimately fell below the control level (Fig* 95)* The 
effect was reversible on changing the bath fluid pH to 
normal (i*e* washing and replacement with "normal” Tyred#*# 
solution* /
ffi,;ure 95 ♦ Isolated guinea pig ileum*
All contractions produced by acetylcholine, 
0*20 jxg* per ml*
At A, the pH of the bath fluid was 8*0 
At B, « » » » it u *
At C, * » • » « •  » » »  9#q
Figure 94* Isolated guinea pig ileum*
All contractions produced by acetylcholine, 
0.15 Pf# | W  «&# ^h© figures at the bottom
of the recording indicate the pH of the 
bath fluid*
.
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solution}* Ho spontaneous activity or reduction of tons 
nas noticed at any pH level between pH 7*7 and pH 5*1* 
lowering the pH from pH 5*1 to pH 3*0 caused a gradual 
reduction in the hei^it of the contraction and there was 
little or no spontaneous activity* Hie effect was still 
reversible on washing with "normal" fyrod©fs solution* A 
reduction of pH to a level below pH 3*0 appeared to causa 
some irreversible change in the tissue and spontaneous 
activity became v/ellmnrked* Ultimately spontaneous 
activity ceased and the tissue remained in a state of 
increased tone*
i*he response of the tissue to different doses of 
acetylcholine was studied at different pH levels between 
pH 9*2 and pH 6*1* At any particular pH level within this 
range the response to acetylcholine appeared to be related 
to the dose used (see Fig* 96*P»354).
(ii) Atropine«*Ace tylcholine Ant ngonigm*
Atropine-aceiy1 choline antagonism was studied using
bath fluid© with reactions between pH 6*2 and pH 9*2*
Atropine antagonism to acetylcholine woe shown at all pH
levels • At both the acid one! alkaline sides of neutrality*
the antagonist wns soon to be proportional to the dose of
atropine used (Fig* 97* p* 355 ) despite the fact that both 
the /
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la elated guinea pig ileus. 
l * I t U «  of leg dose of acetylcholine (abeeisea) 
to the height of contraction (ordinate) at pH 
8.8, 8.0 and 6.9.
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2 3 4 3
Log dose (x/g per mL)
figure 97* Isolated guinea pig ileum*
Log doe* of atropine (abscissa) at pi 9*1* S*0 
ant 6*7 plotted against percentage reduction 
{ordinate} of the height of contraction produced 
bp the came dose of acetylcholine#
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the lower end higher levels of pH increased the height 
of the contractions*
B* Hist amine*
(i) Effects of *Iterin.- the off From the Normal
* MWWMB— ni l   ..... ...........minin ■iinimwi mipn iiTi— ■
(7*7 to 8*0) to pH 5*5 on the Acid Side
n m t m «pn i — w iii- ia iT ir irn x w  », igfiniwi   nw u i*  nri
and to pH 9>2 on the Alkaline side of
Mfiutrplity»
(a) Raising the pH* This always increased the 
height of the contractions (Fig* 98, p* 357)* Ho 
spontaneous activity was seen* Increase in the height of 
the contractions occurred at all pH levels on the alkaline
side of neutrality within the range of pH 8*0 to pH 9*6*
Fhe effect was reversible after washing v/ith "normal*1 
Tyrode’s solution*
(b) Lowering the pH* This always reduced the 
height of contractions, an effect seen at ell pH levels 
from pH 7*4 to pH 5*3 (Fig* 99, p*358 )• Ho spontaneous 
activity was seen but at pH 6*8 or lower the tonus of the 
muscle appeared to be reduced and histamine—induced 
contractions could not be maintained (Fig* 99). ^hen the 
pH of the bath fluid was lowered from normal pH to the acid 
side, the reduction in the height of contraction produced
by /
3r7.
ffirure 38. Isolated guinea pig ileum*
* LI contraction© produced by histamine 0.10 pg. 
per ml* Figure® at the bottom of the record­
ing indicate the pH of the bath fluid*
7 8 7 7 8 7 2 7 0 6 8 7 8 6 6 7-8 6 4- 7 8 6 2 7-8 6 7 8 58 78
g.lgare 99« Isolated guinea pig ileum.
All contractions produced by histamine 0.50 pg.
4- «;
per ml. Figures at the bottom of the record­
ing indicate the pH of the bath fluid.
by the earn® dose of histamine appeared to be related to 
the pH levels and this relationship was linear up to pH 
6*0 (Fig* 1001 p*360)* Ho such linearity was observed to 
the increase in the height of contraction when the pH was 
raised*
A graded dose-re^ponse effect was observed at 
different pH levels ranging from pH 6*5 on the acid side 
and to pH 9*0 on the alkaline side of neutrality {Fig* 101f 
P* 361)*
(ii) Histamine-bepyramine Antagonism*
Antagonism by mepyramine to the response to histamine 
was obtained at pH levels from pH 6*5 to pH 9*0* At 
higher pH levels the contractions were increased in 
magnitude* and at lower pH levels there was a decreased 
response* In all cases there was inhibition of histamine 
induced contractions by mepyramine* although the inhibition 
appeared net to be proportional to the dose used*
• 0* The Effect of Altering Hath Fluid pH without Addition 
of l3ru^%7
Ho direct effect was observed when the tissue was 
suspended in Tyroue *s solutions with reactions ox from pH 9* 
to pH 5*0# Ho change in the activity was caused by 
sudden /
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Figure 100# Isolated guinea pig ileum.
Halation of pi of tie bath fluid (abeoissa) to 
the height of oontraotion (ordinate) prodmoed 
by a given dose of histamine*
361.
 o  pH 8-5
 x pH 8-0
 • pH 6-7
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figure 101* Isolated guinea fig ileus*
Halation of log dose of histamine (sheets** } to 
the hei^it of contraction (ordinate) at pH 
8.5, 8.Q and 6.7.
sudden changes of bath fluid pH from pH 9*6 or pH 5*0 
hack to a normal value (pH 7.7 to 8.0) or from normal to 
pH 9.6 or pH 5*0. ihen the tissue was kept in contact 
with 2yrode’s solution with a reaction of less than pH 
5.0 for one or two minutes and then the pH suddenly 
changed to normal pH (7.7 to 8.0), there wee a spontaneous 
contraction which disappeared on washing with ’’normal” 
fyrode’s solution. If the tissue was treated with 
fyrode’s solution with a pH between 9*8 and 11.0 there was 
a large spontaneous contraction which was always reversible 
on washing with ’'normal* fyrode * & solution (Fig.102,p.363)• 
fhese contractions due to a high pH of the bath fluid were 
reproducible ana were not; antagonised by atropine, meoyreta- 
ine, lysergic acid diethylamide, papaverine hydrochloride, 
hexamethonium bromide or cinchocaine hydrochloride (Fig.103, 
p*364 )* At pH 12.2, a spontaneous contraction was 
obtained but this was reduced in magnitude.
DISCUSSIOff
fhe effects of changes in the reaction of the bath 
fluid upon the activity of preparations of smooth muscle 
has been investigated by many workers. It is known that 
moderate changes of pH towards the acid and alkaline sides 
cause /
Fi ore 102. Isolated guinea pig ileum.
At A, contractions produced by acetylcholine 
0.20 |ig. per ml. at pH 8.0.
At B, spontaneous contraction of the Ileum 
at pH 9*9*
At \7# wash out with normal Tyrodefa solution
364.
?l.;4.re. 103. Isolated guinea pig ileum.
At A* acetylcholine 0.01 jig. per ml. at ph B.O
At B# spontaneous contractions at pH 10.5
At C, histamine 0.05 pg. per ml. at pH 8.0
At , mepyra, line 0.10 pg. per ml. at pH 8.0
At Dtf atropine 0*10 |ig. per ml. at pi 8.0
At h 9 lysergic ©cid diethylamide 0.10 tig. per
ml# at pH 8.0
At V $ papaverine 2.0 fig. per ml. at pH 8.0
At and
A2 acetylcholine 0*10 and 0*50 |ig. per ml.
i*espeetivrely at pH 8.0.
3sr>.
cause relaxation and contract i o n * " o f  the smooth muscle
respectively, whereas large changes of pH towards the ecid
11and alkaline sides always cause contraction • Ivans and 
Underhill”*" and McSwiney and Newton^ have shown that 
rhythmic contraction of the smooth muscles of the intestine 
are slowed and depressed by acid and are quickened in rate 
and depressed in amplitude when the reaction becomes 
alkaline•
In an attempt to investigate the response of 
intestinal smooth muscle to drugs at different pH levels, 
moderate and large alterations have been made towards both 
the acid and alkaline aides of the normal pH of the 
physiological saline solution* At higher pH levels the 
responses of the guinea pig ileum to both acetylcholine and 
histamine are increased, ji*®* they ere greater than those 
produced with the same dose of acetylcholine or histamine 
at the "normal** pH value. At lower pH levels the 
magnitude of the acetylcholine contraction is increased, 
while that induced by histamine is decreased* Change in the 
pH of the bath fluid to a level as high as pH 9*6 or as low 
as pH 3*5 appears to have uq direct effect on the smooth 
muscle of the guinea pig ileum, but the change in pH 
definitely alters the sensitivity to acetylcholine and 
histamine /
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histamine and perhaps also to other drugs* Increased
sensitivity of the tissue to acetylcholine and decreased
sensitivity to histamine at lower pH levels may be due
to the different mode of action of these two drugs upon
the muscle cells* It has been pointed out by hohmnay
and newton^!, T.-yans and unde&ill^ that alterations
of pH have no effect on the local nervous mechanism but
it is difficult to establish the validity of such a
conclusion* Atzler and Leirmxr^  suggested 'that hydrogen
ions acted directly on the muscle protein and t^oSwiney 
11and newton' suggested that the reaction of the smooth 
muscle to changes of pH was of a physicochemical nature. 
Hone of these assumptions appears to explain the difference 
in response to the ileum * suspended in bath fluids of 
lower pH to histamine and yloholine* Whatever lay 
be the cause of this difference in response of the tissue 
to histamine and acetylcholine, a change in pH of the 
fluid bathing the tissue is undoubtedly an important 
factor in determining the response of the tissue to these 
drugs and should be taken into consideration in studying 
the action of drugs upon isolated tissues*
Although the sensitivity of the tissue to drugs is 
changed when pH is altered, the physiological functions 
of /
of the tissue do not appear to be irreversibly changed 
within the limit of the pH levels used# This is shown 
by the fact that in bath fluids of higher and lower pH 
the response of the tissue remains proportional to the 
dose of the drug used, and atropine and sepyramine show 
a graded antagonism to the responses to acetylcholine 
and histamine*
The spontaneous contraction of the ileum when 
suspended in bath fluids of higher pH levels is an 
interesting phenomenon because it is not inhibited by the 
usual antagonists which suggests that the mechanism of 
action m y  be of physico-chemical in nature involving a 
direct action on the muscle protein as suggested by 
Atzler and Lehman*^#
S U O  A. R T
Alteration of the reaction of the bath fluid from 
normal (pH 7*7 to 8*0) to pH 4*0 on the acid side or to 
pH 9*6 on the alkaline side has little or no direct effect 
upon the smooth muscle of the isolated guinea pig ileum*
Bo direct effect is observed when the pH of the 
bath fluid is lowered to pH 3*0# although there is a 
spontaneous /
spontaneous contraction on washing with "normal* Tyroae*s 
solution# A further increase in alkalinity to pH 11*0 
Induces a largo contraction, the magnitude of idiich 
becomes less if the pH is subsequently increased to 12*2* 
These changee in the activity of the tissue are reversible 
on washing with "normal" Tyrod© *s solution#
At higher levels of pH (increased alkalinity) the 
sensitivity of the Ileum to acetylcholine and histamine 
is increased#
At lower levels of pH (increased acidity) the 
sensitivity of the tissue to acetylcholine is increased 
but the sensitivity to histamine la reduced#
Within the Unit of a change from pH 9*6 to pH 6.1
there appears to be no irreversible change in the tissue#
Changes in pH of the fluid bathing the tissue is an
important factor in the response of the tissue to drugs
and should always be taken into account#
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APPE'imXX XV
In 1843, aolagan1 investigated the constituents of 
greenheart bark (lectandra rodioei). and isolated from it 
two amorphous alkaloid fractions which he named sepeerine 
and bebeerine. From the total alkaloids of greenheart 
Grundon2 obtained two crystalline alkaloids for which the 
names sepeerine and ocotine were given,
The pharmacological properties of the alkaloids of 
greenheart have been reported by Pindel et alia-*» who have 
shown that althou#. the crystalline dimethiodide obtained 
from the mixed amorphous alkaloids of greenheart bark 
possessed curare-like activity as measured by the rabbit 
head drop test, the mixed unquatemized alkaloids showed no 
such properties in the rabbit. Somewhat similar results 
were also reported by McKennie et alia^ who showed that 
the crystalline methiodide of greenheart alkaloids had 
little or no effect upon the blood pressure of pentobarbit­
one-anaesthetised dogs. On the other hand the mixed 
amorphous alkaloids caused a marked hypotension.
The mixed amorphous alkaloids of greenheart were made 
available to the author for further pharm, c©logical 
studies. 1though the mixed unqu&ternized greenheart
alkaloid /
alkaloid showed no neuromuscular blocking activity in the 
rabbit, it was felt that they might have some curare-like 
activity in preparation© from other species* It was, 
therefore, decided to carry out a more extensive 
pharmacological investigation with the total alkaloids 
of greenheart on different isolated tissues and on the 
intact cat*-
The main objective was to determine whether the 
greenheart alkaloids, which have been reported to have 
structure related to tubocurarin®, were potent neuromuscular 
blocking agents and, if this was the case, to study their 
properties very fully*
y/Iaterirls and lethods *
The composition of the perfusion fluid© used in this 
investigation is given in Appendix I (Table 1?, p*336).
Drug© used were as follows: acetylcholine chloride
(acetylcholine), adrenaline hydrochloride (adrenaline), 
noradrenaline bitartrate (noradrenaline), histamine acid 
phosphate (histamine), atropine sulphate (atropine), 
mepyrsmine maleate (mepyramine), hexamethonium bromide 
(hexaraethonium), and tubocurarine chloride (tubocurarin©).
The substance investigated was the total alkaloid 
fraction /
fraction isolated from greenheart bark* The alkaloids 
were Insoluble in water but soluble in dilute hydrochloric 
acid to give a dark brown solution with a pH of about 
3*5.
The experimental methods used in this investigation 
were similar to those described in chapter II of part I 
(page 11) and chapter II of part IX£ (page 144) of this 
thesis.
Hesuita,
(1) Frog kectus Abao-miais ;usele.
The greenheart total alkaloids within the dose range 
of from 5 to 50 pg. per ilL. had no direct stimulant effect 
upon the rectus, but antagonised contractions induced by
0.1) to 0.20 j#g* per ml* of acetylcholine (Fig. 104, p.374) 
or 2 pg. per ml. of decamethonium* Tubocurarin©
was about 30 times more potent than the greenheart 
alkaloids on this preparation.
(2) Rat Phrenic Kerve-diaphragm -Preparation.
There was no depression of the twitch amplitude of
the diaphragm when greenheart total alkaloids in the dose 
range of 5 to 10 ug* per ml* were added to the bath.
(3) Cat Gastrocnemius -luscle^clatio Kerve 
'Preparation. ' ri  rv rr'r-|, T" ui
There /
t t t t t t t
A B C D E F G
Fi, ure 104* Frog rectus abdominis mods*
All contractions produced by 0#20 per ml* 
acetylcholine acting for ninety seconds. 
Labelled contractions were preceded one minute 
earlier by
/ t 9 greenbeert r Ike loids 10 p, * per ml*
/t I, “ K 20 |i * per nl*
At C, n " 40 pg. per ml*
At D# tubocurarine 0.50 |ig* ml«
At I, t 1.5 M.g* per ml*
At F, '* 1.0 p.g. per ml*
There was no reduction in the twitch height following 
intravenous infection of 1 to 2 mg* per kg# of greenheart 
total alkaloids, but very large doses of 4 to 8 mg. per 
kg# of the alkaloids however caused about a 20 per cent 
reduction of the twitch height# The maximal depression 
was reached after about half an hour and recovery was 
not complete even after 2 hours elapsed#
(4) Babbit Head Drop Teat*
The intravenous injection of 4 to 10 mg# per kg# of 
the greenheart total alkaloids did not produce head 
drop, but a dose of 10 mg# per kg* caused death within 15 
to 20 minutes# Death v/as associated with the sudden 
onset of convulsions# When a dose of 14 to IB mg* per 
kg# was injected intravenously head drop was seen, but 
the animal convulsed and died after about 15 minutes#
(5) Guinea Pig Ileua*
The total alkaloids of greenheart in the dose range 
of from 50 to 100 p,g# per ml* caused a direct contraction 
of the ileum* The stimulant action was blocked by 
atropine (0*50 pg* per ml#), mepyramine (0*50 jig# per ml#), 
and hexamethonium (20 to 50 fj,g* per ml*)* Contractions 
of the ileum induced by 0,50 to 1*0 pg# per il* of 
acetylcholine /
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acetylcholine or- 0.11 to 0.50 jig, per ;tl. of histamine 
were inhibited by 10 to 30 jj,g. per ral. of the total 
alkaloid (iig. 105,p. 377).
(6) Kabbit Duodenum,
The total alkaloid* of greenheart in doses of from 
10 to 5 pg* )er ml. reduced the tone and inhibited 
apont neous activity of the duodenum (Fig.106a, p#378)#
This effect was preceded by a short period of stimulation# 
They also antagonised the stimulant effects of 
acetylcholine (0*01 to 0.05 HS* per ml.) vdsen a dose of 
20 up# per ml# was used (l ig.l06,b)# The relaxant 
effect of adrenaline (0# 4 HE# P«r ml#) remained unaffected 
when the greenheart alkaloids were added at the same dose 
levels (Fig# 106,c)#
(7) Isolated Rat Hindquarters.
The total alkaloids of greenheart in the dose range 
of 20 to 200 Hg* caused vasoconstriction in the isolated 
perfused rot hindquarters (Fig*107, p# 370)#
(a) Isolated Rabbit Heart#
20 to 1)0 Hg# of the greenheart total alkaloids 
reduced both the rate and amplitude of the heart (Fig#108, 
p.330)# Atropine 1)0 pg# did not modify this effect 
and /
: ;ola ed guir -r oi:• ileiri.
(a) All contractions produced by 0*50 * per ral.
nc ?tylcholine acting for 5 seconds* Addition 
of acetylcholine was preceded one minute earlier 
by
At A# greenheart alkaloids 50 *tg* p e r  ral.
/ l 25 ug* per ml.
^  i:* n u 12.5 t*g. per ml.
(b) All contractions produced by .1 ) *i . , r 3i#
hlata mine acting for 30 seconds. Addition of
histamine was preceded one minute earlier by
At A0 greenheart alkaloids 50 gig* per ml*
A ^ B# n ?J 25 p.g# per ral*
4 4 f I 4 4 4 4 4 4
G  W A A G A A ad ad G
jJi .ire 106 . Isolated rabbit duodenum•
(a) At Gr# greenheart alkaloids 50 p.g* per ml*
At W 9 wash out*
(h) At A, acetylcholine 0*02 pg* per ral*
At U, greenheart alkaloids 20 ug* per ml.
(c) At ad, adrenaline 0*04 dg* per ml«
■ t G# greenheart alkaloids 20 pg. per ;il.
At wash out.
4 4
W ad
t
G ad
iz'v 107• Isolated rabbit hindquarters*
upstroke indicates constriction of the blood 
vessels•
At v, greenheart alkaloids 20 p,g#
At mi, adrenaline 0.05
380.
IO 8 IO 8 8
124 130 120 126 120 120 114 118
j? igure 108# Isolated rabbit heart «
Figures above the recording refer tos
(a) Jpper row, outflow in ml• per minute
(b) Lower row, number of beets per linute
At greenheart alkaloids 50
At g2> greenheart alkaloids H o
* * ^1# atropine 
At atropine
10 Jig,
100 p,g
and the amplitude did not recover to its original level* 
There was no appreciable change in the output of the 
heart following administration of the alkaloids*
(9) Blood Pressure of the Anaesthetised Cat*
Vdien given in the dose range of 0*20 to 1*0 mg# per 
kg* greehheart total alkaloids usually caused a marked fall 
in the blood pressure level of the anaesthetised cat 
(Fig* 109*a, p*3 32)* In a few cats a rise in the blood 
pressure was seen Uig.l09,b)• There was neither 
antagonism nor potentiation of the characteristic effects 
on the cat’s blood pressure of acetylcholine (0*50 to 
1*0 p,g* per kg *), histamine (0*50 to 1*0 |ig* per kg.), 
adren line (0*50 to 2*0 *ig. er kg*), or nor-adrenaline 
(0*50 to 2*0 jig* per kg*).
The effect on the blood pressure of the anaesthetised 
cat was not blocked by atropine (1*0 to 5*0 mg* per kg*) 
or aepyramine (1*0 to 5*0 mg* per kg*)*
In the spinal ©ate greehheart total alkaloids 
(0*50 to 2*0 mg* per kg*) had little or no effect upon the 
blood pressure level*
(10) Toxicity (in mice)*
Very little effect was observed when mice were 
injected /
♦
ad
fri ;ure 10J* Cat. Chior lo e anaesthesia* Blood 
pressure record fro i the co non carotid artery• 
Brays administered intravenously•
(a) At A, acetylcholine 0*50 tig* ier kg.
At Gt greenheart alkaloids 0*40 mg* per kg#
At Bt histamine 0*50 jig* pex k *
(b) At G-, greenheart alkaloids 0*80 mg# per kg*
At ad, adrenaline 0*80 $t&* per kg*
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injected intraperitoneally with l*Og* per kg* of greenheart 
total alkaloids* 2*0g * per kg*, however, killed the
mice within 15 minutes* Before death there was excitement 
and convulsions which were perhaps due to respiratory 
failure *
Summary and Conclusions*
The pharmacological properties of the total alkaloid 
fraction of greenheart bark have been Investigated on 
isolated tissues nd in intact animals• Although they 
inhibit acetylcholine-induced contractions of the frog 
rectus, they otherwise show very little evidence of 
neuromuscular blocking activity on other isolated tissue 
preparations* In bigger doses (4 to 8 mg* per kg*) 
the greenheart alkaloids appear to have some depressant 
effects on the neuromuscular transmission in the cat 
gastrocnemius sciatic preparation* The alkaloids 
caused head drop in the rabbit only when given in lethal 
doses*
The total alkaloids of greenheart have some 
depressant activity on isolated cardiac smooth muscle and 
antagonise drug induced stimulation of intestinal smooth 
muscle* On the other hand the alkaloids themselves have 
some /
3 3 4 *
some stimulant activity when tested on an isolated vascular 
bed or on the isolated intestine*
Following the intravenous administration of the 
greenheart total alkaloids there was usually a fall in the 
blood pressure level of the anaesthetised cat*
Unfortunately the quatemlzed total alkaloids of 
greenheart were not available for testing at the time of 
writing this thesis nor were any of the purified single 
alkaloids, but it is hoped that it will be possible to 
complete this investigation in the future*
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Studies on the ode of Action of Pharranco logically 
Active Substances from haturr.1 Sources with
Additional Studies on £o;ae Synthetic 
heurosaagcular P lochia. ■: Agents#
ghe thesis is divided into parts as followss
.Fart I* Studies on the tone of Action of
iieaolnneroine*
Part 1IA» Studios on Some Synthetic rib­
and Setraqua t emary houro >uscular 
BloclcfSg £f; ;ents«
1 X.I -» fhe Pharmacolo&y of Some : roxy«•
bensyl^soqt* incline Derivatives •
Pert I# Studies on the Mode of Action of I^scinaeaiAns* In 
the noraotensive anaesthetised catf rescinna sine caused little 
or no fall in the level of the blood pressure* It depressed 
or abolished pressor responses elicited by various laboratory 
techniques« Hypertension In anaesthetised or spinal eats
A'ppsndiat III* Some Aspects of the Influence of 
pH on Drug Action*
XV» 3?he rliar-i.acology of the Cotal 
Alkaloid© of Greenheart 
(ftectandra iodioei)*
due to the continuous infusion of adrenaline or noradrenaline 
was reduced by an injection of rescinnamine, but the nreseor 
effects of single injections of adrenaline or norndrenoline 
were either unaltered or only ©lightly depressed*
Although its action is delayed in onset, re sc inn a mine 
ha© been shown to possess soae ganglion blocking activity*
Koocimr .mine depressed the acti vity of preparations of 
isolated cardiac muscle« In isolated vascular and intestinal 
smooth muscle re-scinrmmine reduced the magnitude of drug- 
induced contraction and had a direct relaxant effect on the 
former* In the isolated frog rectus usele, although 
rescinnamine had some direct stimulant effect, acetylcholine 
induced contractions were inhibited# It is concluded that 
while the drug ha® a definite action upon the central nervous 
system, which probably contributes largely to its anti- 
hypertensi/e effect in man, peripherally induced relaxation of 
the vascular .smooth made may also play a part#
Part lift.# Studies on Some synthetic Trie- and ,efcraqua ternary 
ITeuryfiua^Yar '  r "....
the pharmacological properties of a new series of trie- 
and tetr aqua ternary ethoniura compounds have been investi ated 
and found to possess neuromuscular blocking activity. Some < f 
them have a potency equal to, or greater than that of 
tubocurarin© /
3.
tubocurarin© in the cat. Co npounda in whir*- the q atornrry 
centres are separated by fire, eix or eight me >bered poly- 
methylene chains had tubocurarin©-like properties while others 
having ten membered polymethylene chains in between the 
quaternary centres showed typical decr icthoniu:i-like activity* 
vids species variations in the potency of these compounds were 
noted#
It has been shown that an increase in chain length in 
the trie- and tetraouateraary compounds decreases the potency 
and alters the type of activity from being tubocur&rine-libe 
to being decaoiethoniu a-Iike *
Th* methyl analogue of dihexasulphonium, show© less 
activity than the ethonium analogue, although the type of 
activity (tubocurririne-lik©) remains unaltered.
Part lib# The_Pharmapo^ o/.qr of pome lydroxyoengyl^lcoquinoline ^rlvhtlWsV , 'T rmi"mr~,ni
the pharmacological properties of some hydroxybenryliso- 
quinoline derivatives were investigated and found to possess 
little or no neuromuscular blocking activity. Qu&ternication
of the ro.eemic compounds increased the neuromuscular blocking 
activity on pi'eparations of the rat diaphragm and frog rectus 
Snell* The tertiary bases sex's found to possess potent convul< 
sant properties•
Appendix III# /
4 »
Appendix III* So .<e Asr>eotg of the Influence -af p: on^
Ttrwi Kxlon >
Alteration of the reaction of the bath fluid from nor ml 
(pH 7*7 to 8*0) to ;•>'■ 4*>, or to pr 9.6, ?*as likt.lt or no 
direct effect upon the smooth muscle of the isolated guinea pip 
Ileum* A further increase in alkalinity to pH 11*0 induces 
a large contraction, the magnitude of which, beco■ c lerr if the 
pH is subsequently increased to 12.2. These chan es in the 
activity of the tissue are reversible on washing with normal 
fyrod e *s &olut1on.
f
At higher levels of pH (increased alkalinity) the 
sensitivity of the ileum to acetylcholine and h let .-mine is 
increased, whereas at lower levels of pH (increased acidity) 
the sensitivity of the tissue to acetylcholine is increased but 
the sensitivity to histamine is reduced.
Appendix IV» Ihe Phar .aacolo. ;y of the Total Alkaloids of 
•irc^ n-X.’-.rt g : 3 1 7 'b ..ot;io(7i7~
Ihe greenheart alkaloids inhibit acetylcholinci-induced 
contractions of the frog rectus, but they show very little 
evidence of neuromuscular blocking activity on other isolated 
tissue preparations* In bigger doses (4 to i ;• perk;*) 
the greenheart alkaloids appear to have so ie depressant effects 
upon neuromuscular transmission in the cat gastrocnemius 
muael©-sciatic nerve preparation. ihe all aloic a erased -sad 
drop /
drop in the rabbit only when Ivon in lethal doaes.
ftift total alkaloids of greenheart have same depressant 
activity on isolated cardiac uuacle end antagonize drug-* 
induced at! .ulation of intestinal smooth muscle. They 
usually caused a fall in blood pressure level of the 
anaesthetised cat.
